Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,retinoid binding (GO:0005501),0.8503300716407401,2.2074744159005633,0.0,0.0,0.0,6/22,4.62%,CYP26B1;ALDH1A2;NR2F2;RBP4;ABCA4;RBP1
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.8958273113383128,2.123403163749386,0.0,0.0004894099727003095,0.001,4/13,2.81%,ALDH1A1;ALDH1A2;ALDH4A1;ALDH7A1
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.8802529678526492,2.121648770865079,0.0,0.0003262733151335397,0.001,4/15,2.81%,ALDH1A1;ALDH1A2;ALDH4A1;ALDH7A1
prerank,cadherin binding (GO:0045296),-0.45639817109527414,-2.0828345662771537,0.0,0.0020496570282488007,0.002,134/315,21.01%,DOCK9;FMNL2;SPTBN1;PTPRB;STXBP6;BSG;COBLL1;PTPRJ;MRTFB;PTPRM;TJP2;ITGA6;FXYD5;PROM1;LRRFIP1;ESYT2;STK38;HSPA8;KDR;FNBP1L;CDH11;CTNND2;IQGAP1;PKP4;CDH1;TES;CBL;HSP90AB1;HNRNPK;ITGB1;CDH2;EHD4;RPL6;AHNAK;F11R;PLEC;EEF2;SLK;NOTCH3;DAB2IP;CLINT1;RACK1;PKM;TAGLN2;SH3GLB1;BMPR2;RPL34;PACSIN2;CHMP5;SHTN1;RPL24;FLNA;EPS8L2;RPL23A;PPME1;CHMP2B;NCK1;TRIM25;EEF1D;EHD1;CTNNB1;CEMIP2;MPP7;SLC3A2;YWHAB;ATXN2L;RPL14;PCMT1;BAIAP2L1;MYH9;RPS2;TJP1;CTNNA3;TRPC4;LASP1;PAICS;RPL29;PLCB3;SEPTIN9;RTN4;PAK2;APC;RANBP1;HSPA5;LYPLA2;PPP1CA;RPL7A;CD2AP;PTPN1;TXNDC9;RSL1D1;PSMB6;RAB1A;DBNL;RANGAP1;MARK2;TBC1D10A;CDH13;EPN2;EEF1G;EIF4H;TMPO;JUP;ALDOA;PFKP;RPS26;TNKS1BP1;FASN;LDHA;DHX29;DIAPH3;RUVBL1;ARGLU1;DNAJB1;SERBP1;ACVR1;EIF2A;USP8;SCYL1;SNX1;PCBP1;S100A11;CKAP5;PSEN1;CIP2A;CTNNA1;ANK3;SNX2;DBN1;SH3GL1;ARFIP2;MAPRE1;ABI1;ADD1
prerank,retinoic acid binding (GO:0001972),0.8732452049449451,2.0111534109589835,0.0,0.012479954303857892,0.044,2/12,1.14%,CYP26B1;NR2F2
prerank,MHC class II protein complex binding (GO:0023026),-0.7896517387826874,-1.8795771495284708,0.0,0.08557318092938743,0.141,7/11,13.69%,HSPA8;HSP90AA1;HSP90AB1;ATP1B1;PKM;CD74;CD81
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.8201789905956538,1.8346547661786403,0.004166666666666667,0.17540453421579094,0.529,3/10,3.73%,SLC6A13;SLC6A12;SLC6A1
prerank,organic cation transmembrane transporter activity (GO:0015101),0.7484401025042717,1.8228880368067009,0.0,0.1703146704997077,0.582,2/16,0.70%,SLC22A4;SLC22A2
prerank,amino acid:sodium symporter activity (GO:0005283),0.7818663807029936,1.7774608749437235,0.004032258064516129,0.25253554591335964,0.785,4/11,3.73%,SLC6A13;SLC6A12;SLC1A3;SLC6A1
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.7194262380596369,-1.7683594423592313,0.0,0.2903680790019134,0.536,4/12,13.44%,ENTPD1;ENTPD7;ENTPD2;SLC25A42
prerank,monocarboxylic acid binding (GO:0033293),0.685673052079202,1.7610984126755818,0.008097165991902834,0.2683190175329447,0.843,3/18,6.18%,CYP26B1;NR2F2;NAPEPLD
prerank,anion channel activity (GO:0005253),-0.48900900904900774,-1.7487860871615808,0.007317073170731708,0.279009562970368,0.621,18/61,16.89%,SLC26A7;LRRC8C;ANO1;ANO4;LRRC8D;CLIC4;LRRC8B;GABRB3;CLCN5;GABRB1;TTYH3;ANO3;LRRC8A;GABRG3;SLC1A4;ANO2;CFTR;GLRA3
prerank,phospholipid transfer activity (GO:0120014),-0.6106922593440773,-1.7417568160011898,0.0020161290322580645,0.24513898057855657,0.652,11/21,18.85%,PITPNC1;CERT1;PLTP;PITPNM2;TNFAIP8L3;GLTP;ABCA3;PRELID3B;MTTP;PITPNA;PITPNB
prerank,chloride transmembrane transporter activity (GO:0015108),-0.6409610021108271,-1.7395099791209507,0.01532567049808429,0.20872340737666953,0.66,6/16,15.43%,SLC26A7;SLC26A2;SLC1A1;SLC4A8;SLC26A6;CFTR
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.7213265487294341,1.7366451777454521,0.007984031936127744,0.27857215646101613,0.911,4/17,3.71%,EPHA7;EPHA3;EPHA8;EPHA4
prerank,ephrin receptor activity (GO:0005003),0.7213265487294341,1.7366451777454521,0.007984031936127744,0.27857215646101613,0.911,4/17,3.71%,EPHA7;EPHA3;EPHA8;EPHA4
prerank,LRR domain binding (GO:0030275),0.7472816346969517,1.727932485624498,0.008146639511201629,0.27745096270537545,0.93,2/14,0.82%,ROBO1;PAWR
prerank,translation elongation factor activity (GO:0003746),-0.6800848922627839,-1.7267323701678707,0.0019646365422396855,0.2064297435593435,0.71,11/14,28.80%,EEF1A1;EEF2;GFM1;EEFSEC;EEF1B2;EIF5A;EIF5AL1;GTPBP2;TUFM;EEF1A2;GTPBP1
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),-0.5426394678349435,-1.712514864765542,0.0,0.1889100561035978,0.763,15/34,18.10%,NDUFC2;NDUFA7;NDUFA5;NDUFA6;NDUFB5;NDUFA12;NDUFV1;NDUFA4;NDUFB7;NDUFA13;NDUFS1;NDUFB10;NDUFA1;NDUFB4;NDUFS7
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),-0.5426394678349435,-1.712514864765542,0.0,0.1889100561035978,0.763,15/34,18.10%,NDUFC2;NDUFA7;NDUFA5;NDUFA6;NDUFB5;NDUFA12;NDUFV1;NDUFA4;NDUFB7;NDUFA13;NDUFS1;NDUFB10;NDUFA1;NDUFB4;NDUFS7
prerank,amyloid-beta binding (GO:0001540),-0.4520005639473842,-1.7097700941410374,0.0026595744680851063,0.17473326165821026,0.768,41/79,31.55%,APBB2;COL25A1;TGFB2;ITM2B;CST3;FZD4;FZD6;ITM2A;APBB1;CRYAB;GRIN1;ATP1A3;APBB3;CD74;CLU;ADRB2;APBA3;IAPP;C1QA;CACNA1B;GRIA2;PFDN6;ITM2C;PFDN5;INSR;MAPK8IP2;FCGR2B;AGER;PFDN4;SORL1;APBA2;TREM2;ITGB2;CLSTN1;APBA1;TLR4;GRIA1;CD36;TLR6;BCHE;GRIN2B
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.649295588259578,-1.6995103197557888,0.004140786749482402,0.16337474562666482,0.805,5/16,6.03%,PTPRB;PTPRG;PTPRM;PTPRN2;PTPRC
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.649295588259578,-1.6995103197557888,0.004140786749482402,0.16337474562666482,0.805,5/16,6.03%,PTPRB;PTPRG;PTPRM;PTPRN2;PTPRC
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.651964489941713,-1.6887162015446522,0.011811023622047244,0.16980620149415065,0.841,6/15,15.43%,SLC26A7;SLC26A2;SLC39A8;SLC4A8;SLC26A6;CFTR
prerank,CoA-ligase activity (GO:0016405),0.7039582669589813,1.6871281748249696,0.02053388090349076,0.3760299956914045,0.981,2/14,1.86%,ACSS3;ACSL1
prerank,rRNA binding (GO:0019843),-0.5031511543416954,-1.6781988005917137,0.004338394793926247,0.17678291868645907,0.873,21/42,27.58%,RPL11;CAVIN1;RPL23;RPS9;RPS3;RPS14;RPL5;RCC1L;RPLP0;ERAL1;RPS5;RPL12;NOP53;ANG;PPAN;MRPS11;MRPS27;MRPL11;MRPS18C;MRPL18;DDX28
prerank,acetyltransferase activity (GO:0016407),0.58827144994865,1.6776176910257665,0.017110266159695818,0.3790292003959012,0.988,13/31,16.53%,PAFAH2;NAA80;PAFAH1B3;SPHK1;DBT;KAT8;KAT6B;SMARCE1;SAT2;ESCO1;CREBBP;NAT8;NAT14
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.7364479168230235,1.6738757180125987,0.025423728813559324,0.3646104296617305,0.989,1/11,0.28%,SLC22A4
prerank,fatty acid synthase activity (GO:0004312),-0.7228032903982367,-1.671216659049103,0.0149812734082397,0.17633882633033848,0.896,4/10,13.03%,ELOVL7;ELOVL5;ELOVL6;ELOVL1
prerank,intracellular chloride channel activity (GO:0061778),-0.6402481062030847,-1.6650560037570667,0.012145748987854251,0.16541937898572676,0.909,7/16,20.32%,ANO1;ANO4;TTYH3;TTYH2;ANO3;ANO2;ANO8
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.6402481062030847,-1.6650560037570667,0.012145748987854251,0.16541937898572676,0.909,7/16,20.32%,ANO1;ANO4;TTYH3;TTYH2;ANO3;ANO2;ANO8
prerank,semaphorin receptor binding (GO:0030215),-0.5683974931639542,-1.6553417628276403,0.004246284501061571,0.17274053954741284,0.926,10/23,11.39%,SEMA6A;SEMA7A;SEMA6D;SEMA3C;SEMA4D;SEMA3E;SEMA4B;SEMA5B;SEMA6C;SEMA3G
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),-0.4678435453844236,-1.6454240614545736,0.0,0.18085526357153234,0.944,23/57,18.29%,COX4I1;NDUFC2;NDUFA7;NDUFA5;NDUFA6;NDUFB5;NDUFA12;NDUFV1;NDUFA4;NDUFB7;UQCRH;COX6A1;NDUFA13;NDUFS1;UQCR11;COX8A;NDUFB10;COX5A;NDUFA1;UQCRQ;NDUFB4;NDUFS7;UQCRC1
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.6584591301775345,1.6325736526788655,0.025193798449612403,0.48373281701698584,0.997,2/18,0.23%,ALDH1A1;ALDH1A2
prerank,metallopeptidase activity (GO:0008237),0.45786307867168774,1.6306175373038778,0.001579778830963665,0.46120772302345414,0.997,16/113,8.06%,ADAMTS12;ADAMTS9;PAPPA;ADAM12;TRABD2B;ADAMTS5;THSD4;ADAMTS10;ADAMTS15;MMP2;ACE;ADAMTS7;MMP19;NRDC;MMP9;ADAMTSL4
prerank,poly(U) RNA binding (GO:0008266),0.6411779988557528,1.6303685541059236,0.019120458891013385,0.43494152162095734,0.998,7/20,5.90%,ATXN1;RBMS1;RBMS3;HNRNPC;PABPC4L;HNRNPH1;RBMS2
prerank,phosphatidylcholine transporter activity (GO:0008525),-0.6067744220929313,-1.62468210621987,0.022044088176352707,0.20957743113843988,0.97,5/17,1.76%,ATP10A;PITPNC1;ATP8B1;PLTP;PITPNM2
prerank,sodium:proton antiporter activity (GO:0015385),-0.6843746489244354,-1.621739964274728,0.016981132075471698,0.20603933269681993,0.971,3/11,5.56%,SLC9A2;SLC9B2;SLC9A8
prerank,calcium:sodium antiporter activity (GO:0005432),0.7339616867664944,1.6107313445915616,0.036637931034482756,0.48364581079961694,0.999,3/10,3.07%,SLC24A3;SLC8A3;SLC8A1
prerank,sialyltransferase activity (GO:0008373),-0.5813278488182589,-1.6048184795293092,0.014705882352941176,0.2292820884781954,0.984,8/20,9.43%,ST3GAL4;ST6GALNAC3;ST6GAL1;ST3GAL6;ST8SIA4;ST6GALNAC5;ST8SIA1;ST8SIA6
prerank,metalloendopeptidase activity (GO:0004222),0.4755674205533318,1.59735115341416,0.01174496644295302,0.5081621021806161,1.0,13/76,8.06%,ADAMTS12;ADAMTS9;TRABD2B;ADAMTS5;THSD4;ADAMTS10;ADAMTS15;MMP2;ADAMTS7;MMP19;NRDC;MMP9;ADAMTSL4
prerank,protein tyrosine kinase activator activity (GO:0030296),-0.5641646370385323,-1.5819879074737027,0.026156941649899398,0.27082207429774374,0.994,10/19,30.72%,EFNA5;GAS6;PAK2;NRG3;GREM1;ABI1;AFAP1L2;DGKQ;ANGPT4;EGF
prerank,acid-thiol ligase activity (GO:0016878),0.6680419707209873,1.5805422984421118,0.041407867494824016,0.5479434054352664,1.0,3/13,8.71%,ACSS3;ACSL1;AASDH
prerank,outward rectifier potassium channel activity (GO:0015271),0.7000777037981757,1.579982782241239,0.04201680672268908,0.5238551126836931,1.0,4/11,4.07%,KCNK2;KCNA5;KCNT2;KCND3
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.7029255247355449,1.564182610362908,0.045454545454545456,0.5626435013425558,1.0,1/10,0.08%,PRKAG2
prerank,translation initiation factor activity (GO:0003743),-0.49165439761289875,-1.5580593115330923,0.013513513513513514,0.31919138096166216,0.997,19/36,24.23%,EIF3F;EIF1B;EIF4G3;EIF3I;EIF4G1;EIF3D;EIF3B;EIF2B5;EIF3C;EIF1;EIF2B2;EIF2A;EIF5B;EIF2D;EIF3A;EIF3G;EIF4E;EIF5;EIF3K
prerank,acylglycerol lipase activity (GO:0047372),-0.6582141471611666,-1.5537627212233127,0.03551401869158879,0.3176968393785641,0.999,3/11,9.35%,ABHD2;MGLL;LIPE
prerank,diacylglycerol kinase activity (GO:0004143),-0.6574220339647135,-1.5480761389220896,0.033962264150943396,0.32002241177600027,0.999,7/11,24.15%,DGKH;DGKB;DGKI;DGKZ;DGKG;DGKE;DGKQ
prerank,phospholipase activator activity (GO:0016004),0.7092432046979498,1.54555936428071,0.04742268041237113,0.6104431868185425,1.0,2/10,1.89%,ARHGAP6;PDPK1
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.6465080761483721,1.5427472836422425,0.047325102880658436,0.5959789942558019,1.0,5/14,11.64%,SLC7A11;SLC1A3;SLC25A18;SLC25A22;SLC38A7
prerank,poly-pyrimidine tract binding (GO:0008187),0.5853084054313843,1.5427449306398195,0.043233082706766915,0.5721398344855698,1.0,7/23,5.90%,ATXN1;RBMS1;RBMS3;HNRNPC;PABPC4L;HNRNPH1;RBMS2
prerank,insulin-like growth factor receptor binding (GO:0005159),0.6601861377992804,1.5417555887938474,0.07172131147540983,0.5539744421757734,1.0,3/12,3.44%,IGF1;GNAS;IGF2
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.48791527452350103,1.5403762024024852,0.018333333333333333,0.538495980332622,1.0,14/55,12.29%,SLC22A4;SLC6A13;SLC13A3;SLC16A12;SLC38A3;SLC6A12;PDPN;SLC38A9;SLC16A6;SLC19A2;SLC19A1;SLC36A2;SLC38A7;SLC38A2
prerank,amino acid transmembrane transporter activity (GO:0015171),0.5003578349576268,1.5378191495360034,0.026845637583892617,0.5279684869780553,1.0,9/47,6.03%,SLC7A11;SLC22A4;SLC6A13;SLC22A2;SLC38A3;PDPN;SLC6A1;SLC38A9;SLC43A1
prerank,AMP binding (GO:0016208),0.6899634388230338,1.537786863291506,0.04946236559139785,0.5097964294941706,1.0,3/11,6.95%,PRKAG2;PRKAG3;MPPED2
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.48027901505056975,1.5334408306195975,0.023255813953488372,0.5073550050326542,1.0,18/60,11.42%,EPHA7;EFEMP1;EPHA3;FGFR2;FGFR4;KIT;PDGFRB;EPHA8;EPHA4;PDGFRA;DDR1;IGF1R;DDR2;RYK;MUSK;AXL;EPHA2;ERBB2
prerank,cation:chloride symporter activity (GO:0015377),-0.6612851542620308,-1.5318507399947332,0.03898635477582846,0.35326218447984425,1.0,5/10,10.53%,SLC12A7;SLC12A2;SLC12A6;SLC12A8;SLC12A4
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.6263780433588099,-1.526501584576216,0.03468208092485549,0.35440766079523456,1.0,3/12,5.56%,SLC9A2;SLC9B2;SLC9A8
prerank,C-C chemokine receptor activity (GO:0016493),0.5849771015364351,1.5253923873994717,0.05182341650671785,0.518616696877586,1.0,4/21,4.02%,ACKR2;CCR9;CXCR5;CXCR6
prerank,GTPase activity (GO:0003924),-0.35235279078410014,-1.5199023236057716,0.0,0.36102234828603014,1.0,74/192,26.13%,DNM3;EEF1A1;RAP1A;RHOJ;KRAS;RAC1;RASL12;EEF2;RAB31;RAB3C;GNAL;ARHGDIB;RAB27A;GCH1;RERG;NRAS;RHOB;GBP4;GNAI1;RHOT1;GNA14;GNA12;ENTPD7;MRAS;GFM1;DNM2;RAB28;NKIRAS1;SEPTIN9;RHOA;RAB38;GPN3;BMS1;GNA11;RALB;RAB3B;ARL8A;GBP5;RHEB;RAB1A;DNM1;GSPT2;AGAP3;GBP3;RABL3;ATL2;TPPP;RHOG;RRAS;GNAZ;RRAGB;RAB1B;GNA13;RIT2;MTG1;RAB8A;RAP1GAP;MFN2;TSR1;RAB8B;GNAO1;GNG3;RAB7A;RAB3A;GEM;DRG2;RAB2A;RAB14;HRAS;RAB5B;RAB6B;RND1;GNB2;GNB1
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.5694701584536731,-1.5198003989481885,0.047151277013752456,0.3493640404650081,1.0,11/16,32.33%,RPS3;CD38;ADPRH;SMUG1;NEIL1;NEIL3;NTHL1;SARM1;MACROD2;NEIL2;BST1
prerank,phospholipase binding (GO:0043274),0.6762683943515191,1.516279755650483,0.05327868852459016,0.5329062840240495,1.0,3/13,1.89%,ARHGAP6;PRKN;PDPK1
prerank,chloride channel activity (GO:0005254),-0.4234238351810487,-1.5142016232752162,0.01951219512195122,0.35366501432589786,1.0,21/59,25.74%,SLC26A7;ANO1;ANO4;CLIC4;GABRB3;CLCN5;GABRB1;TTYH3;TTYH2;ANO3;GABRG3;SLC1A4;ANO2;CFTR;GLRA3;GABRA5;GABRE;BEST1;CLCN3;GABRG2;GLRA1
prerank,GDP-dissociation inhibitor activity (GO:0005092),-0.6113586252023833,-1.5033675479591786,0.041584158415841586,0.3728774496859498,1.0,7/13,16.92%,SH3BP4;ARHGDIB;ARHGDIA;CCDC88A;RANBP1;GDI2;GDI1
prerank,nucleoside monophosphate kinase activity (GO:0050145),-0.5457691667663669,-1.5010833554509424,0.033126293995859216,0.3681618798468111,1.0,9/20,17.93%,TJP2;DLG2;MAGI3;CMPK1;GUK1;AK2;CASK;LRGUK;AK6
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),-0.5783015867601169,-1.4987958449729553,0.05219206680584551,0.3641155426653752,1.0,8/15,23.86%,PIK3R6;SOCS2;SOCS5;PIK3R5;CISH;CCKBR;PIK3R3;SOCS1
prerank,NAD binding (GO:0051287),0.5497083721383947,1.4977382324268913,0.05660377358490566,0.5813300639365676,1.0,9/26,16.29%,ALDH1A1;CRYL1;SORD;NUDT6;PARP9;CRYZ;BDH2;ALDH2;SIRT3
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.6244837585310892,1.4961728177793465,0.06512605042016807,0.569558052935466,1.0,7/16,11.64%,SLC13A3;SLC25A18;SLC13A5;SLC1A5;SLC25A11;SLC25A22;SLC38A7
prerank,cytokine receptor activity (GO:0004896),0.43873716517709754,1.495927859239474,0.03622047244094488,0.5541798868016762,1.0,7/83,4.03%,IL31RA;LEPR;ACKR2;CCR9;CNTFR;IL13RA1;GFRAL
prerank,MAP kinase activity (GO:0004707),0.6333152088205614,1.4958413353639284,0.0735930735930736,0.5390307060435353,1.0,2/14,4.54%,MAPK4;MAPK9
prerank,frizzled binding (GO:0005109),0.5228661660476686,1.4912582599510407,0.05029013539651837,0.5388536072396002,1.0,8/34,10.14%,WNT4;RNF43;WNT6;NDP;ZNRF3;WNT5B;RYK;DVL3
prerank,lipase activator activity (GO:0060229),0.674359086165129,1.4903664833141985,0.07920792079207921,0.5276869842493969,1.0,2/10,1.89%,ARHGAP6;PDPK1
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.6182969381591882,1.4894999015272468,0.05893909626719057,0.5169926168027525,1.0,6/15,19.77%,KMT2A;ASH2L;SETD1A;KMT2B;WDR82;SETD4
prerank,C-C chemokine binding (GO:0019957),0.5648893438437467,1.488230333749573,0.053742802303262956,0.5081054336574613,1.0,4/22,4.02%,ACKR2;CCR9;CXCR5;CXCR6
prerank,receptor antagonist activity (GO:0048019),0.597400193056043,1.478838519247982,0.06692913385826772,0.5260082891954106,1.0,3/17,2.62%,DKK3;PXDN;DKK1
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.3844311682850745,1.477166176878279,0.002789400278940028,0.5186580448783518,1.0,73/232,19.46%,ASB2;PDZRN3;RNF220;TRIM63;RNF43;PRKN;PELI2;TRIM5;MGRN1;NEDD4;KCMF1;NEURL2;RNF138;RNF2;UFL1;RNF217;ZNRF3;LTN1;FBXO44;SH3RF1;RNF181;UBR2;RNF152;RNF145;TRIM56;RNF135;SIAH2;WWP2;AMFR;PIAS1;RNF216;RNF180;RC3H2;NHLRC1;FBXO6;MDM2;ITCH;RNF149;SMURF2;TRIM35;DTX1;SH3RF2;RBBP6;MYCBP2;RNF14;GID4;TRIM26;TRIM43;RCHY1;TRIM24;RNFT2;BIRC2;TRIM62;UBR1;PPIL2;RNF122;CBX4;HECTD1;TRIM17;CBLB;TRIM69;TRIM39;NHLRC3;PELI3;DTX3L;TRIM9;TRAF6;MKRN2;SHPRH;RNF130;PIAS3;HACE1;XIAP
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.6288924421083448,1.4770391960468554,0.08008213552361396,0.507074258226609,1.0,2/13,1.28%,BMP6;BMP7
prerank,sulfotransferase activity (GO:0008146),0.5128158450652012,1.4753267244248496,0.06741573033707865,0.5010890743215668,1.0,9/33,11.73%,HS3ST3A1;UST;TPST1;GAL3ST3;GAL3ST2;CHST3;CHST15;SULT4A1;HS6ST1
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.4672831960176892,-1.473562322520065,0.035864978902953586,0.42723636713111784,1.0,10/31,13.72%,SLC12A7;SLC12A2;KCNK5;ABCC9;SLC12A6;SLC12A8;SLC12A4;KCNA1;HCN1;TMEM38B
prerank,enoyl-CoA hydratase activity (GO:0004300),0.661383740276805,1.4669338987992384,0.08979591836734693,0.5139674775526939,1.0,4/10,11.74%,EHHADH;ECHDC3;ECHDC1;AUH
prerank,copper ion binding (GO:0005507),0.49112254983927606,1.4660360929193366,0.042435424354243544,0.5055605017994197,1.0,10/42,11.56%,MOXD1;HEPH;SOD3;LOXL3;LACC1;COX17;CCS;DCT;ATP7B;PAM
prerank,ubiquitin protein ligase activity (GO:0061630),0.3813819759599839,1.4597542874615441,0.00423728813559322,0.5129641292587797,1.0,65/228,17.80%,ASB2;PDZRN3;RNF220;TRIM63;RNF43;PRKN;PELI2;TRIM5;MGRN1;NEDD4;KCMF1;NEURL2;RNF138;RNF2;RNF217;ZNRF3;LTN1;FBXO44;SH3RF1;RNF181;UBR2;RNF152;RNF145;TRIM56;RNF135;SIAH2;WWP2;AMFR;RNF216;RNF180;RC3H2;UBE4A;NHLRC1;FBXO6;MDM2;ITCH;RNF149;SMURF2;TRIM35;DTX1;SH3RF2;RBBP6;MYCBP2;RNF14;GID4;TRIM26;TRIM43;RCHY1;TRIM24;RNFT2;BIRC2;TRIM62;UBR1;PPIL2;RNF122;HECTD1;TRIM17;CBLB;TRIM69;TRIM39;NHLRC3;PELI3;DTX3L;TRIM9;UBE4B
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.6094350605895086,1.4589982617769488,0.09343936381709742,0.5045408976896274,1.0,3/14,5.55%,ALDH4A1;AASS;MTHFR
prerank,pyridoxal phosphate binding (GO:0030170),0.5720001045431624,1.4583186746487802,0.09,0.4961818086491015,1.0,6/20,13.02%,ABAT;CBS;ACCS;SRR;THNSL2;SHMT1
prerank,store-operated calcium channel activity (GO:0015279),-0.6302668165348952,-1.4569504522466867,0.07212475633528265,0.46666705089003596,1.0,6/10,17.03%,TRPC3;TRPC6;TRPC4;STIM2;TRPC1;ORAI1
prerank,nucleoside-triphosphatase activity (GO:0017111),-0.32551568531726577,-1.4549244504804841,0.0,0.4601480028418558,1.0,95/248,26.13%,DNM3;EEF1A1;RAP1A;RHOJ;KRAS;RAC1;HSP90AA1;MYL6;RASL12;EEF2;RAB31;RAB3C;GNAL;ARHGDIB;RAB27A;GCH1;RERG;NRAS;RHOB;GBP4;GNAI1;RHOT1;GNA14;SMCHD1;GNA12;ENTPD7;KIF26A;MRAS;MYH9;GFM1;DNM2;ABCB10;RAB28;NKIRAS1;SEPTIN9;RHOA;TOR1B;RAB38;GPN3;TOR3A;BMS1;GNA11;KIF1A;RALB;RAB3B;ARL8A;GBP5;RHEB;RAB1A;ATP2B1;DNM1;GSPT2;CLU;AGAP3;GBP3;ABCD2;RABL3;ATL2;CFTR;TPPP;DHX29;RHOG;RUVBL1;ABCA3;RRAS;GNAZ;RRAGB;RAB1B;GNA13;RIT2;MTG1;KIF15;ATAD1;RAB8A;RAP1GAP;VCP;MFN2;TSR1;RAB8B;GNAO1;GNG3;HSPA1B;RAB7A;RAB3A;GEM;DRG2;RAB2A;RAB14;HRAS;RAB5B;RAB6B;RND1;KIF14;GNB2;GNB1
prerank,N-acetyltransferase activity (GO:0008080),0.5690149514669349,1.4542383030467703,0.08383233532934131,0.4977690950340307,1.0,11/19,25.02%,NAA80;AANAT;SMARCE1;SAT2;ESCO1;NAT8;NAT14;KAT2B;NAA50;NAA10;ATAT1
prerank,BMP receptor binding (GO:0070700),0.6288932381706894,1.448492112831849,0.10504201680672269,0.5042458122649109,1.0,2/12,1.28%,BMP6;BMP7
prerank,metal ion:proton antiporter activity (GO:0051139),-0.5804726063263186,-1.4476074201117697,0.05813953488372093,0.47158293152577013,1.0,3/13,5.56%,SLC9A2;SLC9B2;SLC9A8
prerank,ankyrin binding (GO:0030506),-0.521996809256251,-1.4427238935615756,0.06932773109243698,0.47575692944159664,1.0,7/19,14.99%,SPTBN1;CDH1;PLEC;NRCAM;PTPRC;SPTBN4;KCNQ2
prerank,disordered domain specific binding (GO:0097718),-0.5037198997083052,-1.4408617189838515,0.053169734151329244,0.4700119772903031,1.0,7/23,10.74%,FN1;HSP90AA1;CALM1;HSP90AB1;FYN;GAPDH;KCNA1
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),-0.5324444393412355,-1.4406168269389517,0.06458333333333334,0.4595730990412494,1.0,8/18,23.86%,PIK3R6;SOCS2;SOCS5;PIK3R5;CISH;CCKBR;PIK3R3;SOCS1
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.5106019542590551,-1.4389084919012762,0.06477732793522267,0.453584220215678,1.0,14/22,25.10%,ATP6V0A1;ATP2C1;ATP2A2;ATP2A3;ATP6V1A;ATP6V0C;TCIRG1;ATP6V1E1;ATP6V0A4;ATP6V0A2;ATP5F1B;ATP6V0D2;ATP6V0E2;ATP6V1B2
prerank,sterol binding (GO:0032934),0.456760327696137,1.436625201112236,0.04436860068259386,0.5290521804890346,1.0,6/56,4.04%,RORA;SIDT1;OSBPL8;INSIG2;GRAMD1C;ABCA1
prerank,RNA binding (GO:0003723),-0.28185394308964723,-1.4305919582313573,0.0,0.4677984668659007,1.0,387/1321,22.06%,SPTBN1;MSI2;SORBS2;TMSB4X;SYNE1;EEF1A1;MBNL1;ACTN4;MSN;LRRFIP1;HSPA8;RPL37A;TFRC;FAU;RPL41;NOVA2;RPL11;TPT1;RPL13;RPL27A;HSP90AA1;RPS21;CAVIN1;TES;RPL17;RPL23;HSP90AB1;RPS24;HNRNPK;RPL19;RPL21;RPS9;PPARGC1A;TARDBP;ADARB1;RPL6;RPS15;AHNAK;RPL38;CMSS1;RPL37;PLEC;SUCLG1;EEF2;RPL4;MAP4;RPSA;RPS7;VIM;RPS8;RPS3;RACK1;PPIA;RBFOX1;RPL8;RPS23;SMC1A;RPS19;PKM;RPS11;ADARB2;RPL34;IREB2;PSTK;RPL28;RPL18A;RPL26;CDK11B;QKI;UCHL5;RPL24;LUC7L2;SRSF2;RBFOX3;RPS14;FLNA;ACTN1;RPL18;CKAP4;RPS6;RPL23A;ATP5F1A;RPS12;HSPB1;HNRNPAB;RFTN1;G3BP1;RBFOX2;RBM47;RPS20;PABPC1;PINX1;SRP9;CALR;YBX3;TRIM25;RPS25;RPS18;EIF1B;HSP90B1;RTCB;SRSF1;RPL3;SARS1;SLC3A2;TFB2M;RPL32;LGALS1;ATXN2L;GNL3;RPL36;RPS27A;UBC;COL14A1;RPL14;KCTD12;SRRM3;ARF1;MYH9;TCF20;RPL5;GFM1;PUM2;EIF4G3;DCAF13;RPS2;HNRNPU;HNRNPA3;EIF3I;YBX1;PPIE;MTHFSD;CISD2;JUN;SF3B1;SF3B2;RPL27;MRPL32;RCC1L;LARP7;CPSF7;RPL31;MAK16;RPS27;TIAL1;PATL1;PHF5A;RPL29;SFPQ;KHDC4;RBM14;DDX5;DIDO1;DDX52;CPNE3;GRN;STAU1;LLPH;RALYL;DDX20;PDAP1;CCDC47;PPP1R10;PYM1;SRSF5;ZC3H12C;PPIB;RTN4;IMP3;RPLP0;APEH;RPL35A;DDX39B;EIF4G1;ANKHD1;PDCD11;ZFP36L1;BMS1;ADAR;ZC3H8;STRBP;YWHAG;SSB;EIF3D;MRPS14;NUDT4;MEPCE;RPL7A;RPS28;RPL7;STAT3;CPSF3;TUBB4B;POP5;PTPN1;TUBA1B;RPN1;RSL1D1;KIN;S100A16;HNRNPH2;ALDH18A1;RPS17;SRSF9;YTHDF3;RPS10;CPSF6;LBR;CLNS1A;DGCR8;RPUSD4;CWC15;DDX54;RALY;RPL30;MYO5A;DNM1;RANGAP1;TASOR;ZRANB2;RPS4X;RBM8A;GSPT2;MARK2;YARS1;OAS2;MYBBP1A;HSPD1;DHX37;RRBP1;STRAP;CANX;KHDRBS3;ERAL1;RNPS1;SHFL;SNRPC;SRSF6;BUD23;EIF4H;WDR3;FBL;PRPF40B;ZCCHC9;PPRC1;RPS27L;SRPK1;HNRNPDL;RSL24D1;POP4;EIF3B;ALDOA;GRSF1;MTCL1;SAMSN1;GDI2;RPP21;NUDT1;FUS;SF3B5;TENT5A;RPF1;RPS26;NELFCD;LARP1B;AGFG1;RTRAF;RPS16;ALKBH8;NUFIP2;MRPS5;HNRNPA0;RPS5;RCC2;TBL2;FASN;MRPL23;DHX32;RPL13A;RIDA;EIF3C;IFIH1;RBM42;EIF1;LIN28B;AKAP1;DHX29;SAFB2;AKAP8;GLRX3;POLR2G;RBM28;IMMT;YTHDC2;TOP2A;CPSF2;BTF3;SERBP1;ZC3H7A;SPEN;RPL36A;EIF2A;COA6;RPL12;RPP30;N4BP1;ZC3H12A;CSTF2T;TBL3;UTP18;NELFE;PCBP1;DSP;UTP15;SMG5;EIF5A;PCF11;CSTF2;ZBED4;FASTKD3;DDX17;EIF5B;MTREX;RPL9;EBNA1BP2;NOLC1;BST2;HNRNPUL1;DALRD3;DCN;KRI1;MRPS35;MRPS28;YTHDC1;MRPL13;SUPV3L1;EDC3;R3HDM1;CTNNA1;EXOSC10;PRKRIP1;THUMPD1;MEX3A;PPP1CC;PCBP4;FKBP4;HSPA9;NOP53;HNRNPLL;PTBP1;ANG;AGO3;DDX24;RPL35;NOC2L;RBM22;TRUB2;NKAP;SNIP1;MEX3B;TSN;MAGOH;FARSA;METTL3;MAPRE1;FMR1;ADD1;NHP2;UBA1;LRRC47;SLTM;CCDC124;CCDC137;RPL22;ELP5;EIF3A;TRA2B;PWP2;MAZ;TSNAX;PPAN;RO60;EIF4B;VCP;EIF3G;PUM3;TRMT10C
prerank,cAMP response element binding (GO:0035497),0.6598023212829508,1.430352230515643,0.1038135593220339,0.5367257594949584,1.0,1/10,0.08%,CREB5
prerank,poly-purine tract binding (GO:0070717),0.5226809375103216,1.429300405323963,0.0748663101604278,0.5298859900721535,1.0,6/27,5.90%,ATXN1;RBMS1;RBMS3;RBPMS;PABPC4L;RBMS2
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.5837205291566702,-1.4291461897743234,0.09494949494949495,0.4613824553702329,1.0,6/12,18.64%,PIK3R6;PIK3C2B;PIK3CD;PIK3C2A;PIK3C3;PIK3R3
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.45122851290775084,1.4286166948546695,0.05583756345177665,0.5222093392343702,1.0,17/60,11.42%,EPHA7;EPHA3;FGFR2;FGFR4;KIT;PDGFRB;EPHA8;EPHA4;PDGFRA;DDR1;IGF1R;DDR2;RYK;MUSK;AXL;EPHA2;ERBB2
prerank,androgen receptor binding (GO:0050681),-0.4859424681372828,-1.428153289390593,0.07311827956989247,0.4537940660542845,1.0,8/25,9.16%,FOXP1;CALR;KDM4C;KDM3A;ARID5A;DDX5;TMF1;ZBTB7A
prerank,acetylation-dependent protein binding (GO:0140033),0.566994637418851,1.4265288019994722,0.10877862595419847,0.5097076073575645,1.0,9/20,20.80%,KMT2A;DPF2;PSME4;PHIP;TRIM24;ATAD2B;BRD7;BRDT;CARM1
prerank,lysine-acetylated histone binding (GO:0070577),0.566994637418851,1.4265288019994722,0.10877862595419847,0.5097076073575645,1.0,9/20,20.80%,KMT2A;DPF2;PSME4;PHIP;TRIM24;ATAD2B;BRD7;BRDT;CARM1
prerank,leak channel activity (GO:0022840),0.5655059942564671,1.426009357338609,0.10677618069815195,0.502455279903666,1.0,3/18,5.96%,KCNK2;NALCN;TMEM175
prerank,ligand-gated anion channel activity (GO:0099095),-0.5358912392532255,-1.4245466498911539,0.06990291262135923,0.4541104261608186,1.0,9/17,25.74%,GABRB3;GABRB1;GABRG3;CFTR;GLRA3;GABRA5;GABRE;GABRG2;GLRA1
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.5806364467748875,-1.4218593557604382,0.0761904761904762,0.4520583990388738,1.0,7/12,23.57%,CISD2;ISCU;CISD1;XDH;CIAPIN1;ISCA2;ISCA1
prerank,death receptor binding (GO:0005123),-0.5488828690241795,-1.4201009667732842,0.07770961145194274,0.44755115235574333,1.0,11/15,32.30%,DAB2IP;NGF;EDA;TMBIM1;CASP8AP2;MADD;MYD88;BID;FADD;NTF3;PIDD1
prerank,hydro-lyase activity (GO:0016836),0.47585019946459306,1.4105762927532357,0.07992895204262877,0.5367914941251258,1.0,13/41,16.18%,GMDS;CBS;HACD1;EHHADH;HACD3;ECHDC3;ECHDC1;L3HYPDH;AUH;ENO2;FAHD2A;ACO2;HACD4
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.5488530208859163,-1.407488949820967,0.0975609756097561,0.47470475071594936,1.0,5/14,17.58%,SLC26A7;SLC26A2;SLC26A6;SLC25A30;SLC26A11
prerank,phosphatidylglycerol binding (GO:1901611),-0.5614935769462928,-1.4051477852699477,0.0803921568627451,0.47185154447315636,1.0,6/13,18.80%,PITPNC1;PLTP;STOML2;PLEKHN1;UQCC3;PITPNA
prerank,GTP binding (GO:0005525),-0.32894334481752535,-1.405072416391511,0.0034602076124567475,0.46272012146554053,1.0,62/172,25.17%,EEF1A1;RAP1A;RHOJ;KRAS;RAC1;RASL12;RAB31;RAB27A;GCH1;TGM2;RERG;NRAS;RHOB;TUBB3;GBP4;GNAI1;RHOT1;ARF5;GNL3;SCG5;ARF1;MRAS;DNM2;RAB28;RHOA;RAB38;BMS1;ARHGEF5;RALB;ARL8A;TUBB4B;TUBA1B;GBP5;RHEB;GBP3;TUBB2A;TUBA1A;RABL3;ATL2;RHOG;EIF2B2;RRAS;TUBB4A;RRAGB;RAB1B;RAB39A;RIT2;ARFIP2;INSR;RAB8A;TUBD1;TSR1;RAB7A;ARL4A;GEM;SEPHS1;DRG2;TUBB2B;RAB2A;RAB14;NUDT16;HRAS
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.4460591038381535,1.4047495314971583,0.0576271186440678,0.545039572930578,1.0,16/53,12.76%,SLC7A11;SLC22A2;SLC38A3;SLC6A9;SLC1A3;SLC25A18;SLC38A9;SLC43A1;SLC1A5;SLC25A22;SLC36A2;SLC38A7;SLC25A2;SLC38A2;OCA2;SLC25A38
prerank,histone methyltransferase binding (GO:1990226),-0.5917213057676948,-1.4035644238986016,0.08269230769230769,0.4581968870168882,1.0,3/11,6.01%,HSP90AB1;LCORL;CTNNB1
prerank,phosphatidic acid binding (GO:0070300),-0.5068406765980542,-1.4010361555417787,0.07740585774058577,0.4571121900736005,1.0,8/19,19.26%,PITPNC1;PLTP;PACSIN2;MARK1;PLEKHN1;ATP13A2;UQCC3;JPH2
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.32673749155066817,1.3963548490356528,0.0,0.5612649844298828,1.0,142/831,13.94%,GLIS3;CREB5;RORA;SOX5;MAF;TCF4;TCF7L2;OSR1;AEBP1;ARNT2;RBPJ;ZIC1;HOXC6;EPAS1;HLF;PPARA;NR2F2;NPAS3;IKZF2;HOXC4;ZEB2;ZKSCAN2;KCNIP3;PRRX1;MEIS1;HOXB4;ESRRG;MXI1;CUX1;SATB1;PRDM5;ZEB1;ZIC2;EBF1;MYBL1;DMRT1;SCX;NR1I2;ASCL2;SOX6;ZBTB20;HOXB3;HIF3A;PAX5;NFYB;ZIC5;HOXA3;BBX;HOXC5;PKNOX2;VSX2;STAT5B;NFAT5;ZFP90;HOXA7;FOXD1;NFIB;TEAD1;ELF4;MGA;TEF;ZNF367;IKZF4;GMEB1;SOX1;SIX5;SALL4;ZFHX2;IRF8;ZNF250;GLI3;ZNF569;HIVEP2;MXD1;MYNN;ZBTB32;TCF7L1;ZFP37;THAP1;SALL1;RFXAP;ZNF23;SMAD3;EN1;PBX4;NR6A1;RBL2;ZKSCAN5;TCF12;TEAD3;NFIA;ARNT;ZNF628;MITF;KDM6B;CEBPG;EBF4;NFYC;HOXB6;NSD1;BATF2;IRF3;ZSCAN29;IRX1;ATOH8;NEUROD2;HDAC1;ZBTB11;TFAP2A;ZNF8;HOXC8;TFAP2B;ZIC4;ZNF568;RXRA;ZBTB38;MYB;ZBTB39;NPAS2;ZBTB37;ZNF177;E2F6;SOX13;GMEB2;HSF1;AR;HIVEP1;KLF5;HOXD4;NFATC4;HOXA6;NR1I3;FOXK2;SNAI1;ZNF697;HOXB9;TFDP2;MLXIP;CLOCK;ZNF148;SRF;DMRTA2
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.5223901306751715,1.3953083037760818,0.10877862595419847,0.5551645706453672,1.0,3/25,1.11%,CYP26B1;MICAL3;CYP27A1
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),-0.5757461231008212,-1.3952005878391662,0.09774436090225563,0.4644370999565246,1.0,5/11,16.21%,SLC25A25;LRRC8A;SLC25A42;SLC35B2;SLC17A9
prerank,GTPase regulator activity (GO:0030695),0.36274630695088556,1.3947334514093208,0.025885558583106268,0.5480459484771656,1.0,34/212,9.48%,ARHGAP28;RANBP3L;ALDH1A1;ARHGAP24;ERRFI1;GMIP;NPRL3;RIN2;ARHGAP29;ASAP1;SMAP2;PLCB1;ARHGAP20;ALS2;ARFGAP3;SYDE2;LLGL2;ARHGAP26;CPEB2;WASL;NPRL2;ARHGAP40;LRRK2;HACD3;TBC1D9B;ASAP3;GNAQ;ARHGAP35;ARHGAP9;MYO9B;TBC1D4;SIRPA;ARHGEF10L;GNB5
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.6008503181897551,-1.3944951439432038,0.09343936381709742,0.45778158063651403,1.0,5/10,18.74%,ANKRD13A;IDE;LAPTM5;FAAP20;ANKRD13B
prerank,peptidase inhibitor activity (GO:0030414),0.4921247328323189,1.3922961868370833,0.08477842003853564,0.5463191760883673,1.0,9/33,11.22%,TFPI;ITIH2;SERPIND1;PROS1;A2ML1;GPC3;SIMC1;CST7;RENBP
prerank,chemokine receptor activity (GO:0004950),0.5321010645021278,1.3909456600620242,0.08897485493230174,0.5416036639427486,1.0,4/24,4.02%,ACKR2;CCR9;CXCR5;CXCR6
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.6097866957006941,-1.3896099580353458,0.10666666666666667,0.463570198058664,1.0,6/10,18.17%,CD200;CXADR;JUP;CD47;DSG2;DSP
prerank,PDZ domain binding (GO:0030165),0.4244714844162941,1.3893450283013993,0.06856187290969899,0.5382768169441737,1.0,11/61,8.27%,TGFBR3;SLC22A4;ARHGAP29;PLEKHA2;PRKN;SDC2;LLGL2;SSTR2;SYNJ2;PTEN;SRR
prerank,ATPase binding (GO:0051117),-0.3709103826360314,-1.389127160421594,0.03523035230352303,0.4569836200614015,1.0,28/71,19.26%,CAV1;PDE4D;ESR1;ATXN3;ATP1B1;UBXN1;ATP6V0A1;NKD2;DERL1;S100A1;RALB;PIH1D1;TCIRG1;ATP6V1E1;SVIP;FBL;PPP3CA;BBC3;NR1H2;TRPC1;DNAJC10;ATP5IF1;WFS1;ATP6V0A4;PLN;DNAJB1;ATP6V0A2;PSEN1
prerank,potassium:proton antiporter activity (GO:0015386),-0.6064482198869777,-1.3851865496452198,0.09369024856596558,0.4605897392703577,1.0,2/10,5.56%,SLC9A2;SLC9A8
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.6269002339067672,1.3846633834008917,0.14705882352941177,0.5423100775106922,1.0,4/10,7.94%,KDM7A;KDM2B;PHF8;KDM2A
prerank,leucine zipper domain binding (GO:0043522),0.6416783407676204,1.381910637571191,0.13530655391120508,0.5417048677244336,1.0,1/10,0.82%,PAWR
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.3240909468852175,1.3785975288351535,0.0022988505747126436,0.5427769384191083,1.0,130/731,13.94%,GLIS3;CREB5;RORA;SOX5;MAF;TCF4;TCF7L2;ARNT2;RBPJ;ZIC1;HOXC6;HLF;PPARA;NR2F2;IKZF2;HOXC4;ZEB2;ZKSCAN2;KCNIP3;PRRX1;MEIS1;HOXB4;ESRRG;MXI1;SATB1;PRDM5;ZEB1;ZIC2;EBF1;MYBL1;DMRT1;SCX;NR1I2;ASCL2;SOX6;ZBTB20;HOXB3;HIF3A;PAX5;NFYB;ZIC5;HOXA3;HOXC5;PKNOX2;STAT5B;NFAT5;HOXA7;FOXD1;NFIB;TEAD1;ELF4;MGA;TEF;ZNF367;IKZF4;GMEB1;SOX1;SIX5;SALL4;ZFHX2;IRF8;ZNF250;GLI3;ZNF569;HIVEP2;MXD1;MYNN;ZBTB32;TCF7L1;THAP1;SALL1;ZNF23;SMAD3;EN1;PBX4;NR6A1;ZKSCAN5;TCF12;TEAD3;NFIA;ARNT;ZNF628;MITF;KDM6B;CEBPG;EBF4;NFYC;HOXB6;CREB3L2;NSD1;BATF2;IRF3;ZSCAN29;IRX1;ATOH8;NEUROD2;HDAC1;ZBTB11;TFAP2A;ZNF8;TFAP2B;ZIC4;ZNF568;RXRA;ZBTB38;MYB;ZBTB39;NPAS2;ZBTB37;E2F6;SOX13;GMEB2;HSF1;AR;HIVEP1;KLF5;HOXD4;NFATC4;HOXA6;NR1I3;FOXK2;SNAI1;ZNF697;HOXB9;MLXIP;CLOCK;TRIM24;ZNF148;SRF;DMRTA2
prerank,glutamate receptor binding (GO:0035254),-0.5231656225465742,-1.370985306287319,0.08858267716535433,0.49306410511754617,1.0,5/17,8.94%,HIP1;SHANK3;NSF;HOMER1;SYNDIG1
prerank,FAD binding (GO:0071949),0.5243395916982694,1.3695901494481573,0.11637080867850098,0.5599549244795398,1.0,7/24,11.85%,MICAL3;DDO;SQOR;MTHFR;NDOR1;PRODH;CRY1
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",-0.5306427289261512,-1.3687464543778733,0.10141987829614604,0.4911319849188835,1.0,6/14,19.16%,IREB2;ISCU;NDUFS1;RSAD2;RSAD1;ISCA2
prerank,triglyceride lipase activity (GO:0004806),0.5229383529129867,1.3641140416220194,0.1134020618556701,0.568308374778165,1.0,4/20,7.58%,CEL;LIPH;LIPC;DAGLB
prerank,CARD domain binding (GO:0050700),-0.5346359693376167,-1.3639638383613013,0.10943396226415095,0.49620180597810104,1.0,9/14,32.29%,NOD1;CARD10;CARD14;CARD16;CARD19;CASP1;CARD11;MAVS;NOD2
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.44891720998561313,-1.363708726667573,0.08227848101265822,0.4890580846354618,1.0,11/27,17.58%,SLC26A7;SLC26A2;ANO1;SLC39A8;LRRC8A;SLC26A6;SLC25A30;SLC39A14;XPR1;ANKH;SLC26A11
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.5749215071402979,-1.3630030961330957,0.11007462686567164,0.4832310450885625,1.0,2/11,0.97%,SGMS1;SGMS2
prerank,Wnt-activated receptor activity (GO:0042813),-0.5306021819421889,-1.3625847138079676,0.10444874274661509,0.47680146619637725,1.0,5/15,6.13%,ROR1;PKD1;FZD4;FZD6;LRP5
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.5625142820025943,1.3602084637210718,0.15444015444015444,0.5712094117485806,1.0,2/15,1.52%,ACKR2;CCR9
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.31966280075481357,1.3590743399575858,0.0011534025374855825,0.5664551700465006,1.0,127/732,13.94%,GLIS3;CREB5;RORA;SOX5;MAF;TCF4;TCF7L2;ARNT2;RBPJ;ZIC1;HOXC6;HLF;PPARA;NR2F2;IKZF2;HOXC4;ZEB2;ZKSCAN2;KCNIP3;PRRX1;MEIS1;HOXB4;ESRRG;MXI1;SATB1;PRDM5;ZEB1;ZIC2;EBF1;MYBL1;DMRT1;NR1I2;ASCL2;SOX6;ZBTB20;HOXB3;HIF3A;PAX5;NFYB;ZIC5;HOXA3;HOXC5;PKNOX2;STAT5B;NFAT5;HOXA7;FOXD1;NFIB;TEAD1;ELF4;MGA;TEF;ZNF367;IKZF4;GMEB1;SOX1;SIX5;SALL4;ZFHX2;IRF8;ZNF250;GLI3;ZNF569;HIVEP2;MXD1;MYNN;ZBTB32;TCF7L1;THAP1;SALL1;ZNF23;SMAD3;EN1;PBX4;NR6A1;ZKSCAN5;TCF12;TEAD3;NFIA;ARNT;ZNF628;MITF;KDM6B;CEBPG;EBF4;NFYC;HOXB6;NSD1;BATF2;IRF3;ZSCAN29;IRX1;ATOH8;NEUROD2;HDAC1;ZBTB11;TFAP2A;ZNF8;TFAP2B;ZIC4;ZNF568;RXRA;ZBTB38;MYB;ZBTB39;NPAS2;ZBTB37;E2F6;SOX13;GMEB2;HSF1;AR;HIVEP1;KLF5;HOXD4;NFATC4;HOXA6;NR1I3;FOXK2;SNAI1;ZNF697;HOXB9;MLXIP;CLOCK;ZNF148;SRF;DMRTA2
prerank,ubiquitin protein ligase binding (GO:0031625),-0.30630137492442644,-1.358949621970631,0.007194244604316547,0.4791940466120446,1.0,91/254,23.48%,ACTG1;PRR5L;HSPA8;RPL11;HSP90AA1;RPL23;HSP90AB1;ATXN3;FBXO7;PPARGC1A;MID1;UBB;NFKBIA;DNAJA1;TRIB2;FZD4;UBXN1;FZD6;CALR;NKD2;FAF1;NEDD8;ARRB1;BAG6;RPS27A;UBC;GSK3B;TNFRSF1B;UCHL1;RPL5;CUL3;APBB1;MAP1LC3B;SMAD5;BAG1;JUN;FOXO1;DERL1;CHEK2;UBE2B;RTN4;RBX1;APC;HSPA5;ATP6V0C;RALB;ISG15;TUBA1B;CAMLG;HSPD1;CLU;OTUB1;ELOB;RNF34;PRKAR1A;CUL1;TPI1;CKB;TRAF1;ERLIN2;CASP8;UBE2G1;UBA52;WFS1;LAPTM5;HERC2;SPOPL;PER1;AUP1;CD40;SMG5;UQCRC1;UBE2D1;PINK1;TMBIM6;ARRB2;SCAMP3;JAK1;HSPA9;DIO2;GABARAPL1;ARIH1;KCNH2;CDKN1A;VCP;HDAC6;MFN2;UBOX5;TRIB3;RELA;HSPA1B
prerank,ion gated channel activity (GO:0022839),-0.4675597201859044,-1.3511085385457287,0.10970464135021098,0.4932530693890258,1.0,9/24,20.32%,ANO1;ANO4;TTYH3;TTYH2;KCNT1;ANO3;ANO2;TRPM4;ANO8
prerank,chemokine binding (GO:0019956),0.47941954277071513,1.3495197699502308,0.12429378531073447,0.5854136911289269,1.0,5/30,4.02%,ACKR2;CCR9;CXCR5;PDPN;CXCR6
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.5519473339485362,-1.3487868630754438,0.1446028513238289,0.49237656521887235,1.0,4/13,10.64%,PIP5K1B;PIK3C2B;PIK3CD;PIK3C2A
prerank,poly(A) binding (GO:0008143),0.5227519261761749,1.3487345495907213,0.12734082397003746,0.5798137828575106,1.0,5/21,5.90%,RBMS1;RBMS3;RBPMS;PABPC4L;RBMS2
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),-0.5483745349711029,-1.3454056450438692,0.14119922630560927,0.49476610720867564,1.0,5/12,16.21%,SLC25A25;LRRC8A;SLC25A42;SLC35B2;SLC17A9
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.41505682870562277,1.3389505198597833,0.08858603066439523,0.6002613315169295,1.0,10/60,7.48%,LRRK1;PPM1M;CTDSPL;SSU72;PPM1E;CDC14B;MTMR3;LRRK2;LRRC40;PTEN
prerank,deubiquitinase activity (GO:0101005),-0.34847864773753506,-1.3371839111827208,0.03439153439153439,0.5108992931717554,1.0,39/88,29.66%,USP53;ATXN3;USP38;OTUD7A;MINDY2;PAN2;UCHL5;MINDY1;EIF3F;USP29;USP31;UCHL1;ZRANB1;USP50;USP37;USP39;OTUD3;UCHL3;OTUB1;OTUD1;MYSM1;USP28;USP9X;ZC3H12A;USP8;OTUD6B;OTUD7B;TNFAIP3;USP5;OTULIN;JOSD2;USP49;USP33;YOD1;USP22;USP2;USP10;USP32;USP9Y
prerank,double-stranded RNA binding (GO:0003725),-0.3609307378463107,-1.3340580033985616,0.06345177664974619,0.5123996166548556,1.0,20/70,13.36%,MBNL1;MSN;LRRFIP1;TFRC;HSP90AB1;ADARB1;VIM;ADARB2;ACTN1;RFTN1;SLC3A2;HNRNPU;ADAR;STRBP;TUBB4B;TUBA1B;DGCR8;OAS2;HSPD1;EIF4H
prerank,guanyl ribonucleotide binding (GO:0032561),-0.30911955957334475,-1.3325726029558131,0.010752688172043012,0.5092531662932812,1.0,68/196,25.20%,EEF1A1;RAP1A;RHOJ;KRAS;RAC1;RASL12;RAB31;RAB27A;GCH1;TGM2;RERG;NRAS;RHOB;TUBB3;GBP4;GNAI1;RHOT1;ARF5;GNL3;SCG5;ARF1;MRAS;PDE2A;DNM2;RAB28;RHOA;RAB38;BMS1;ARHGEF5;RALB;RAB3B;ARL8A;MIEF1;TUBB4B;TUBA1B;GBP5;RHEB;GBP3;TUBB2A;TUBA1A;PDE11A;RABL3;ATL2;RHOG;EIF2B2;RRAS;TUBB4A;RRAGB;RAB1B;RAB39A;RIT2;ARFIP2;INSR;RAB8A;TUBD1;TSR1;RAB8B;RAB7A;ARL4A;GEM;SEPHS1;DRG2;TUBB2B;RAB2A;RAB14;NUDT16;HRAS;RAB5B
prerank,histone demethylase activity (GO:0032452),0.4997319243118085,1.331698703119587,0.15355805243445692,0.6127921336101589,1.0,13/27,18.39%,KDM7A;JARID2;KDM2B;PHF8;KDM2A;KDM5B;KDM6B;KDM3B;KDM5C;KDM6A;PHF2;RIOX2;KDM4D
prerank,ephrin receptor binding (GO:0046875),-0.4708064683305858,-1.3310703100034098,0.13664596273291926,0.5060090788489227,1.0,8/21,11.86%,EFNA5;CBL;FYN;CHN1;ANKS1A;PTPN1;CRK;EFNB3
prerank,MHC protein binding (GO:0042287),-0.46528607902148733,-1.3240875783028665,0.12525252525252525,0.5179174457955805,1.0,7/20,18.49%,ATP5F1A;DERL1;TUBB4B;CD74;CD81;TAPBP;ATP5F1B
prerank,MHC class I protein binding (GO:0042288),-0.5197054525808227,-1.3229832756335886,0.12295081967213115,0.5139791979013361,1.0,5/13,18.49%,ATP5F1A;DERL1;TUBB4B;TAPBP;ATP5F1B
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.574923599683482,-1.3215416095388886,0.13043478260869565,0.5112801135065691,1.0,2/10,4.53%,MECOM;PRDM16
prerank,glycerophospholipid flippase activity (GO:0140333),-0.5433850295256374,-1.3193604691836684,0.14038461538461539,0.5107556530196041,1.0,6/11,12.13%,ATP10A;ATP8B1;ATP8A1;ATP8A2;ATP11C;ATP11A
prerank,P-type ion transporter activity (GO:0015662),-0.545771857261058,-1.3175396565335191,0.12716763005780346,0.508834011993376,1.0,7/12,20.29%,ATP2C1;ATP2A2;ATP2A3;ATP2B1;ATP6V1E1;ATP2B2;ATP2B4
prerank,ubiquitin-like protein ligase binding (GO:0044389),-0.2957220795194454,-1.3171585659913683,0.02631578947368421,0.5033353275332263,1.0,93/269,23.48%,ACTG1;PRR5L;HSPA8;RPL11;HSP90AA1;RPL23;HSP90AB1;ATXN3;FBXO7;PPARGC1A;MID1;UBB;NFKBIA;DNAJA1;TRIB2;FZD4;UBXN1;FZD6;CALR;NKD2;FAF1;NEDD8;ARRB1;BAG6;RPS27A;UBC;GSK3B;TNFRSF1B;UCHL1;RPL5;CUL3;APBB1;MAP1LC3B;SMAD5;BAG1;JUN;FOXO1;DERL1;CHEK2;UBE2B;RTN4;RBX1;APC;HSPA5;ATP6V0C;RALB;ISG15;TUBA1B;HGS;CAMLG;HSPD1;CLU;OTUB1;ELOB;RNF34;PRKAR1A;CUL1;TPI1;CKB;TRAF1;ERLIN2;CASP8;UBE2G1;UBA52;WFS1;LAPTM5;HERC2;SPOPL;PER1;SUMO3;AUP1;CD40;SMG5;UQCRC1;UBE2D1;PINK1;TMBIM6;ARRB2;SCAMP3;JAK1;HSPA9;DIO2;GABARAPL1;ARIH1;KCNH2;CDKN1A;VCP;HDAC6;MFN2;UBOX5;TRIB3;RELA;HSPA1B
prerank,neurexin family protein binding (GO:0042043),0.5884959357096597,1.3171548697032283,0.20362903225806453,0.6461968495956342,1.0,3/10,8.59%,CEL;NLGN2;SYTL3
prerank,Tat protein binding (GO:0030957),-0.5712438579609396,-1.3162077861675543,0.13940520446096655,0.499804974584619,1.0,5/10,22.46%,ACTB;DNAJA1;MDFIC;GABARAPL1;DLL1
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.5342396514960881,-1.3161284326387206,0.15037593984962405,0.49373675739228295,1.0,5/13,13.66%,GSK3B;CSK;KCNQ1;RYR2;PRKAR1A
prerank,estrogen receptor binding (GO:0030331),-0.4196401923382343,-1.311774246876386,0.10874200426439233,0.49940779147553493,1.0,9/32,11.82%,LEF1;ESR1;RERG;CTNNB1;DCAF13;ARID5A;WBP2;DDX54;NRIP1
prerank,transferrin receptor binding (GO:1990459),-0.5714068795827179,-1.3088549861049408,0.14944649446494465,0.5008286956891109,1.0,5/10,20.52%,IKBKB;CHUK;CD81;SNX1;SNX2
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.5606692867559471,1.30433437643316,0.17721518987341772,0.677392962720793,1.0,1/12,0.68%,B3GALT1
prerank,TBP-class protein binding (GO:0017025),-0.4627186668682013,-1.2967778458869903,0.1419624217118998,0.5282188413764078,1.0,10/21,36.61%,ESR1;AHR;HHEX;YEATS2;RUVBL1;THRA;TAF11;PSMC5;PSMC1;TAF1B
prerank,potassium ion leak channel activity (GO:0022841),0.5321352767808618,1.2960189602390826,0.19507186858316222,0.694179105278119,1.0,2/15,5.96%,KCNK2;TMEM175
prerank,alkali metal ion binding (GO:0031420),0.5662359798988087,1.2944387920318727,0.1963927855711423,0.6903943348225698,1.0,1/13,0.21%,ATP1A2
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.46172565667889276,1.2930408531443127,0.1509090909090909,0.6864273287836901,1.0,8/32,8.89%,KDM7A;KDM2B;TET1;PHF8;BBOX1;KDM2A;PHYH;TMLHE
prerank,glutathione transferase activity (GO:0004364),0.49388571261432795,1.2925822825118543,0.17702448210922786,0.6793953861991524,1.0,3/23,5.01%,GSTM2;GSTT4;GSTT1
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.5356738518159652,-1.2918141355957424,0.1450381679389313,0.5355094996483607,1.0,2/11,5.27%,LEF1;GATA2
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.5528175416368569,-1.2907539409672282,0.1695906432748538,0.5320065668910491,1.0,5/10,18.64%,PIK3C2B;PIK3CD;PIK3C2A;PIK3C3;PIK3R3
prerank,protein tyrosine kinase activity (GO:0004713),0.3681288882245305,1.2899437292810605,0.09815950920245399,0.6793243473448248,1.0,23/108,11.42%,EPHA7;EPHA3;FGFR2;FGFR4;KIT;PDGFRB;FER;EPHA8;EPHA4;PDGFRA;BAZ1B;DDR1;IGF1R;TTK;DDR2;RYK;MUSK;FRK;AXL;ABL1;EPHA2;JAK2;ERBB2
prerank,GTPase activator activity (GO:0005096),0.3240902065659446,1.289084704454697,0.037227214377406934,0.6737966193562472,1.0,52/313,9.87%,ARHGAP28;RANBP3L;ALDH1A1;ARHGAP24;ERRFI1;GMIP;NPRL3;RIN2;ARHGAP29;DENND4A;ASAP1;DOCK11;FGD4;SBF2;SMAP2;DENND2A;FNIP1;PLCB1;RAB3IL1;ARHGAP20;ALS2;RAB3IP;ARFGAP3;SYDE2;LLGL2;RCBTB2;ARHGAP26;IQSEC2;AKAP13;NPRL2;ARHGAP40;LRRK2;HACD3;TBC1D9B;ASAP3;ARHGEF11;GNAQ;RABIF;ARHGAP35;EPS8L1;RAPGEF4;ARHGAP9;RGL1;RALGPS1;MYO9B;TBC1D4;FARP1;ARHGEF10L;ARFGEF2;GNB5;ARHGEF18;RIC1
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.5332759792606536,-1.2877556317722803,0.17037037037037037,0.5342574043458053,1.0,6/12,24.99%,GABRB3;GABRB1;GABRG3;GABRA5;GABRE;GABRG2
prerank,anion:anion antiporter activity (GO:0015301),-0.4722756553068766,-1.2871900634938143,0.14951456310679612,0.5295065119357002,1.0,6/17,21.40%,SLC26A7;SLC26A2;SLC4A2;SLC26A6;SLC26A11;SLC25A4
prerank,protein tyrosine kinase binding (GO:1990782),-0.34549048620796896,-1.286160861131041,0.06940874035989718,0.525865131310083,1.0,21/71,14.69%,GRB14;TJP2;PITPNM2;HSP90AA1;PTPN14;GAS6;CBL;ITGB1;RACK1;BMPR2;NCK1;TOB1;SOCS5;CEACAM1;CPNE3;PTPN1;CRK;DUSP3;PITPNM3;NEDD9;NRG3
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.5536453638757717,-1.2818728600428475,0.16470588235294117,0.5320472078103138,1.0,5/10,18.74%,ANKRD13A;IDE;LAPTM5;FAAP20;ANKRD13B
prerank,kinesin binding (GO:0019894),-0.43073827670981496,-1.2811499093775711,0.16326530612244897,0.5281738422127353,1.0,15/27,31.71%,ACTB;AP1AR;TOR1B;ARHGEF10;TTBK2;SPAG9;MAPK8IP2;ATCAY;KLC2;KIF1B;CLSTN1;MAPK8IP3;MAPK8IP1;SPTBN5;FAM83D
prerank,sequence-specific DNA binding (GO:0043565),0.3045557347987416,1.2804743944856516,0.026410564225690276,0.6921508992982307,1.0,94/590,14.06%,CREB5;RORA;MAF;TCF4;TCF7L2;OSR1;ARNT2;RBPJ;ZIC1;EPAS1;HLF;PPARA;NR2F2;HOXC4;ZEB2;KMT2A;HOXB4;ESRRG;BCL2;CUX1;SATB1;PRDM5;DMRT1;SCX;NR1I2;ASCL2;ZBTB20;ZIC5;BBX;PKNOX2;VSX2;NFAT5;MYRFL;HOXA7;FOXD1;NFIB;TEAD1;ELF4;TEF;GMEB1;KDM2B;IRF8;ZNF250;ACD;GLI3;TET1;ZBTB32;TCF7L1;CXXC5;THAP1;ZNF23;XRCC5;SMAD3;EN1;PBX4;NR6A1;KDM2A;TCF12;ARNT;KDM5B;CEBPG;HOXB6;IRF3;ZSCAN29;IRX1;ABL1;NEUROD2;TFAP2A;HOXC8;TFAP2B;ZIC4;RXRA;ZBTB38;NPAS2;KMT2B;ZBTB37;ZNF177;SOX13;GMEB2;HSF1;HIVEP1;KLF5;HOXD4;NFATC4;HOXA6;NR1I3;FOXK2;SNAI1;HOXB9;CLOCK;ZNF148;SRF;DMRTA2;BATF
prerank,fibroblast growth factor binding (GO:0017134),0.5048561643098216,1.275290585907613,0.18473895582329317,0.7004075503559785,1.0,4/21,3.19%,FGFR2;FGFR4;KL;CXCL13
prerank,insulin-like growth factor binding (GO:0005520),0.5281761556977674,1.274328103884486,0.21584158415841584,0.6956962761934898,1.0,4/15,5.73%,IGFBP2;IGFBP4;IGF1R;LRP2
prerank,inward rectifier potassium channel activity (GO:0005242),-0.43721723725633876,-1.2725285481736135,0.15090543259557343,0.5451637221069667,1.0,10/24,30.45%,KCNJ2;ABCC9;KCNN2;KCNJ8;KCNJ15;KCNH2;KCNJ6;KCNJ16;KCNJ10;ABCC8
prerank,insulin-like growth factor I binding (GO:0031994),0.5481408023539526,1.271462577848249,0.22845691382765532,0.6966228557485461,1.0,4/13,5.73%,IGFBP2;IGFBP4;IGF1R;LRP2
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.5320289918851933,-1.2705472047820978,0.2,0.544674076376377,1.0,6/12,18.27%,DAB2IP;ITGA5;CCDC88A;VEGFA;CADM4;GREM1
prerank,ubiquitin-protein transferase activity (GO:0004842),0.31632659600051466,1.2704531144718256,0.05829015544041451,0.6918299374091574,1.0,85/346,17.75%,ASB2;PDZRN3;RNF220;TRIM63;RNF43;PRKN;PELI2;UBE2E2;TRIM5;MGRN1;NEDD4;RNF213;KCMF1;NEURL2;RNF138;DDB2;RNF2;RNF217;ZNRF3;LTN1;BCOR;FBXO44;SH3RF1;UBE2L3;RNF181;UBR2;RNF152;RNF145;TTC3;TRIM56;RNF135;SIAH2;WWP2;AMFR;BIRC6;RNF216;RNF180;TRAF7;RC3H2;NHLRC1;FBXO6;MDM2;ITCH;UBA7;RNF149;SMURF2;TRIM35;DTX1;SH3RF2;RBBP6;TRIM45;FBXO4;MYCBP2;CUL4B;RNF14;GID4;TRIM26;TRIM43;RNF20;FBXO11;RCHY1;RNF214;TRIM24;RNFT2;UBE2A;CHFR;BIRC2;TRIM62;UBR1;PPIL2;RNF122;UBE2H;PML;HECTD1;TRIM17;CBLB;TRIM69;OBI1;TRIM39;UBE2E1;NHLRC3;PELI3;KLHL13;DTX3L;TRIM9
prerank,calcium activated cation channel activity (GO:0005227),-0.47776770599464874,-1.2664813415844558,0.1656686626746507,0.5500353812258636,1.0,10/17,37.94%,ANO1;KCNMA1;KCNMB4;KCNN2;TRPM4;KCNN4;KCNMB2;TMEM63A;TMEM63B;KCNMB1
prerank,histone acetyltransferase activity (GO:0004402),0.4543876953156013,1.266245628249265,0.16266173752310537,0.6966831633362427,1.0,11/30,14.11%,BAZ1A;NCOA3;KAT8;BRCA2;KAT6B;TADA2A;NAA60;EPC2;SRCAP;CLOCK;CREBBP
prerank,GDP binding (GO:0019003),-0.3487733966027671,-1.2658753120558908,0.08955223880597014,0.5458193056502552,1.0,24/63,25.20%,RAP1A;KRAS;RASL12;RAB31;RAB27A;RERG;NRAS;GNAI1;MRAS;RAB28;RALB;RAB3B;MIEF1;RHEB;RRAS;RIT2;RAB8A;RAB8B;RAB7A;GEM;RAB2A;RAB14;HRAS;RAB5B
prerank,microtubule minus-end binding (GO:0051011),0.5339630314273298,1.2658275725013117,0.21052631578947367,0.6903872419244147,1.0,4/13,9.85%,MACF1;HAUS4;TUBGCP6;TUBGCP2
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.3787266982312926,1.2655383284989166,0.14262295081967213,0.6838162437916517,1.0,10/72,4.92%,FRMPD4;TULP3;ADAP2;SNX21;PARD3;GSDMA;PLCB1;AVIL;TULP1;SNX18
prerank,peptidoglycan binding (GO:0042834),-0.5465157980189662,-1.2647247234434524,0.1974169741697417,0.5430404481316652,1.0,3/10,6.99%,NOD1;PGLYRP1;HK1
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),-0.3070688933400784,-1.2601599702900534,0.04854368932038835,0.5493187588677007,1.0,29/147,6.96%,DOCK9;RAPGEF5;FGD5;ARHGEF28;ELMO1;CYTH3;FGD6;RAP1A;TIAM1;RASGEF1B;DOCK1;CYTH1;RASGRF2;DOCK10;ARHGEF15;PREX1;DENND3;RIN3;EPS8L2;DENND1B;SPATA13;ARHGEF17;ARHGEF6;DOCK2;DENND5B;EEF1D;CCDC88A;ABR;BCR
prerank,cation transmembrane transporter activity (GO:0008324),0.40953517173704557,1.2589800624542535,0.14380165289256197,0.6953786803601418,1.0,14/48,12.76%,SLC22A2;SLC38A3;SLC6A9;SLC41A1;MMGT1;CHRNE;SLC38A9;SLC1A5;SLC36A2;SLC38A7;SLC25A2;SLC38A2;OCA2;SLC25A38
prerank,vinculin binding (GO:0017166),-0.5387161388442722,-1.2566553861440515,0.20080321285140562,0.5530904403547666,1.0,5/11,6.08%,UTRN;CORO2B;ACTN1;PXN;RTCB
prerank,omega peptidase activity (GO:0008242),-0.3259943068714905,-1.2550404886324635,0.08163265306122448,0.5516505487458201,1.0,38/89,29.66%,USP53;ATXN3;USP38;OTUD7A;PAN2;UCHL5;USP29;USP31;UCHL1;ZRANB1;APEH;USP50;USP37;USP39;OTUD3;UCHL3;OTUB1;OTUD1;MYSM1;USP28;USP9X;ZC3H12A;USP8;OTUD6B;OTUD7B;TNFAIP3;GGT1;USP5;OTULIN;JOSD2;USP49;USP33;YOD1;USP22;USP2;USP10;USP32;USP9Y
prerank,general transcription initiation factor binding (GO:0140296),-0.42888501888197417,-1.2519196816766773,0.1723404255319149,0.5541630792588033,1.0,13/25,37.10%,ESR1;AHR;HHEX;YEATS2;RUVBL1;RELA;THRA;THAP7;TAF11;PSMC5;PSMC1;TAF1B;TBP
prerank,DNA binding (GO:0003677),0.29300293671883937,1.2509182235037333,0.0313588850174216,0.7117360440882522,1.0,140/694,15.91%,RORA;TCF4;TCF7L2;RBPJ;DENND4A;APLP2;EPAS1;HLF;PPARA;NR2F2;POLR2D;ZEB2;RBMS1;MEIS1;ARID5B;BCL2;CUX1;SATB1;PRDM5;ZIC2;SCX;SOX6;TSHZ3;NFYB;RAD51B;SSBP2;MYRFL;HOXA7;FOXD1;NFIB;ZDHHC1;TEAD1;SPHK1;ARID4A;RAD51AP2;COLEC11;RNF138;DDB2;RAD51C;KDM2B;CAMTA1;SOX1;TDP2;DMC1;DDX60;GTF3C5;PDS5B;MTERF2;TET1;HIVEP2;ZBTB32;TCF7L1;PARP4;CXXC5;THAP1;XRCC5;SMAD3;BLM;XRCC4;RBM5;PBX4;CHD4;NR6A1;WDR48;MTF2;POLR2A;AUNIP;LYAR;CCNT1;ARNT;SSBP1;MAU2;KDM5B;NUPR1;BRCA2;CEBPG;FUBP1;RC3H2;CLSPN;TIGD4;NFYC;IRF3;MBD4;IRX1;NHEJ1;ABL1;ZMYM4;PRKDC;DCLRE1A;RFC1;SMARCA5;TSHZ1;TFAP2A;ZNF8;DCLRE1B;TFAP2B;ARID3A;GTF3C3;ZIC4;RXRA;PCBP2;NPAS2;BCLAF3;CUL4B;CRY1;SOX13;TRIM26;HSF1;MPG;EZH1;INO80;SMARCB1;CGGBP1;SPO11;FOXK2;ZBP1;MRE11;CLOCK;ZNF148;POLR3C;APEX1;BATF;CREBBP;RAD23B;GLI2;BANF2;CENPX;MLH1;SOX12;SMARCA2;WRN;BARX2;MEIS2;PATZ1;STN1;SMAD4;MCM2;PSIP1;POU3F1;RAD18
prerank,syntaxin-1 binding (GO:0017075),0.47164579090676984,1.2493672611104107,0.18609022556390978,0.7091550504427485,1.0,3/22,5.48%,UNC13C;DAPK1;LRRK2
prerank,ribosome binding (GO:0043022),-0.37248654024334715,-1.2490272240193838,0.12441314553990611,0.5565741177358206,1.0,24/46,29.98%,EEF2;RPSA;RACK1;NOMO1;BAG6;CCDC47;PYM1;CPEB1;YTHDF3;TMEM147;SHFL;EIF3C;SERBP1;EIF2A;ZC3H12A;FMR1;EIF6;GTPBP6;NAA16;MRPS27;ETF1;CPEB3;SEC61B;MTIF3
prerank,metalloexopeptidase activity (GO:0008235),0.40498969362765097,1.2485011315949526,0.16843971631205673,0.7044879965793691,1.0,6/51,8.19%,CPQ;AEBP1;ACE;NPEPPS;AGBL2;CPXM1
prerank,GTPase binding (GO:0051020),-0.29062024350274523,-1.2475240387563145,0.04180064308681672,0.5549598606238201,1.0,53/195,18.47%,SPTBN1;UNC13B;FGD5;CAV1;FGD6;FNBP1L;TBC1D30;HSP90AA1;IQGAP1;RASIP1;EXOC4;SH3BP4;ARHGDIB;RABGAP1L;NCKAP1;RIN3;FLNA;YBX3;EHD1;SOD1;PEX5L;SGSM1;YBX1;PAK1;CYRIB;EPS8;EXOC5;PAK2;RANBP1;LAMTOR1;KCTD13;STOML2;EVI5;MYO5A;RANGAP1;WHAMM;ARHGEF2;MLPH;PPP6R1;CDC42EP5;IARS1;RCC2;DMXL2;BICDL1;RAF1;TRIP11;BICD1;RABGAP1;RTKN;KIF3B;CDC42EP2;RABGGTB;RRAGB
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.48530601422066133,1.240150432464803,0.2345924453280318,0.7224190594987895,1.0,2/20,1.78%,AGPAT4;LPGAT1
prerank,flavin adenine dinucleotide binding (GO:0050660),0.4025439538772798,1.2396454098635914,0.19023569023569023,0.7164566517526308,1.0,12/53,13.77%,MICAL3;DPYD;DDO;SQOR;ACADL;MTHFR;GCDH;NDOR1;PRODH;CRY1;MTO1;ACOX1
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.5392783394777172,-1.238827038707774,0.2168458781362007,0.5727083346431857,1.0,4/10,9.15%,SLCO1C1;SLCO2A1;SLCO2B1;SLCO3A1
prerank,thiol-dependent deubiquitinase (GO:0004843),-0.3276973775295732,-1.2373024433103705,0.08974358974358974,0.5712075744404631,1.0,36/83,29.66%,USP53;ATXN3;USP38;OTUD7A;PAN2;UCHL5;USP29;USP31;UCHL1;ZRANB1;USP50;USP37;USP39;OTUD3;UCHL3;OTUB1;OTUD1;MYSM1;USP28;USP9X;ZC3H12A;USP8;OTUD6B;OTUD7B;TNFAIP3;USP5;OTULIN;JOSD2;USP49;USP33;YOD1;USP22;USP2;USP10;USP32;USP9Y
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.4760892213724042,-1.236699861681342,0.2250996015936255,0.5620940393183259,1.0,10/16,25.10%,ATP6V0A1;ATP6V1A;ATP6V0C;TCIRG1;ATP6V0A4;ATP6V0A2;ATP5F1B;ATP6V0D2;ATP6V0E2;ATP6V1B2
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.4760892213724042,-1.236699861681342,0.2250996015936255,0.5620940393183259,1.0,10/16,25.10%,ATP6V0A1;ATP6V1A;ATP6V0C;TCIRG1;ATP6V0A4;ATP6V0A2;ATP5F1B;ATP6V0D2;ATP6V0E2;ATP6V1B2
prerank,protein tyrosine phosphatase activity (GO:0004725),0.37373017932223046,1.2329559843325733,0.1716171617161716,0.7296319637005294,1.0,11/71,7.48%,EYA4;EYA1;PTPN13;EYA2;PTPN4;CDC14B;PTPRA;MTMR3;PTPN9;PTPRD;PTEN
prerank,hormone activity (GO:0005179),0.3973694578187925,1.230952311566762,0.1929530201342282,0.7283195696707656,1.0,1/54,0.03%,IGF1
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),-0.3561998833736151,-1.226174521006213,0.16136363636363638,0.5854864637579758,1.0,19/49,22.67%,OTUD7A;MINDY2;UBXN1;MINDY1;BAG6;ZRANB1;UBQLN4;AGAP3;TAB3;ZFAND2B;FAAP20;SPRTN;SHARPIN;RNF168;OTUD7B;VCP;HDAC6;TNFAIP3;UBL7
prerank,receptor ligand activity (GO:0048018),0.31402390522104084,1.2244328884215683,0.10643889618922471,0.7409283135723704,1.0,30/245,11.42%,IGF1;EPHA7;BMP6;IL34;WNT4;WNT6;IL18;BMP7;SEMA3B;DKK1;CXCL13;IGF2;ARTN;TAFA4;NDP;FGF1;TAFA5;PTN;IL6;NBL1;WNT5B;CSF1;VEGFB;GDF1;IL17D;CCL4;FGF9;TNFSF13;APLN;TGFA
prerank,cell adhesion mediator activity (GO:0098631),-0.4115374455030057,-1.2228618093027999,0.20386266094420602,0.5888262373022419,1.0,14/24,27.65%,BSG;ESAM;ROBO4;BCAM;CNTN6;CD47;NTNG1;NPTN;DSCAML1;PLXNB3;JAM3;VSTM2L;CNTN2;EMB
prerank,tropomyosin binding (GO:0005523),0.4895339232401952,1.2209888064979768,0.23387096774193547,0.7444543386678998,1.0,3/16,3.73%,TNNT2;CALD1;NEBL
prerank,UDP-galactosyltransferase activity (GO:0035250),0.5535399692040518,1.219106463199879,0.25925925925925924,0.7427643391449178,1.0,3/10,9.85%,B3GALT1;B4GALT1;B3GALT6
prerank,carbohydrate kinase activity (GO:0019200),0.5398744547419682,1.215984480069414,0.26195426195426197,0.7448913005445891,1.0,3/11,9.67%,HK2;GALK2;GALK1
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",-0.37368138618221536,-1.214786861455266,0.17798594847775176,0.6046583124863047,1.0,8/34,10.42%,CYTH3;ARAP2;MYO10;IQGAP1;ARAP3;FERMT2;HIP1R;OGT
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.40030741998540736,-1.2147252262866644,0.2062780269058296,0.599270824158358,1.0,11/30,21.21%,SLC39A10;SLC40A1;SLC30A5;SLC31A1;SLC39A8;SLC30A1;SLC39A7;SLC39A14;TMEM165;SLC39A6;SLC11A1
prerank,endopeptidase regulator activity (GO:0061135),0.4126319276235346,1.213704112474617,0.21794871794871795,0.7443556318754576,1.0,5/40,3.76%,TFPI;ITIH2;SERPIND1;PROS1;A2ML1
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.5286470483989231,1.2133871457963301,0.27944111776447106,0.738258935080992,1.0,5/12,14.83%,CDK8;CDK7;CDK1;MAPK1;CDK4
prerank,wide pore channel activity (GO:0022829),0.46071551669336697,1.2086748650244494,0.2455795677799607,0.7450813676980081,1.0,3/23,5.06%,GJB6;GJA3;GJA1
prerank,gap junction channel activity (GO:0005243),0.4662832673696058,1.2071107369483003,0.2619047619047619,0.7429871985555635,1.0,3/22,5.06%,GJB6;GJA3;GJA1
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.5284978202861156,-1.205686608495381,0.24763705103969755,0.6190523222682719,1.0,4/10,17.59%,FAP;NAALAD2;DPP4;PRCP
prerank,mRNA 3'-UTR binding (GO:0003730),0.36231437747647344,1.2055496430760113,0.1650485436893204,0.7406107641426684,1.0,10/79,5.90%,CELF2;IGF2BP1;CSDC2;RBMS1;RBMS3;CPEB2;HNRNPC;CPEB4;PABPC4L;RBMS2
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.3482142457478454,1.205075915605506,0.18037974683544303,0.7352877793454036,1.0,12/91,5.75%,FRMPD4;TULP3;ADAP2;SNX21;PARD3;GSDMA;PLCB1;AVIL;TULP1;SH3PXD2B;SNX18;WIPI1
prerank,gated channel activity (GO:0022836),-0.4804710779474165,-1.203388974236402,0.23877551020408164,0.6197258049871363,1.0,4/14,10.76%,PIEZO2;PIEZO1;TMC6;TMEM266
prerank,pyrophosphatase activity (GO:0016462),-0.3456688630995097,-1.201670815889676,0.1585081585081585,0.6187951169301491,1.0,13/50,17.32%,ENTPD1;PLPP1;NUDT3;ENTPD7;PRUNE1;ALPL;ENTPD2;BNIP2;NUDT4;NUDT1;PRUNE2;DHX29;DCPS
prerank,cytokine activity (GO:0005125),0.33040561476767666,1.2001310131967406,0.16591251885369532,0.7438682006492775,1.0,15/131,10.07%,BMP6;IL34;WNT4;WNT6;IL18;BMP7;CXCL13;NDP;IL6;WNT5B;CCL19;CSF1;GDF1;IL17D;CCL4
prerank,DNA-directed DNA polymerase activity (GO:0003887),-0.4217462952911831,-1.1983024044489428,0.22916666666666666,0.6228508660577119,1.0,12/21,26.39%,REV3L;POLQ;POLK;POLA1;POLN;POLE4;POLE;POLD3;POLB;POLD1;POLI;POLL
prerank,protein phosphatase binding (GO:0019903),-0.2995786838220259,-1.1982801690670604,0.11470588235294117,0.6174591797599512,1.0,36/117,22.73%,MAP3K5;IQGAP1;PTK2;DAB2IP;RACK1;PPP1R16B;PXN;PPME1;CTNNB1;HSP90B1;SOD1;AKAP11;MET;GRIN3A;CEACAM1;KCNQ1;FLT4;FOXO1;CDKN1B;MAP2K7;STAT3;MTMR9;MASTL;PPP6R1;JUP;VRK3;PPP1R16A;FBXL2;BOD1;SMG5;JAK3;JAK1;ATP2B4;VCP;ANAPC7;STRN4
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.42675565297727064,1.1967564269872788,0.2332695984703633,0.7469522259450104,1.0,9/29,11.64%,SLC13A3;SLC25A18;SLC13A5;ABCC2;SLC1A5;SLC25A11;SLC25A22;SLC19A1;SLC38A7
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.40951560787885166,-1.189363936554982,0.23689727463312368,0.6374522473376737,1.0,8/23,19.26%,HIP1;CLVS2;CLVS1;HIP1R;SNX14;ATP13A2;GBF1;JPH2
prerank,histone acetyltransferase binding (GO:0035035),0.45921386501224376,1.186991411569032,0.2570888468809074,0.7690948928887285,1.0,4/21,10.66%,EPAS1;KANSL1L;GLI3;KANSL1
prerank,N-acyltransferase activity (GO:0016410),0.4217871425011322,1.1863023620082356,0.23473282442748092,0.7644924232690278,1.0,10/32,16.53%,NMT2;NAA80;CERS6;CERS5;CERS1;SMARCE1;SAT2;ESCO1;NAT8;NAT14
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.46410454828766534,-1.1853380595792273,0.2505175983436853,0.6432742566416021,1.0,6/14,13.61%,MAL;RACK1;NOD1;ATP2A3;CASP8AP2;RPS27L
prerank,heme binding (GO:0020037),0.3692928605974661,1.1848535950366674,0.20098039215686275,0.7623826040253958,1.0,6/65,7.03%,CYP26B1;CYP27A1;CBS;PXDN;FLVCR2;PGRMC1
prerank,cytokine receptor binding (GO:0005126),0.3497070921494554,1.1828992588240648,0.20436817472698907,0.761823092889497,1.0,10/83,8.79%,TGFBR3;IL34;IL18;PXDN;IL13RA1;IL6;SMAD3;CCL19;CSF1;VEGFB
prerank,SH3 domain binding (GO:0017124),-0.32663141916176053,-1.18111517166462,0.17632241813602015,0.6496449265561061,1.0,16/62,10.85%,AFAP1L1;SHANK3;ELMO1;SGIP1;CBL;ADAM15;ARHGAP27;DAB2IP;PTPN12;WIPF1;SYNJ1;DNM2;ABI3;MICAL1;CD2AP;CRK
prerank,voltage-gated calcium channel activity (GO:0005245),0.4032499248208642,1.1809934610711692,0.24573378839590443,0.7609744419589998,1.0,6/37,7.35%,CACNA2D3;CACNA1D;CACNB4;CACNG7;TMC2;CACNA2D1
prerank,anion transmembrane transporter activity (GO:0008509),-0.4864503065490997,-1.1806429588128267,0.25650557620817843,0.6453727292887294,1.0,4/12,11.07%,ABCG2;SLCO2B1;SLC39A8;SLC4A2
prerank,E-box binding (GO:0070888),0.41292862008668313,1.1793934922916125,0.2571428571428571,0.75925993865626,1.0,9/34,13.72%,TCF4;ZEB1;SCX;ASCL2;MITF;ATOH8;NEUROD2;SNAI1;CLOCK
prerank,DNA polymerase activity (GO:0034061),-0.40988197791972775,-1.1776322286673928,0.24667931688804554,0.6478121889871062,1.0,12/22,26.39%,REV3L;POLQ;POLK;POLA1;POLN;POLE4;POLE;POLD3;POLB;POLD1;POLI;POLL
prerank,ADP binding (GO:0043531),0.4326211874305571,1.1769836524554467,0.2514177693761815,0.7603147062556875,1.0,5/25,12.27%,PRKAG2;MYO18A;MYO9B;MYH10;PRKAG1
prerank,amino acid binding (GO:0016597),-0.38252394496292547,-1.1757410602919827,0.22737306843267108,0.647751402589945,1.0,16/31,32.68%,NOS3;GRM7;GRIN3A;DDAH1;GRIN1;NOS1;GLRA3;DDAH2;AARS2;CASTOR1;GLRA1;GLDC;GNMT;GRIN2B;AGXT;NOS2
prerank,syntaxin binding (GO:0019905),0.3680599639200752,1.1740193956487939,0.24623115577889448,0.7630750863606643,1.0,11/61,11.30%,UNC13C;STXBP4;DAPK1;ABCA1;SYT12;LRRK2;STX16;SNAP47;GOLGA2;ABL1;STX8
prerank,kinase binding (GO:0019900),-0.24860916206071765,-1.173123503304658,0.04216867469879518,0.6497497476120113,1.0,91/434,12.99%,UTRN;FRMD5;SLC12A7;SLC12A2;CAV1;PTPRJ;ACTB;EEF1A1;TIAM1;ESR1;DLG2;MSN;TFRC;NSF;BCAR3;ADAM10;RAC1;ACVRL1;IQGAP1;CALM1;GSN;HSP90AB1;FBXO7;PTK2;UNC5C;TTC28;PLCG2;NBEA;EEF2;CSPG4;PDE8A;CAV2;DAB2IP;RPS7;RPS3;PIK3IP1;RPS19;PKD1;LIMS1;TRIM14;FLNA;RPS6;HSPB1;BCAR1;CIT;AP2A2;STX1A;WARS1;IKBKB;RHOB;MTCP1;FERMT2;CTNNB1;PTPRC;FAF1;BCL2L1;GSK3B;SPRED2;CEACAM1;ACTA2;CDC37;ADD2;CHP1;LRRC14;PDCD10;EMP2;CHEK2;SRCIN1;RHOA;PAK2;MAP3K1;APC;CDKN1B;MAP2K7;SLC12A4;STAT3;ATF4;PTPN1;CRK;PIH1D1;DUSP3;TOLLIP;CEP68;USP37;PTPN23;DNM1;MSH2;IBTK;PFKM;IRAK3;MAP3K12
prerank,clathrin adaptor activity (GO:0035615),-0.4503438356906224,-1.1719835753967331,0.25851703406813625,0.6476244190568423,1.0,5/15,9.34%,HIP1;STON2;AP2A2;HIP1R;AP2M1
prerank,MAP-kinase scaffold activity (GO:0005078),0.5248129717067526,1.1718106317454253,0.3083511777301927,0.7628377082679577,1.0,3/11,6.66%,KSR1;AKAP13;SH3RF1
prerank,glutamate receptor activity (GO:0008066),-0.4210623721964674,-1.1715192171909246,0.2662473794549266,0.6435256513570097,1.0,7/19,21.18%,GRM3;GRM7;GRIK4;GRM8;GRIA2;GRIK2;GRID2
prerank,single-stranded DNA binding (GO:0003697),0.3361482871049327,1.1705058365772845,0.2042483660130719,0.7607181710624501,1.0,23/93,17.60%,POLR2D;RBMS1;RAD51B;SSBP2;RAD51AP2;RNF138;TDP2;DMC1;BLM;WDR48;SSBP1;BRCA2;FUBP1;PCBP2;POLR3C;RAD23B;MLH1;STN1;MCM2;RAD51;REXO4;XPC;PURA
prerank,cell-cell adhesion mediator activity (GO:0098632),-0.35074252822943647,-1.1690520901010801,0.23195876288659795,0.6448650777666972,1.0,15/42,20.76%,STXBP6;BSG;ESAM;CD200;ROBO4;BAIAP2L1;PPP1CA;CNTN6;CD47;NTNG1;S100A11;NPTN;DSCAML1;PLXNB3;JAM3
prerank,phospholipase inhibitor activity (GO:0004859),0.5401401847944,1.1688901631762079,0.31385281385281383,0.7592406355521593,1.0,4/10,18.24%,ANXA1;APOC1;ANXA5;SNCA
prerank,transcription corepressor binding (GO:0001222),0.4388394721603157,1.1688638078895108,0.2723735408560311,0.7532528466229371,1.0,4/27,8.09%,RORA;USP11;MTF2;PER3
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.46129994958826304,-1.1687544985328904,0.2732342007434944,0.6405506158402022,1.0,6/13,25.74%,GABRG3;GLRA3;GABRA5;GABRE;GABRG2;GLRA1
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.43049110019221515,1.1680898535326243,0.2655038759689923,0.7494886469230659,1.0,4/26,3.73%,SLC6A13;SLC16A12;SLC6A12;SLC6A1
prerank,hormone receptor binding (GO:0051427),-0.4584018977681692,-1.167587085148954,0.2784552845528455,0.638419362941686,1.0,5/14,25.78%,SOCS2;PTHLH;JAK1;ADCYAP1;NPPC
prerank,actin binding (GO:0003779),-0.2755971142937609,-1.1674865401439056,0.109375,0.6336425938156716,1.0,33/170,9.36%,UTRN;MYRIP;TMSB4X;SYNE1;NOS3;ACTN4;KLHL2;FXYD5;PARVB;MICAL2;ABLIM1;MAP1B;GSN;PTK2;ITGB1;CORO2B;KCNMA1;TMSB10;EPS8L2;FERMT2;CCDC88A;SMTN;CAP2;PDLIM7;CEACAM1;MYH9;ADD2;HNRNPU;MICAL1;EPS8;SSH2;LDB3;SSH1
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.4216233237401782,-1.1664047644865074,0.26348547717842324,0.6317267142300268,1.0,6/20,13.34%,SLC39A10;SLC30A5;SLC39A8;SLC30A1;SLC39A7;SLC39A14
prerank,myosin V binding (GO:0031489),-0.4424993474581883,-1.1628806804939882,0.26806083650190116,0.635759121483095,1.0,6/15,25.58%,RAB3C;RAB3B;RAB8A;RAB3A;RAB14;RAB6B
prerank,secondary active transmembrane transporter activity (GO:0015291),0.3746001459087162,1.1620925905068,0.22822299651567945,0.7609053380285158,1.0,14/51,12.24%,SLC22A4;SLC5A5;SLC20A2;SLCO1B1;SLC28A3;MCU;SLC25A11;SLC20A1;SLC35E2B;SLC35E2A;SLC22A6;SLC35A1;CLCN4;SLC46A2
prerank,Hsp90 protein binding (GO:0051879),-0.37458482731997744,-1.1613219607428231,0.23684210526315788,0.6349364475739034,1.0,5/33,7.41%,SLC12A2;KDR;RPS3;AHR;CHORDC1
prerank,RNA methyltransferase activity (GO:0008173),0.4585647012169555,1.1612262611395021,0.2826510721247563,0.7574384030619633,1.0,6/19,9.45%,TRMT9B;METTL4;FTSJ3;METTL8;LCMT2;TRDMT1
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.4707612381216537,1.160850543952971,0.29980276134122286,0.7527353012676202,1.0,2/17,6.82%,DPYD;PTGR1
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.3970416481951912,1.1604016267390738,0.26334519572953735,0.7481647899590609,1.0,8/34,10.64%,LTF;ALS2;IGF2;FAM20A;RICTOR;CCNT2;CCNT1;MLST8
prerank,kinase activator activity (GO:0019209),0.41358358416800817,1.160057541403988,0.26666666666666666,0.7434772597496013,1.0,1/30,0.08%,PRKAG2
prerank,mechanosensitive ion channel activity (GO:0008381),-0.48260708775808764,-1.1594930068598328,0.26627218934911245,0.6351276927305616,1.0,3/12,8.36%,PIEZO2;PIEZO1;TMC6
prerank,phosphatidylinositol kinase activity (GO:0052742),-0.44221081017380093,-1.1592223188621966,0.26587301587301587,0.6309838106054414,1.0,6/15,18.64%,PIK3C2B;PIK3CD;PIK3C2A;PIK3C3;PI4KB;PIK3R3
prerank,metal ion binding (GO:0046872),-0.24644128697551007,-1.1577221560617177,0.0594059405940594,0.629999844472263,1.0,97/477,15.71%,CSGALNACT1;SLIT2;SPOCK2;LTBP4;ADGRL3;MAP3K5;ITPR2;ACER3;RASGRP3;ESYT2;STK38;TPD52;PITPNM2;THBS1;TPT1;CDH11;IQGAP1;CDH1;CALM1;GSN;SPARCL1;S100A6;AGRN;CDH2;CDC42BPA;MT1A;MT1H;MT1M;MT1E;MT1G;MT1X;MT1B;MT1F;MCTP1;ASPN;TGM2;STK38L;CALR;NUDT3;CAMKK2;HPRT1;HSP90B1;CEMIP2;GNAI1;ADPRH;CLEC3B;MT2A;PDE2A;ATP2A2;CHP1;RPH3A;NOTCH4;RYR2;MARK1;NRXN1;NUCB1;SNN;CCDC47;DYSF;C2CD5;BNIP2;CERK;IDS;S100A1;HSPA5;PIR;STIM2;GRIN1;MAP2K7;SYT10;S100A16;RHEB;PCLO;CALU;MSH2;S100A10;MARK2;CDH13;SYT4;TKT;CANX;SDF4;IRAK3;PITPNM3;PPP3CA;SRPK1;RET;MT3;SPOCK1;ITPR3;SPARC;KCNIP2;PLA2G4A;AASDHPPT;TPM4;CALM2;TPPP
prerank,chemorepellent activity (GO:0045499),-0.38847410876165667,-1.1555291709065862,0.26609442060085836,0.6310037416891625,1.0,11/25,11.39%,SEMA6A;SEMA7A;SEMA6D;SEMA3C;SEMA4D;SEMA3E;SEMA4B;SEMA5B;SEMA6C;DPP4;SEMA3G
prerank,G protein-coupled amine receptor activity (GO:0008227),-0.4053245361318177,-1.1525687067719166,0.2587268993839836,0.6245693951079456,1.0,13/22,40.53%,CHRM3;HTR2A;HRH1;HRH2;HTR2C;CHRM1;HTR1A;HTR1B;HTR1F;HRH3;CHRM5;HTR6;HTR1D
prerank,serotonin receptor activity (GO:0099589),-0.4053245361318177,-1.1525687067719166,0.2587268993839836,0.6245693951079456,1.0,13/22,40.53%,CHRM3;HTR2A;HRH1;HRH2;HTR2C;CHRM1;HTR1A;HTR1B;HTR1F;HRH3;CHRM5;HTR6;HTR1D
prerank,G protein-coupled serotonin receptor activity (GO:0004993),-0.4053245361318177,-1.1525687067719166,0.2587268993839836,0.6245693951079456,1.0,13/22,40.53%,CHRM3;HTR2A;HRH1;HRH2;HTR2C;CHRM1;HTR1A;HTR1B;HTR1F;HRH3;CHRM5;HTR6;HTR1D
prerank,chloride channel regulator activity (GO:0017081),-0.4620318548620337,-1.1514013208814136,0.29571984435797666,0.6231774258170221,1.0,8/14,17.13%,STX7;STX1A;VTI1B;VAMP8;WNK3;CFTR;WNK2;SGK1
prerank,histone deacetylase binding (GO:0042826),-0.29707324934196766,-1.150942262313851,0.19623655913978494,0.6196894720298982,1.0,28/88,23.48%,LEF1;MEF2C;MEF2D;HSP90AA1;HSP90AB1;HES1;HDAC5;YWHAB;SFPQ;SP2;HEY2;MAPK8;MEF2B;TAL1;KCTD21;AKAP8;BRMS1;TOP2A;RAD9A;SMG5;SPI1;TFAP4;HDAC9;NACC1;HDAC6;SATB2;RELA;HSPA1B
prerank,transcription cis-regulatory region binding (GO:0000976),0.2813840051072658,1.1475933268906522,0.14762516046213095,0.7728524999199554,1.0,62/406,13.66%,RORA;SOX5;TCF7L2;OSR1;AEBP1;EPAS1;NPAS3;ARID5B;MXI1;CUX1;SMAD6;SATB1;PRDM5;DMRT1;SCX;NR1I2;ASCL2;SOX6;TBL1XR1;ZBTB20;HIF3A;NFYB;BBX;VSX2;ZFP90;ASH2L;TEAD1;ARID4A;GLI3;ZFP37;BCOR;RFXAP;XRCC5;SMAD3;GABPB1;GABPB2;RBL2;TCF12;PER3;ARNT;NFYC;CREB3L2;AGO2;HDAC1;TFAP2A;HOXC8;TFAP2B;ZNF568;RXRA;ZNF177;E2F6;SOX13;HSF1;PSPC1;AR;HOXD4;NONO;NR1I3;FOXK2;SNAI1;TFDP2;MLXIP
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.4741585197819164,1.1471022733654124,0.298989898989899,0.7684030953333325,1.0,1/13,0.83%,AGPAT4
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.461671838553476,1.144169061291423,0.2674897119341564,0.7707330514854888,1.0,4/15,15.33%,PLA2G10;PLA2G4B;PLA2G4C;PLA2G12A
prerank,calcium ion binding (GO:0005509),-0.2504156612834542,-1.1437746688646107,0.108,0.6340687218924388,1.0,76/323,18.96%,SLIT2;SPOCK2;LTBP4;ADGRL3;ITPR2;ACER3;RASGRP3;ESYT2;TPD52;PITPNM2;THBS1;TPT1;CDH11;IQGAP1;CDH1;CALM1;GSN;SPARCL1;S100A6;AGRN;CDH2;MCTP1;ASPN;TGM2;CALR;CAMKK2;HSP90B1;CEMIP2;CLEC3B;ATP2A2;CHP1;RPH3A;NOTCH4;RYR2;NRXN1;NUCB1;CCDC47;DYSF;C2CD5;BNIP2;IDS;S100A1;HSPA5;STIM2;GRIN1;SYT10;S100A16;PCLO;CALU;S100A10;CDH13;SYT4;TKT;CANX;SDF4;PITPNM3;PPP3CA;RET;SPOCK1;ITPR3;SPARC;KCNIP2;PLA2G4A;TPM4;CALM2;AOC3;DSG2;TUBB4A;SYT2;CETN2;SYT7;DSPP;S100A11;TRPM4;LETM1;PADI2
prerank,protein kinase binding (GO:0019901),-0.23816328916919835,-1.143662459355918,0.059880239520958084,0.6298552438084559,1.0,93/479,12.08%,UTRN;FRMD5;SLC12A7;SLC12A2;CAV1;PTPRJ;ACTB;EEF1A1;TJP2;ESR1;MSN;STK38;TFRC;NSF;ADAM10;RAC1;ACVRL1;HSP90AA1;IQGAP1;DUSP16;CALM1;FBXO7;PTK2;UNC5C;ITGB1;PLCG2;ROR2;NBEA;EEF2;CSPG4;CAV2;DAB2IP;RPS7;RPS3;RACK1;RPS19;BMPR2;PKD1;TRIB2;LIMS1;GCH1;TRIM14;RPS6;HSPB1;BCAR1;CIT;ADCY4;AP2A2;WARS1;IKBKB;RHOB;HDAC5;MTCP1;FERMT2;PTPRC;CCDC88A;FAF1;CAVIN2;BCL2L1;GSK3B;SPRED2;CEACAM1;ACTA2;CSK;ADD2;KCNQ1;PDCD10;EMP2;RYR2;CHEK2;SRCIN1;RHOA;APPL1;PAK2;MAP3K1;APC;YWHAG;CDKN1B;MAP2K7;SLC12A4;STAT3;ATF4;PTPN1;DUSP8;CRK;PIH1D1;DUSP3;CEP68;HINT1;USP37;PTPN23;DNM1;MSH2
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.5176320961762846,1.143343201601603,0.3111587982832618,0.7673005804586023,1.0,5/10,13.93%,MGME1;DCLRE1A;DCLRE1B;TATDN1;APEX1
prerank,lipid phosphatase activity (GO:0042577),0.4903473229557026,1.142890064433779,0.29206963249516443,0.7628821893575691,1.0,6/14,18.66%,PLPP3;EPHX2;SGPP1;PLPP2;PLPPR3;PLPP7
prerank,GTPase inhibitor activity (GO:0005095),-0.4591257996660017,-1.1405341343837871,0.3051181102362205,0.6331130744580907,1.0,2/13,2.13%,SLIT2;IQGAP1
prerank,O-acyltransferase activity (GO:0008374),-0.3740279496581429,-1.1404678490276385,0.2689655172413793,0.6288792093911206,1.0,15/30,31.34%,MBOAT1;LPCAT3;GPAT4;GPAT3;DGAT1;LPCAT1;PLA2G4A;LCAT;GPAM;PRDX6;PIGW;PLAAT1;PLA2G15;MBOAT2;LPCAT4
prerank,CoA hydrolase activity (GO:0016289),0.46498086120826954,1.1372439211316803,0.30638297872340425,0.7729391019943106,1.0,8/16,23.13%,ACOT4;ACAA2;ACOT1;HIBCH;NUDT7;ACOT11;ACOT13;ACOT6
prerank,proton transmembrane transporter activity (GO:0015078),-0.3471112645451446,-1.1364584900056105,0.2617924528301887,0.6349880174702872,1.0,16/39,28.35%,COX4I1;CLCN5;NDUFA4;UQCRH;COX6A1;UQCR11;COX8A;COX5A;UQCRQ;UQCRC1;NDUFA4L2;UQCR10;CLCN3;ATP6V1B2;COX15;COX4I2
prerank,solute:anion antiporter activity (GO:0140323),0.47628122492135155,1.1337237990268776,0.32432432432432434,0.7773603591019684,1.0,1/14,0.11%,SLC7A11
prerank,small GTPase binding (GO:0031267),-0.26707990557209504,-1.1265958701039118,0.19047619047619047,0.6565404850623711,1.0,51/170,21.93%,UNC13B;FGD5;CAV1;FGD6;TBC1D30;IQGAP1;EXOC4;SH3BP4;ARHGDIB;RABGAP1L;NCKAP1;RIN3;FLNA;YBX3;EHD1;SOD1;PEX5L;SGSM1;PAK1;CYRIB;EPS8;EXOC5;PAK2;RANBP1;KCTD13;EVI5;MYO5A;RANGAP1;WHAMM;ARHGEF2;MLPH;PPP6R1;CDC42EP5;RCC2;DMXL2;BICDL1;RAF1;TRIP11;BICD1;RABGAP1;RTKN;KIF3B;CDC42EP2;RABGGTB;IFT20;PEX5;ARFIP2;RABGGTA;RAB8A;RAP1GAP;EXOC8
prerank,phosphoric ester hydrolase activity (GO:0042578),0.36524769905155063,1.124677481852049,0.2923076923076923,0.7974424969568511,1.0,8/49,8.83%,ATP1A2;PXYLP1;LHPP;DUSP10;EPHX2;ACP3;MPPED2;HDHD2
prerank,lipoprotein particle receptor binding (GO:0070325),-0.36959990651323504,-1.1237786099792375,0.29605263157894735,0.6599123499888851,1.0,8/27,12.65%,DNAJA1;HSP90B1;APBB1;AP2M1;RELN;APBB3;MESD;CLU
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.26761408705164846,1.1234424488178874,0.17005988023952096,0.7954450202008515,1.0,93/597,14.06%,CREB5;SOX5;MAF;TCF4;TCF7L2;OSR1;ARNT2;ZIC1;HLF;HOXC4;HOXB4;ESRRG;ARID5B;CUX1;SMAD6;PRDM5;DMRT1;NR1I2;ASCL2;SOX6;TBL1XR1;ZBTB20;NFYB;ZIC5;BBX;PKNOX2;VSX2;NFAT5;HOXA7;ASH2L;NFIB;TEAD1;ELF4;ARID4A;TEF;GMEB1;IRF8;ZNF250;GLI3;ZBTB32;TCF7L1;BCOR;ZNF23;XRCC5;SMAD3;EN1;NR6A1;GABPB1;GABPB2;TCF12;PER3;ARNT;KDM5B;CEBPG;NFYC;HOXB6;CREB3L2;IRF3;MBD4;ZSCAN29;IRX1;ABL1;NEUROD2;TFAP2A;HOXC8;TFAP2B;ZIC4;ZNF568;RXRA;NPAS2;ZBTB37;ZNF177;ORC2;SOX13;GMEB2;HSF1;PSPC1;AR;HIVEP1;KLF5;HOXD4;NFATC4;TSPYL2;HOXA6;NONO;NR1I3;FOXK2;SNAI1;HOXB9;CLOCK;SRF;DMRTA2;BATF
prerank,endopeptidase activity (GO:0004175),0.2842357435802974,1.1224105983960737,0.20314547837483618,0.7930801832790659,1.0,26/257,8.96%,ADAMTS12;ADAMTS9;TRABD2B;CORIN;ADAMTS5;THSD4;ADAMTS10;KLK2;ADAMTS15;CTSH;USP11;MMP2;PCSK9;ACE;TPP1;ADAMTS7;MMP19;PSMA2;NRDC;PSMA3;MMP9;USP24;ADAMTSL4;USP25;USP7;USP34
prerank,protein heterodimerization activity (GO:0046982),0.29779250926625217,1.1156158343774318,0.24447717231222385,0.80654763501011,1.0,25/178,11.42%,ATP1A2;BMP6;TCF4;ARNT2;EPAS1;NPAS3;BDKRB2;TPM1;BCL2;IRAK2;TOP2B;ZHX2;PAFAH1B3;ITGA3;ALG2;ARNT;PAFAH1B1;BCL2L2;PGLYRP3;MICU1;NEUROD2;UBA3;TFAP2B;FXR1;ERBB2
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.4488994612780892,1.1123415701775634,0.33134920634920634,0.8104150005286509,1.0,1/15,0.83%,AGPAT4
prerank,protein kinase activator activity (GO:0030295),0.34831074981124005,1.1122606120628495,0.30528052805280526,0.8050182288454215,1.0,6/60,5.14%,PRKAG2;LTF;ALS2;IGF2;FAM20A;RICTOR
prerank,beta-tubulin binding (GO:0048487),0.4024523570313333,1.1116203515900271,0.3378119001919386,0.8014105179173524,1.0,2/31,1.94%,GJB6;EML4
prerank,voltage-gated sodium channel activity (GO:0005248),0.4217847312817142,1.1105953128193264,0.34375,0.7985896947690788,1.0,1/22,0.09%,SCN7A
prerank,"DNA binding, bending (GO:0008301)",-0.4372604771811781,-1.1104943700856966,0.3339920948616601,0.6900581711329746,1.0,3/14,16.86%,LEF1;HHEX;TOP2A
prerank,symporter activity (GO:0015293),0.5013001829504643,1.1093086262178184,0.33974358974358976,0.7970524156758155,1.0,3/10,12.24%,SLC5A5;SLC28A3;SLC46A2
prerank,Toll-like receptor binding (GO:0035325),-0.4691772429300629,-1.108563777461185,0.36153846153846153,0.6904851359083021,1.0,7/11,32.64%,DAB2IP;TOLLIP;TIRAP;MYD88;CD36;TLR6;TLR1
prerank,thyroid hormone receptor binding (GO:0046966),0.39676141694845074,1.1084194518695505,0.3220338983050847,0.7941602717821684,1.0,15/28,25.18%,BRD8;NCOA3;NSD1;MED1;MED13;TACC1;ZNHIT3;TRIP6;NCOR1;HMGN3;TRIP12;THRAP3;GTF2H1;MED24;GTF2B
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.5019614535386185,1.1077394755774772,0.36419753086419754,0.7907551306561296,1.0,3/10,13.64%,DUOX2;NCF2;DUOX1
prerank,transforming growth factor beta binding (GO:0050431),-0.37987867515696644,-1.1062453218078807,0.29809725158562367,0.6919311981269441,1.0,8/23,12.03%,LTBP4;THBS1;ACVRL1;ENG;TGFBR2;CD109;LTBP1;NRROS
prerank,transforming growth factor beta receptor binding (GO:0005160),0.4381112345533479,1.1051535225235993,0.34833659491193736,0.7927462737799613,1.0,3/18,7.08%,TGFBR3;SMAD6;SMAD3
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.47105614888969416,-1.1051436750400707,0.35195530726256985,0.6902561652132544,1.0,4/11,24.62%,MAP3K5;MAP3K1;MAP3K6;MAP3K15
prerank,tau protein binding (GO:0048156),-0.3384545506579023,-1.1047833110893042,0.31494252873563217,0.6866079566881397,1.0,16/40,23.28%,ACTB;HSP90AA1;HSP90AB1;FYN;LGMN;GSK3B;MARK1;BIN1;MARK2;CLU;CDK5;DCTN1;TTBK2;HDAC6;BRSK2;MAP1A
prerank,hexose transmembrane transporter activity (GO:0015149),-0.4689278611257889,-1.1037015581220166,0.32688588007736946,0.6850843771064495,1.0,1/12,0.80%,SLC2A1
prerank,G protein-coupled receptor binding (GO:0001664),0.3047998059468395,1.1032164844929842,0.28346456692913385,0.7928506380257953,1.0,17/132,7.93%,WNT4;RNF43;WNT6;PRKN;TULP3;GNAS;ADM;NDP;ACE;ZNRF3;TAFA5;ARHGEF11;GNAQ;WNT5B;GRK3;CCL19;RYK
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.44569160056591484,-1.102389195815139,0.33714285714285713,0.6841768556745662,1.0,5/13,7.87%,PTPRJ;ITGA5;IL1R1;PDGFC;VEGFA
prerank,phosphotyrosine residue binding (GO:0001784),-0.33557362338212154,-1.1020001451573935,0.29955947136563876,0.6805327164928803,1.0,10/37,20.42%,BCAR3;SHE;PLCG2;NCK2;CRK;SAMSN1;SHB;YES1;PIK3R3;SHC3
prerank,semaphorin receptor activity (GO:0017154),0.4828158439185799,1.098363301948448,0.36875,0.8006489569180905,1.0,2/11,4.57%,PLXNA2;PLXNC1
prerank,WW domain binding (GO:0050699),-0.3666459615810862,-1.0971144252663367,0.3125,0.6888831153975566,1.0,13/26,37.60%,NDFIP2;TCEAL8;TCEAL9;WBP1;NDFIP1;TCEAL5;PRRG4;TCEAL1;SCNN1A;TCEAL3;TCEAL6;LITAF;NFE2
prerank,protein kinase inhibitor activity (GO:0004860),-0.3296007310216672,-1.093977045335457,0.29638009049773756,0.6925147295924594,1.0,19/42,31.43%,RACK1;CIT;NCK1;YWHAB;SPRED2;CDKN1B;SPRY4;IBTK;SMCR8;CAMK2N1;PRKRIP1;CDKN1A;INKA2;SOCS1;SPRY2;RPTOR;GMFB;MAPK8IP1;CEP43
prerank,bHLH transcription factor binding (GO:0043425),0.4233838122636784,1.0927528848767718,0.3577075098814229,0.8103093744081202,1.0,4/19,7.97%,FHL2;SCX;SMAD3;TCF12
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.48275242229554727,1.092361117712465,0.36285097192224625,0.8062171243791956,1.0,1/11,0.79%,ITPR1
prerank,mRNA 5'-UTR binding (GO:0048027),-0.38050067528344395,-1.0920335241380317,0.3516260162601626,0.6930712886348557,1.0,7/24,10.92%,RPL41;RPS7;RPL26;RPS14;GNL3;RPL5;RSL1D1
prerank,double-stranded DNA binding (GO:0003690),0.2625935045191847,1.091981736561418,0.2460220318237454,0.8020766380982156,1.0,87/531,14.90%,CREB5;MAF;TCF4;OSR1;ARNT2;ZIC1;HLF;HOXC4;RBMS1;HOXB4;ESRRG;CUX1;SATB1;DMRT1;NR1I2;ASCL2;ZBTB20;ZIC5;BBX;RAD51B;PKNOX2;VSX2;NFAT5;HOXA7;NFIB;TEAD1;ELF4;RAD51AP2;TEF;GMEB1;CAMTA1;IRF8;ZNF250;DMC1;DDX60;GLI3;ZBTB32;TCF7L1;ZNF23;XRCC5;EN1;NR6A1;WDR48;TCF12;ARNT;MAU2;KDM5B;CEBPG;HOXB6;IRF3;ZSCAN29;IRX1;ABL1;PRKDC;NEUROD2;TFAP2A;HOXC8;TFAP2B;ZIC4;RXRA;NPAS2;ZBTB37;CRY1;ZNF177;GMEB2;HSF1;HIVEP1;KLF5;CGGBP1;HOXD4;NFATC4;HOXA6;NR1I3;ZBP1;MRE11;SNAI1;HOXB9;CLOCK;SRF;APEX1;DMRTA2;BATF;GLI2;HOXD8;CENPX;KLF13;SOX12
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.4733339372625795,1.0910644551094841,0.35785288270377735,0.7992253088800938,1.0,6/12,21.84%,FRS2;PIK3R1;GAB2;BLNK;SHC1;IRS1
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.4545281596783898,-1.0881825334922188,0.369140625,0.6984530636578714,1.0,7/11,15.64%,ITPR2;TRPC3;TRPC6;RPH3A;TRPC4;ITPR3;TRPC1
prerank,metal ion transmembrane transporter activity (GO:0046873),-0.3592147356512714,-1.0872424636288818,0.31521739130434784,0.696174388745764,1.0,8/27,11.79%,SLC12A2;ITPR2;SLC9B2;MAGT1;ATP2A3;SLC4A8;KCNA1;ATP2B1
prerank,UDP-glycosyltransferase activity (GO:0008194),0.3300475658074018,1.0868959323710914,0.3090909090909091,0.8058556030741898,1.0,8/70,7.54%,B3GALT1;LARGE1;GXYLT2;B3GNT5;B4GALT1;CHSY1;HAS1;EXTL1
prerank,transaminase activity (GO:0008483),0.48549051372457563,1.086122628302185,0.3726315789473684,0.8028305972427658,1.0,1/11,1.55%,ABAT
prerank,manganese ion binding (GO:0030145),0.3595874534676965,1.0853596287961673,0.33865248226950356,0.7998374856988731,1.0,16/48,19.30%,LARGE1;PPM1M;B4GALT1;TDP2;MPPED2;HMGCL;NEK4;XYLT2;ABL1;PRIMPOL;WRN;POMGNT1;XPNPEP3;XXYLT1;PCK2;GALNT3
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.4495204592193137,-1.0832588327463644,0.39223300970873787,0.7024238687590773,1.0,5/12,7.62%,PDE4D;PDE3A;PDE8A;PDE2A;PDE8B
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.44627220981616755,1.0811221288183643,0.3498964803312629,0.80664551700465,1.0,5/15,11.64%,SLC1A3;SLC25A18;SLC1A5;SLC25A22;SLC38A7
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),-0.4072475111958526,-1.0800252487768818,0.35555555555555557,0.7062787118831488,1.0,8/16,22.59%,SYNJ1;MTM1;MTMR6;MTMR9;SACM1L;MTMR12;INPP5F;MTMR1
prerank,alanine transmembrane transporter activity (GO:0022858),-0.4409635166629104,-1.079960020835448,0.38336713995943206,0.7021087498062388,1.0,6/12,16.40%,SLC6A6;SLC38A5;SLC3A2;SLC36A1;SLC1A4;SLC36A4
prerank,Notch binding (GO:0005112),0.40916928376976935,1.07978358610057,0.3530571992110454,0.8052161966992856,1.0,2/22,3.29%,SNED1;MEGF10
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.3502285436522339,1.0797632506063768,0.3379073756432247,0.8003001052351456,1.0,4/48,4.49%,TRPM3;NALCN;SLC41A1;MMGT1
prerank,lipase activity (GO:0016298),0.35885102962237203,1.0794705041026587,0.332089552238806,0.7961108922793967,1.0,6/43,7.58%,CEL;LIPA;PLA2G10;LIPH;LIPC;DAGLB
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.3237310862651363,1.0783874123033337,0.3202054794520548,0.794091554363457,1.0,7/73,10.63%,NPR3;LGR4;BDKRB2;KISS1R;PTH2R;GLP1R;NPR1
prerank,kinase activity (GO:0016301),-0.2745690183626306,-1.0762375401890933,0.28888888888888886,0.7073957409887395,1.0,37/109,25.12%,DGKH;PSTK;DGKB;PRKD3;NADK;GSK3B;PGM2L1;PIK3C2B;DGKI;NMRK1;MTOR;PAPSS2;CERK;PIK3CD;PIK3C2A;DGKZ;DGKG;PIK3C3;MASTL;CKB;RFK;ITPKB;PI4KB;PRKD1;ETNK1;IRAK1;CDK5;PINK1;SEPHS2;PANK2;AKT1;TRIB3;DGKE;DGKQ;IDNK;SEPHS1;SPHK2
prerank,epidermal growth factor receptor binding (GO:0005154),0.3913027172627368,1.075759521044417,0.3538175046554935,0.7961721435888636,1.0,3/25,3.35%,EFEMP1;FER;FAM83B
prerank,protein phosphatase regulator activity (GO:0019888),0.34042382935856613,1.0715087926672013,0.34296028880866425,0.802585183182946,1.0,6/53,5.91%,RCAN2;PPP2R2B;PPP4R4;DMPK;PTPA;PTN
prerank,protein serine/threonine kinase activity (GO:0004674),0.265266716732259,1.0699252631567295,0.29649595687331537,0.8020579578952785,1.0,60/335,14.87%,MAPK4;ROCK2;OXSR1;NRK;WNK4;CDK8;DAPK1;PDPK1;CAMK1D;BMP2K;MYLK;DMPK;MAP4K5;CDK7;FAM20A;IRAK2;SRPK2;ARAF;MAPK9;SIK1;PRKAA2;LRRK2;PRKCZ;PRKCB;STK17B;TTK;PRKCA;GRK3;PRKAA1;NEK4;NRBP1;GRK5;PKN2;CDK1;CAMK2D;PIK3R4;MAP3K2;NEK10;VRK2;SBK3;LATS1;STKLD1;PRKDC;RPS6KB1;IKBKE;BMPR1A;MAPKAPK2;HIPK3;PRKD2;STK24;TBK1;MAPK1;MAP3K7;NIM1K;CDKL5;NLK;CDK15;PRKCI;CDK4;SIK3
prerank,snoRNA binding (GO:0030515),-0.3460655856702948,-1.069882868438098,0.3727087576374745,0.7202607278444666,1.0,13/30,28.81%,IMP3;BMS1;NUDT4;DHX37;WDR3;NUDT1;TBL3;NHP2;TSR1;RRP9;NUDT16;BYSL;NOP10
prerank,cholesterol binding (GO:0015485),0.3510119977981373,1.0673223306132602,0.35701906412478335,0.8042753744225729,1.0,4/47,4.04%,SIDT1;OSBPL8;GRAMD1C;ABCA1
prerank,telomeric DNA binding (GO:0042162),0.3768399311176356,1.0670667964164398,0.36074766355140186,0.8001650339460185,1.0,16/32,24.24%,ACD;XRCC5;BLM;APEX1;WRN;STN1;TELO2;PURA;UPF2;HNRNPA2B1;RAD50;UPF3A;TERF2;SMG1;NCL;KDM1A
prerank,NADP binding (GO:0050661),0.3813466647714807,1.0666162137579318,0.38209982788296043,0.7966903423834873,1.0,3/32,2.52%,DPYD;GMDS;HSD17B1
prerank,organic anion transmembrane transporter activity (GO:0008514),0.29633918277464427,1.065307697033474,0.35294117647058826,0.7954486182023217,1.0,28/134,12.76%,SLC6A13;SLC13A3;SLC16A12;SLC38A3;SLC6A9;SLC1A3;PDPN;SLC6A1;SLC25A18;GJA1;SLC38A9;SLCO1B1;SLC2A10;SLC13A5;ABCC2;SLC1A5;SLC25A22;SLC27A1;SLC22A6;SLC19A2;SLC19A1;SLC36A2;SLC35A1;SLC38A7;SLC25A2;SLC38A2;OCA2;SLC25A38
prerank,cytochrome-c oxidase activity (GO:0004129),-0.41759238284544103,-1.0650930556909948,0.3754863813229572,0.7287151843614865,1.0,8/15,28.35%,COX4I1;NDUFA4;COX6A1;COX8A;COX5A;NDUFA4L2;COX15;COX4I2
prerank,cation channel activity (GO:0005261),0.3036373123182701,1.0648596571047142,0.3478964401294498,0.7919279347790973,1.0,4/94,1.67%,TRPM3;SLC24A3;KCNQ4;NALCN
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.4624904573114394,-1.0645935791645846,0.4083969465648855,0.7256773666520393,1.0,2/10,1.63%,SHANK3;NSF
prerank,purinergic nucleotide receptor activity (GO:0001614),-0.41914767764093225,-1.062967520391925,0.392578125,0.7257074586515522,1.0,12/15,50.87%,GPR34;P2RY12;PTAFR;P2RY1;P2RX5;P2RX7;P2RX3;P2RX6;GPR171;P2RX1;GPR87;P2RY13
prerank,transmitter-gated ion channel activity (GO:0022824),-0.3470311968816532,-1.0573292784615904,0.38562091503267976,0.7364002890956509,1.0,12/29,24.99%,GABRB3;GRIK4;GABRB1;GABRG3;GLRA3;GRIA2;GRIK2;GABRA5;GRID2;GABRE;CHRNB1;GABRG2
prerank,transition metal ion binding (GO:0046914),0.2600932273712938,1.056159682588346,0.33997509339975096,0.8102818613914071,1.0,89/397,16.94%,MOXD1;PAPPA;HEPH;AGMO;KDM7A;PRKN;UPB1;LARGE1;KMT2A;SOD3;ZEB1;PPM1M;LTF;LOXL3;LACC1;B4GALT1;BAZ1B;RNF2;IKZF4;KDM2B;TDP2;SORD;ACE;TET1;ZBTB32;NAPEPLD;ZFP37;PHF8;CXXC5;THAP1;RABIF;ENPP2;MPPED2;SMAD3;NPEPPS;HMGCL;BLM;MMP9;CHD4;NEK4;BBOX1;ZKSCAN5;KDM2A;SLC30A8;SLU7;DPYS;COX17;KDM5B;TRAF7;XYLT2;MDM2;NSD1;CCS;DCT;ABL1;ATP7B;ZNF8;RXRA;ENPP3;MYCBP2;PAM;KMT2B;ITGB1BP2;EEA1;CYLD;RCHY1;S100A9;SHMT1;PRIMPOL;ESCO1;TRIM24;NUDT12;KDM5C;MNAT1;GLI2;BIRC2;ACO2;WRN;SKI;POMGNT1;ZMYM2;NAALADL1;PHF2;SIRT3;SEC24A;XPNPEP3;CBLB;XXYLT1;TYW5
prerank,tubulin binding (GO:0015631),-0.23330331324581077,-1.0560090160892854,0.291497975708502,0.735293234625089,1.0,90/295,24.41%,DNM3;MTUS1;SGIP1;TTLL7;STARD9;MAP1B;UNC5C;REEP3;REEP1;FYN;MAP4;MID1;RPS3;CLIP1;MAP6;BLOC1S2;CLIP2;CCDC88A;RP1;EML6;PRUNE1;EFHC2;KIF26A;MDM1;CHP1;GAPDH;STMN2;MAP1LC3B;DNM2;PAK1;NAV3;APPL1;APC;KIF1A;ARL8A;RMDN3;GIT1;DNM1;WHAMM;ARHGEF2;RAB11FIP5;STMN1;ALDOA;MTCL1;TOGARAM1;GAS2L3;KIF13A;HOOK1;RCC2;CCDC66;NDE1;CCDC88C;RMDN1;TPPP;KIF21B;STMN4;FHDC1;APC2;TPPP3;RABGAP1;CEP295NL;KIF3B;CCDC69;STMN3;GAS2L1;CDK5;CKAP5;MID2;IRAG2;HAUS6;POLB;KIF15;FMR1;B9D2;NUMA1;GABARAPL1;DCTN1;VAPA;TRIM36;HDAC6;MAST1;SPAG5;KIFC1;TRAPPC14;MAP1A;CLASP2;SPEF1;CEP295;TTLL6;SAXO2
prerank,DNA-binding transcription factor binding (GO:0140297),0.2758238935774563,1.0545215520758888,0.32595870206489674,0.8101478922805491,1.0,35/189,14.11%,TCF7L2;RBPJ;FHL2;PPARA;PRRX1;RUNX1T1;BCL2;PRDM5;SCX;NFYB;FIZ1;SIK1;TLE3;CXXC5;TTC8;SMAD3;CHD4;RBL2;TCF12;TEAD3;WWP2;LYAR;PIAS1;TLE1;BBS7;HDAC1;GTF2I;AR;CRTC1;CRTC3;CGGBP1;IFI27;SRF;MTDH;CREBBP
prerank,phosphatase binding (GO:0019902),-0.26464723759700026,-1.0544338107882816,0.3415977961432507,0.7351516920026022,1.0,30/105,22.64%,MAP3K5;IQGAP1;PTK2;RACK1;PXN;PPME1;NFATC2;CTNNB1;HSP90B1;MET;CEACAM1;FLT4;CHCHD3;CDKN1B;MAP2K7;STAT3;SPTBN4;MTMR9;PPP6R1;JUP;TERF2IP;VRK3;FBXL2;PPP3R1;JAK3;JAK1;CTSC;MAPK3;VCP;ANAPC7
prerank,iron ion binding (GO:0005506),0.34429980048992964,1.0535019840747442,0.3644214162348877,0.8081864592615522,1.0,7/48,8.56%,HEPH;AGMO;KDM7A;LTF;TET1;PHF8;PHYH
prerank,purine ribonucleoside triphosphate binding (GO:0035639),-0.22369628028399108,-1.0533833057947608,0.2537313432835821,0.7336693394273733,1.0,139/431,25.17%,EEF1A1;MAP3K5;RAP1A;RHOJ;STK38;HSPA8;KRAS;ATP1A1;RPS6KA5;RAC1;ACVRL1;HSP90AA1;HSP90AB1;CDC42BPA;RASL12;PRAG1;RAB31;RAB27A;MINK1;CDK11B;GCH1;TGM2;STK38L;PRPS2;ATP5F1A;RERG;NRAS;RHOB;TUBB3;GBP4;ATP5F1D;GNAI1;RHOT1;ARF5;GNL3;SCG5;WNK3;ARF1;MRAS;MYH9;HNRNPU;DNM2;RAB28;HSPA14;MARK1;PEAK1;RHOA;RAB38;PXK;EIF4G1;BMS1;CDK6;HSPA5;ARHGEF5;RALB;ARL8A;TUBB4B;TUBA1B;GBP5;NDUFA13;RHEB;ATP1A3;ABCD3;GUK1;MSH2;PDK2;MARK2;OAS2;LMTK2;KCNJ8;PFKM;IRAK3;STK36;IDE;GBP3;TUBB2A;SRPK1;TUBA1A;ABCD2;PFKP;SYN2;RABL3;ATL2;CLP1;MTHFD1L;RHOG;RPS6KA4;EIF2B2;WNK2;PEX1;RRAS;TUBB4A;ACVR1;AK6;UBA2;ABCD4;RRAGB;ABCA2;RAB1B;LIG4;MTREX;PINK1;ABCG1;ACLY;TLK2;RAB39A;HSPA9;RIT2;AKT1;MAP3K6;ARFIP2;INSR;MKNK2;NUAK2;RAB8A;UHMK1;SMC4;TUBD1;PYGL;MAST1;BRSK2;KIFC1;TSR1;SIK2;HSPA1B;NEK11;RAB7A;AARS2;ARL4A;GEM;DDX25;SEPHS1;DRG2;TUBB2B;RAB2A;CDC42BPB;RAB14;NUDT16;HRAS
prerank,mRNA binding (GO:0003729),-0.23539502930135187,-1.051660129056279,0.29571984435797666,0.7338963822193643,1.0,78/249,22.30%,RPL41;NOVA2;HNRNPK;TARDBP;ADARB1;RPS7;RPS3;RBFOX1;PKM;IREB2;RPL26;QKI;LUC7L2;RBFOX3;RPS14;HNRNPAB;G3BP1;RBFOX2;RBM47;PABPC1;CALR;YBX3;SRSF1;GNL3;SRRM3;RPL5;PUM2;EIF4G3;RPS2;HNRNPU;PPIE;SF3B1;RBM14;DDX5;SRSF5;ZC3H12C;CPEB1;EIF4G1;ZFP36L1;SSB;EIF3D;RPL7;RSL1D1;YTHDF3;CPSF6;RBM8A;KHDRBS3;RNPS1;SHFL;SRSF6;GRSF1;RPS26;HNRNPA0;RPS5;RPL13A;RIDA;SERBP1;EIF2A;N4BP1;ZC3H12A;CSTF2T;PCBP1;PCF11;CSTF2;YTHDC1;MRPL13;EDC3;PCBP4;HNRNPLL;PTBP1;RPL35;SNIP1;METTL3;FMR1;EIF3A;TRA2B;PUM3;RBM24
prerank,adenylate cyclase binding (GO:0008179),0.4692581667354929,1.0514657147360742,0.42332613390928725,0.8086999265945988,1.0,1/10,0.40%,ADCY5
prerank,transcription coactivator binding (GO:0001223),0.4181141457980385,1.050777791764248,0.415506958250497,0.805856377986522,1.0,4/20,8.04%,RORA;VGLL4;SMAD3;CCNT2
prerank,peptide hormone receptor binding (GO:0051428),-0.4377073944628731,-1.049508844521538,0.4069264069264069,0.7350804662466393,1.0,6/11,45.18%,PTHLH;GNRH1;ADCYAP1;PSMC5;VIP;UCN2
prerank,phosphatase activity (GO:0016791),0.3167494543997511,1.0492626899108555,0.35993485342019543,0.8052553727226429,1.0,9/73,8.83%,ATP1A2;PXYLP1;PLPP3;LHPP;DUSP10;EPHX2;ACP3;NT5M;HDHD2
prerank,sodium channel activity (GO:0005272),0.3590710236907284,1.0472643591028592,0.3740875912408759,0.8060937687784437,1.0,2/37,2.90%,SCN7A;SHROOM2
prerank,methylated histone binding (GO:0035064),0.32522623882148055,1.0459126899184912,0.38461538461538464,0.8051772870865492,1.0,15/62,16.25%,KDM7A;PYGO1;L3MBTL2;DPF2;PHF8;MTF2;CBX8;CBX2;KAT8;MBTD1;RRP8;TRIM24;MORC3;PHF1;PHF2
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.42756555491677833,1.0457430008954172,0.4012096774193548,0.8011019350928811,1.0,4/18,15.05%,HSD17B1;HSD17B10;DHRS11;HSD17B14
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),-0.3434079985837517,-1.0452315557788605,0.39293598233995586,0.7421819878927001,1.0,11/28,32.30%,DAB2IP;EDA;TMBIM1;CASP8AP2;TRAF1;MADD;MYD88;STAT1;BID;FADD;PIDD1
prerank,potassium ion antiporter activity (GO:0022821),0.424557464880998,1.045146193695237,0.4085106382978723,0.7981308591059784,1.0,1/15,0.36%,SLC24A3
prerank,protease binding (GO:0002020),0.3013735816626742,1.04491571316431,0.38449612403100775,0.7942936650925535,1.0,15/99,8.91%,BDKRB2;TIMP3;STIM1;PRKN;BCL2;ECM1;A2ML1;CCBE1;COL1A2;ITGA3;NOL3;PTEN;ADAMTSL4;AMFR;BRCA2
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.3768756086574016,1.0446449612157407,0.4094903339191564,0.7907003273071292,1.0,1/29,0.08%,PRKAG2
prerank,lysophospholipase activity (GO:0004622),-0.374567320190044,-1.042234067332973,0.42061855670103093,0.7458233432762358,1.0,6/20,15.14%,MGLL;GDPD1;GDPD3;LYPLA2;PNPLA6;PLA2G4A
prerank,GABA receptor activity (GO:0016917),-0.3723217381887226,-1.041429699338279,0.405189620758483,0.7437343567900747,1.0,7/21,25.15%,GABRB3;GABRB1;GABRG3;GABRA5;GABRE;GABRG2;GABBR1
prerank,aminoacyl-tRNA ligase activity (GO:0004812),-0.32344927661132544,-1.0410200120890891,0.3920704845814978,0.7406383561652595,1.0,13/37,29.61%,WARS2;LARS2;WARS1;SARS1;YARS1;IARS1;NARS1;FARSA;AARS2;CARS1;KARS1;MARS2;GARS1
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",-0.2808914878517336,-1.038943998369189,0.37844611528822053,0.7420967509608783,1.0,20/74,16.22%,DGKH;PKM;DGKB;NADK;FAM20C;PGM2L1;PIK3C2B;DGKI;HK1;NMRK1;PAPSS2;PIK3CD;PIK3C2A;DGKZ;DGKG;PIK3C3;RFK;PI4KB;CLP1;ETNK1
prerank,actin monomer binding (GO:0003785),-0.3674446340925299,-1.0386010429078323,0.40717299578059074,0.7386952479210754,1.0,3/22,3.94%,TMSB4X;NOS3;TMSB10
prerank,low-density lipoprotein particle receptor binding (GO:0050750),-0.36234215756551036,-1.035129130392407,0.4264069264069264,0.743370749703624,1.0,7/22,12.65%,DNAJA1;HSP90B1;APBB1;AP2M1;APBB3;MESD;CLU
prerank,death receptor activity (GO:0005035),-0.4324774796517041,-1.035117541914022,0.42369477911646586,0.7392977012029672,1.0,4/11,19.28%,TNFRSF11A;TNFRSF1B;FAS;TNFRSF10B
prerank,BMP binding (GO:0036122),-0.43803644030965583,-1.0350696093563,0.4480769230769231,0.7353538753655697,1.0,2/11,3.91%,ENG;BMPR2
prerank,ATPase regulator activity (GO:0060590),-0.3183876252865259,-1.0328919008745374,0.40315315315315314,0.7367116977600717,1.0,10/38,16.82%,FNIP2;ATP1B1;DNAJA1;BAG1;SIL1;DNAJC1;DNAJC10;ATP5IF1;PLN;DNAJB1
prerank,solute:sodium symporter activity (GO:0015370),0.37551442924443157,1.0326443028828878,0.4194831013916501,0.8166691623374148,1.0,7/27,13.39%,SLC20A2;SLC13A5;SLC34A3;SLC28A3;SLC4A9;SLC20A1;SLC5A7
prerank,thioesterase binding (GO:0031996),-0.436797579441301,-1.032142590890253,0.4215500945179584,0.7346962199436714,1.0,2/11,14.71%,RAC1;TRAF1
prerank,phosphate ion binding (GO:0042301),-0.4435785948598939,-1.032085829407118,0.43014705882352944,0.7308910774327527,1.0,5/10,36.38%,PDE2A;RPH3A;RELA;CHST14;ADSS1
prerank,phosphatidylinositol phosphate binding (GO:1901981),-0.2616466713633984,-1.0313236031315705,0.3753501400560224,0.7289010159248981,1.0,14/100,7.60%,CERT1;HIP1;CYTH3;ARAP2;MYO10;IQGAP1;ARAP3;DAB2IP;DENND1B;CLVS2;CLVS1;FERMT2;RPH3A;HIP1R
prerank,potassium channel regulator activity (GO:0015459),-0.3026043282679231,-1.031108126336761,0.3813953488372093,0.7255950290992326,1.0,12/49,17.13%,ABCC9;NEDD4L;KCNS3;FLNA;KCNAB1;WNK3;CHP1;KCNMB4;ADRB2;KCNIP2;WNK2;SGK1
prerank,5'-3' RNA polymerase activity (GO:0034062),0.3746528164949847,1.0301794023160133,0.40388349514563104,0.8185355481048552,1.0,6/27,13.81%,POLR2D;POLR2A;TENT2;POLR1F;POLR1A;POLR1D
prerank,hexosyltransferase activity (GO:0016758),0.29282314409308163,1.027705861639388,0.3932926829268293,0.8206384547588719,1.0,12/101,8.14%,B3GALT1;TMTC4;LARGE1;TMTC1;B3GNT5;A4GALT;B4GALT1;ALG6;CHSY1;HAS1;EXTL1;ALG9
prerank,carboxylic acid binding (GO:0031406),-0.31501763052638415,-1.0276085204332068,0.4170403587443946,0.7306046086916855,1.0,8/38,10.82%,NOS3;SESN3;GRM7;PSAP;GRIN3A;SESN2;GRIN1;NOS1
prerank,chloride channel inhibitor activity (GO:0019869),-0.4528297005548303,-1.0270928151116712,0.4463276836158192,0.7281867494566566,1.0,7/10,16.55%,STX7;STX1A;VTI1B;VAMP8;WNK3;CFTR;WNK2
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.3773931674494386,-1.0267139672917744,0.4381551362683438,0.7253844099658204,1.0,6/17,19.86%,PTK2B;GRIK4;GRIN3A;GRIN1;GRIA2;GRIK2
prerank,protein phosphorylated amino acid binding (GO:0045309),-0.3016292583002464,-1.024461271495488,0.4214123006833713,0.7271185135684195,1.0,11/42,20.42%,BCAR3;SHE;PLCG2;YWHAB;NCK2;CRK;SAMSN1;SHB;YES1;PIK3R3;SHC3
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),-0.3232882382132597,-1.0236052399505264,0.43013100436681223,0.725541224460498,1.0,10/35,20.56%,PTK2;FYN;PTK2B;BMX;CSK;PEAK1;STYK1;YES1;SLA;TXK
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.3792525385720665,-1.0235034837261363,0.4254473161033797,0.7219943431967906,1.0,5/18,5.04%,LTBP4;ACVRL1;ENG;BMPR2;TGFBR2
prerank,pre-mRNA binding (GO:0036002),0.3724976396606617,1.022897691640521,0.4056603773584906,0.8292739598062466,1.0,1/28,0.17%,CELF2
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),-0.381053946552001,-1.020242568420688,0.44676409185803756,0.7266773732110954,1.0,5/18,13.96%,GAS6;SERPINB9;BIRC3;RPS6KA1;MT3
prerank,sodium channel regulator activity (GO:0017080),0.34928756088909807,1.0198656341844783,0.4288256227758007,0.8326236055132429,1.0,8/37,12.39%,SNTA1;GPD1L;NEDD4;PCSK9;CAMK2D;SCN3B;PTPN3;SCN2B
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),-0.3544418500443032,-1.017665972386971,0.4195519348268839,0.7291365823798817,1.0,12/22,30.54%,DUSP16;DUSP8;DUSP3;SBF1;DUSP1;DUSP12;DUSP6;DUSP4;CDKN3;DUSP18;PPM1F;DUSP7
prerank,methylation-dependent protein binding (GO:0140034),0.3177165246846413,1.016582402444363,0.44107744107744107,0.836278002930673,1.0,14/57,16.25%,KDM7A;PYGO1;L3MBTL2;PHF8;MTF2;CBX8;CBX2;KAT8;MBTD1;RRP8;TRIM24;MORC3;PHF1;PHF2
prerank,hexosaminidase activity (GO:0015929),0.44118868095039965,1.0163836608301888,0.4449152542372881,0.8325350483249087,1.0,4/12,15.04%,CEMIP;HEXD;HYAL1;SPAM1
prerank,myosin II binding (GO:0045159),-0.44297365537468203,-1.0144015037266696,0.4573170731707317,0.733458264381634,1.0,3/10,8.16%,SHROOM4;GSN;SHROOM1
prerank,phosphatidylinositol binding (GO:0035091),-0.26294978372745675,-1.0142734413707373,0.42934782608695654,0.730005639094085,1.0,30/91,21.93%,PITPNC1;HIP1;EPB41;MCF2L;ITPR2;ESYT2;PITPNM2;SCARB1;TNFAIP8L3;DENND1B;CCDC88A;RPH3A;HIP1R;SNX16;APPL1;MTM1;WDFY3;RNF34;ITPR3;PLEKHN1;SNX1;PITPNA;PITPNB;SNAP91;THY1;MREG;SNX2;NUMA1;PLEKHF2;EXOC8
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),-0.34484171802646524,-1.0134932820696079,0.45610278372591007,0.7281924183012513,1.0,9/24,25.05%,ZDHHC14;ZDHHC15;GOLGA7;ZDHHC2;ZDHHC7;ZDHHC4;ZDHHC8;ZDHHC20;ZDHHC17
prerank,phosphatase activator activity (GO:0019211),-0.40142137561085034,-1.0134675572813654,0.4431818181818182,0.7246258579743818,1.0,7/14,24.06%,CALM1;PPP2R5C;BMP2;CALM2;PPP2R5A;CALM3;PPP1R15A
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.3743939121380445,1.0131849454252384,0.4483985765124555,0.8365749760434936,1.0,3/27,3.07%,SLC8A3;SLC41A1;SLC8A1
prerank,ubiquitin binding (GO:0043130),-0.274097061215475,-1.0122161106387106,0.4263959390862944,0.7237236483895103,1.0,25/73,22.66%,FBXO7;MVB12B;UBXN1;HSPB1;BUB3;UBAP1;FAF1;UCHL1;TOLLIP;NSFL1C;UCHL3;OTUB1;MVB12A;TOP2A;UBAP1L;RNF19B;AUP1;N4BP1;SPRTN;SHARPIN;RNF168;RBCK1;TNFAIP3;USP5;PLAA
prerank,U6 snRNA binding (GO:0017070),-0.4050950148848349,-1.0099750955478337,0.44731610337972166,0.7256601663892595,1.0,6/14,26.46%,LARP7;DDX39B;PRPF4;EIF5A;RBM22;LSM8
prerank,GABA-A receptor activity (GO:0004890),-0.3762380328968257,-1.0094153127304586,0.46360153256704983,0.7234426830275686,1.0,6/18,24.99%,GABRB3;GABRB1;GABRG3;GABRA5;GABRE;GABRG2
prerank,hyaluronic acid binding (GO:0005540),0.45534971062374957,1.0083443424374712,0.44258872651356995,0.8446252523679744,1.0,1/10,0.75%,CEMIP
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.409693362599822,-1.0057735875478842,0.46586345381526106,0.7289408332730156,1.0,5/12,13.61%,RACK1;NOD1;ATP2A3;CASP8AP2;RPS27L
prerank,filamin binding (GO:0031005),0.4459230999542986,1.0057234272251532,0.46555323590814196,0.8469517078078839,1.0,2/11,3.73%,DPYSL3;NEBL
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.41085649699831933,-1.0056550849979515,0.4473684210526316,0.7256288246919442,1.0,5/12,5.04%,LTBP4;ACVRL1;ENG;BMPR2;TGFBR2
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.26469920686687737,1.0031719474122087,0.43555555555555553,0.8491840279138683,1.0,31/181,13.03%,TCF7L2;ARNT2;RBPJ;PPARA;PRRX1;NR1I2;NCOA2;FIZ1;SETD6;TTC8;NCOA3;SMAD3;CHD4;NCOA7;RBL2;TEAD3;WWP2;PIAS1;ARNT;MED1;BBS7;PARP9;HDAC1;SMARCE1;TACC1;RXRA;CRY1;GTF2I;AR;SMARCB1;IFI27
prerank,calcium-activated potassium channel activity (GO:0015269),-0.42199949725085506,-1.0028482034546184,0.4720616570327553,0.7286480743789651,1.0,3/11,12.36%,KCNMA1;KCNMB4;KCNN2
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.38609013669813036,0.9998654355389012,0.4766355140186916,0.8534660706582672,1.0,4/21,6.94%,PDE1A;PDE7B;PDE7A;PDE5A
prerank,endopeptidase inhibitor activity (GO:0004866),0.2924158412589625,0.9995552857487922,0.43902439024390244,0.8499187989867699,1.0,7/82,3.76%,TFPI;TIMP3;ITIH2;SERPIND1;LTF;PROS1;A2ML1
prerank,protein phosphatase activator activity (GO:0072542),-0.411005386368268,-0.9988102160871383,0.482,0.7350109902465796,1.0,6/13,24.06%,CALM1;PPP2R5C;CALM2;PPP2R5A;CALM3;PPP1R15A
prerank,fibroblast growth factor receptor binding (GO:0005104),0.3911504057119401,0.997166650826647,0.47102803738317756,0.8516178443142385,1.0,5/21,14.50%,KL;FGF1;FRS2;FGF9;FGF20
prerank,four-way junction DNA binding (GO:0000400),0.4034827661002289,0.9958582250976551,0.4553191489361702,0.8506388007918746,1.0,5/17,15.10%,RAD51B;RAD51C;BLM;ABL1;WRN
prerank,SUMO transferase activity (GO:0019789),0.4072659642757912,0.9945390423869518,0.4867075664621677,0.8498604175940874,1.0,5/16,19.02%,PIAS1;MDM2;CBX4;HDAC4;PIAS3
prerank,calcium-dependent phospholipid binding (GO:0005544),-0.2889263597759583,-0.99434722023831,0.4530120481927711,0.7421689278591618,1.0,23/49,29.70%,ESYT2;MCTP1;CPNE8;RPH3A;CPNE2;CPNE3;DYSF;C2CD5;SYT10;PCLO;SYT4;PLA2G4A;CPNE9;SYT2;SYT7;SYT15;PLA2G4F;ANXA8;DOC2B;CPNE5;SYT17;SYT1;ESYT3
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.36616278794458135,0.9939906399282527,0.4732824427480916,0.8468837823123654,1.0,5/24,11.17%,OSBPL8;GSDMA;PLEKHF1;GSDMD;PLEKHA8
prerank,mannosyltransferase activity (GO:0000030),0.3807894720839372,0.9926898963742243,0.474169741697417,0.8459475606341321,1.0,5/21,9.84%,TMTC4;TMTC1;ALG2;ALG9;PIGV
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.4330230740883986,-0.9919509183823806,0.4888475836431227,0.744212729540549,1.0,4/10,24.99%,GABRG3;GABRA5;GABRE;GABRG2
prerank,titin binding (GO:0031432),0.4344109122712116,0.9884407949918745,0.49581589958158995,0.8525039547126385,1.0,3/13,11.92%,TRIM63;CAMK2D;ACTN2
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.4367399397145469,0.9869316335281446,0.48326359832635984,0.8522258991288054,1.0,1/11,0.41%,SASH1
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.36228490941389907,0.9867699893012145,0.4501915708812261,0.8484363539418155,1.0,3/26,5.56%,B3GALT1;B3GNT5;CHSY1
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),-0.344418337544932,-0.9817090503701892,0.5079681274900398,0.7648849294796027,1.0,9/22,22.29%,OTUD7A;MINDY2;ZRANB1;TAB3;FAAP20;SPRTN;RNF168;OTUD7B;TNFAIP3
prerank,delayed rectifier potassium channel activity (GO:0005251),-0.30941988325937764,-0.9805229219952186,0.4611872146118721,0.7642536640688178,1.0,7/32,11.07%,KCNQ3;KCNB2;KCNS3;KCNB1;KCNQ1;KCNA1;KCNQ5
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),-0.29807471227819815,-0.9794374887232888,0.490521327014218,0.7634923860155023,1.0,9/38,14.16%,SERPINE2;SERPINI1;SERPINF1;SERPINB9;APP;A2M;FURIN;SPINT2;SPOCK1
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),-0.319097464069817,-0.9788016388252038,0.47240618101545256,0.7614089132203116,1.0,9/32,12.14%,SLC6A6;SLC7A5;SFXN1;SLC1A1;SLC38A5;SLC3A2;SLC43A2;SLC36A1;SLC1A4
prerank,calcium channel activity (GO:0005262),0.28733653407221654,0.9767156962835746,0.4904153354632588,0.8693774220879371,1.0,8/84,7.85%,CACNA2D3;SLC24A3;CACNA1D;CACNB4;CACNG7;TMC2;CACNA2D1;MCU
prerank,receptor tyrosine kinase binding (GO:0030971),-0.27671448527128517,-0.9759305213995322,0.5106382978723404,0.7648877380488845,1.0,14/56,14.69%,GRB14;PITPNM2;PTPN14;GAS6;CBL;RACK1;NCK1;TOB1;SOCS5;CPNE3;PTPN1;DUSP3;PITPNM3;NRG3
prerank,ATP binding (GO:0005524),0.24744800322316077,0.9749089985782537,0.5155615696887687,0.8695845852136638,1.0,45/266,15.15%,PRKAG2;ATP1A2;OXSR1;KSR1;WNK4;DAPK1;CLPX;DMPK;MAP4K5;SRPK2;ABCA1;SPHK1;PTPA;SIK1;STK17B;MYO18A;TRNT1;SARS2;BLM;MYO9B;SRR;PMVK;HSPA1L;GALK1;NOL9;LATS1;ABL1;SMARCA5;ATP7B;MYH10;RTEL1;BMPR1A;PRKAG1;ABCB8;PRKACB;PPIP5K2;STK26;NIM1K;CDKL5;NLK;TAP2;PRKCI;HACL1;SIK3;MTHFS
prerank,protein homodimerization activity (GO:0042803),0.22986660418307092,0.9747887949075377,0.5439814814814815,0.8657333006509926,1.0,60/589,8.49%,MAPK4;CPQ;DPYD;NPR3;MTUS2;APPL2;FGFR2;NR2F2;KIT;NADK2;TPM1;UPB1;KMT2A;JAML;FBLN5;SNX6;LHPP;CBS;BCL2;TNNC1;HSD17B1;CRYL1;GSTM2;SOX6;TPST1;TRIM5;ALS2;IRAK2;RBPMS;ZHX2;PAFAH1B3;CRPPA;CBY1;PDGFRA;PTPA;GLIPR2;NDP;LRRK2;SNX9;EPHX2;THAP1;BNIP3;PDCD6;ACP3;HOGA1;PGRMC1;SMAD3;BLM;RPE;NR6A1;KLHL7;NRBP1;SLC30A8;MYO9B;MUC13;CSF1;ZDHHC3;SRR;ARNT;SSBP1
prerank,transcription coregulator binding (GO:0001221),0.3121625464256844,0.9742689698891266,0.4838709677419355,0.8627852900549456,1.0,10/50,12.50%,RORA;USP11;VGLL4;SMAD3;MTF2;CCNT2;PER3;CHD6;CNOT2;AR
prerank,mitogen-activated protein kinase binding (GO:0051019),-0.31824801320384116,-0.9739663879208688,0.49455337690631807,0.7660018472885056,1.0,4/29,5.66%,PTPRJ;DUSP16;GCH1;NFATC1
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.3713885585653095,0.9723981321110486,0.5085066162570888,0.863230631943524,1.0,4/23,6.94%,PDE1A;PDE7B;PDE7A;PDE5A
prerank,palmitoyltransferase activity (GO:0016409),-0.3244306412177509,-0.9710690092390922,0.5180180180180181,0.7695079814241241,1.0,11/28,27.61%,ZDHHC14;ZDHHC15;GOLGA7;ZDHHC2;ZDHHC7;HHAT;ZDHHC4;ZDHHC8;ZDHHC20;ZDHHC17;ZDHHC5
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.3500637386112041,0.9705384861284376,0.4922779922779923,0.8636903084103225,1.0,6/27,13.81%,POLR2D;POLR2A;POLR1F;POLR1A;PRIMPOL;POLR1D
prerank,cAMP binding (GO:0030552),-0.4085697336785876,-0.9698337226711695,0.526,0.76888708187474,1.0,3/11,12.59%,PDE4D;PDE2A;HCN1
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.41694751480110026,-0.9691882877274989,0.523719165085389,0.7632715927076417,1.0,2/11,8.66%,BAG1;SIL1
prerank,adenyl nucleotide binding (GO:0030554),-0.41694751480110026,-0.9691882877274989,0.523719165085389,0.7632715927076417,1.0,2/11,8.66%,BAG1;SIL1
prerank,adenyl ribonucleotide binding (GO:0032559),0.24288419599367658,0.9645679034009261,0.5464190981432361,0.8745294504633117,1.0,48/291,14.87%,PRKAG2;ATP1A2;OXSR1;KSR1;WNK4;DAPK1;PRKAG3;CLPX;DMPK;MAP4K5;SRPK2;ABCA1;SPHK1;PTPA;SIK1;STK17B;MYO18A;TRNT1;MPPED2;SARS2;BLM;RAPGEF4;MYO9B;SRR;PMVK;HSPA1L;GALK1;NOL9;LATS1;ABL1;SLC19A1;SMARCA5;ATP7B;MYH10;RTEL1;BMPR1A;PRKAG1;ABCB8;PRKACB;PPIP5K2;STK26;NIM1K;CDKL5;NLK;TAP2;PRKCI;HACL1;SIK3
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.4421513472270495,0.9619579356920795,0.5070140280561122,0.8769261677040558,1.0,2/10,8.36%,DPYSL3;DPYS
prerank,voltage-gated ion channel activity (GO:0005244),-0.37572985463136954,-0.9609286421142748,0.5331991951710262,0.779730713869699,1.0,4/14,19.59%,CACNA1E;CACNA1H;HCN1;KCND2
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),-0.31450488185200054,-0.9608576967116134,0.5190156599552572,0.7763821324320788,1.0,9/30,16.03%,GAS6;CST3;SERPINB9;BIRC3;RPS6KA1;MT3;SPOCK1;PTTG1;CARD16
prerank,NAD+ binding (GO:0070403),0.41958435184261444,0.9608135445383971,0.5053533190578159,0.8755452933108965,1.0,5/12,23.83%,CRYL1;PARP9;SIRT3;SIRT5;HADH
prerank,steroid hydroxylase activity (GO:0008395),0.39263636165456994,0.9597017575177338,0.5195071868583162,0.8741499483554764,1.0,1/16,1.11%,CYP27A1
prerank,calcium channel regulator activity (GO:0005246),0.32684442414994347,0.958999900661925,0.5109489051094891,0.8717524507247837,1.0,4/37,4.91%,ITPR1;STIM1;CACNG1;CACNG7
prerank,microtubule binding (GO:0008017),-0.22003593152129677,-0.958057779276275,0.5678571428571428,0.7797090099248453,1.0,79/222,26.90%,DNM3;MTUS1;SGIP1;STARD9;MAP1B;REEP3;REEP1;MAP4;MID1;RPS3;CLIP1;MAP6;CLIP2;CCDC88A;RP1;EML6;KIF26A;MDM1;CHP1;GAPDH;MAP1LC3B;DNM2;NAV3;APC;KIF1A;RMDN3;DNM1;WHAMM;ARHGEF2;MTCL1;TOGARAM1;GAS2L3;KIF13A;HOOK1;RCC2;CCDC66;NDE1;CCDC88C;RMDN1;TPPP;KIF21B;FHDC1;APC2;CEP295NL;KIF3B;CCDC69;GAS2L1;CDK5;CKAP5;MID2;IRAG2;HAUS6;MAPRE1;POLB;KIF15;FMR1;NUMA1;DCTN1;TTBK2;VAPA;HDAC6;KNSTRN;MAST1;SPAG5;KIFC1;MAP1A;CLASP2;SPEF1;CEP295;CAMSAP3;SAXO2;CAMSAP1;KIFC2;REEP2;KIF14;KIF1B;CETN3;EZR;NEFM
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.44315611761634643,0.9574110720223047,0.5200845665961945,0.8717767374545263,1.0,4/10,20.67%,ASH1L;NSD1;SETD2;NSD3
prerank,phosphatase inhibitor activity (GO:0019212),-0.3411808262677291,-0.9571215256529068,0.5132924335378323,0.7786157717783424,1.0,9/20,29.64%,PPME1;PPP1R2;SET;LMTK2;BOD1;MGAT5;URI1;ARPP19;SAG
prerank,low-density lipoprotein particle binding (GO:0030169),-0.35803981459596046,-0.952163483656864,0.525911708253359,0.7864386956796694,1.0,5/16,5.22%,PLTP;THBS1;SCARB1;SCARF1;STAB1
prerank,active ion transmembrane transporter activity (GO:0022853),-0.29598003510132576,-0.9510895413704636,0.5540838852097131,0.7853938022574969,1.0,14/37,18.29%,SLCO1C1;SLCO2A1;SLCO2B1;COX4I1;SLCO3A1;NDUFA4;UQCRH;COX6A1;UQCR11;COX8A;COX5A;UQCRQ;SLCO4A1;UQCRC1
prerank,platelet-derived growth factor binding (GO:0048407),0.426456116041777,0.9501018923824098,0.5317796610169492,0.8851989606228745,1.0,3/11,4.40%,PDGFRB;COL1A2;PDGFRA
prerank,pentosyltransferase activity (GO:0016763),0.3303268290111825,0.948806574864129,0.5237226277372263,0.8842006840118926,1.0,10/36,20.04%,LARGE1;LACC1;PARP4;PARP10;PARP9;UPP2;SIRT3;QPRT;TIPARP;PARP14
prerank,calcium ion transmembrane transporter activity (GO:0015085),-0.2717087135889113,-0.9481911155692877,0.5341463414634147,0.7888355586852295,1.0,20/55,20.29%,ITPR2;TRPC3;PKD1;ATP2C1;ATP2A2;ATP2A3;RYR2;SLC24A2;GRIN1;ATP2B1;PANX1;CACNB2;TRPV2;SLC24A5;TRPC1;ORAI1;TMEM165;PSEN1;ATP2B2;ATP2B4
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.32850057259450405,0.9479408074471951,0.5459272097053726,0.8822549086052779,1.0,9/38,15.95%,SNX21;PARD3;SH3PXD2B;WIPI1;PLEKHF1;ZFYVE26;SNX12;RUFY4;DENND1A
prerank,MAP kinase phosphatase activity (GO:0033549),-0.3929613251098106,-0.9439849334517003,0.5373134328358209,0.7953848275860534,1.0,7/12,30.54%,DUSP16;DUSP8;DUSP3;DUSP1;DUSP6;DUSP4;DUSP7
prerank,protein kinase C activity (GO:0004697),-0.37249505358041113,-0.9407059780892459,0.5584905660377358,0.7995513422024028,1.0,6/14,20.19%,PRKCH;PRKD3;PRKD1;PRKCE;PRKCG;PRKCD
prerank,carboxylic ester hydrolase activity (GO:0052689),0.27498736463629325,0.9400345056153386,0.5548172757475083,0.8969002453547826,1.0,9/85,7.58%,CEL;LIPA;PLA2G10;PAFAH2;PAFAH1B3;ENPP2;LIPC;H6PD;DAGLB
prerank,potassium channel activity (GO:0005267),-0.2406369001024167,-0.9397946309533894,0.589041095890411,0.7980402567553362,1.0,19/89,15.63%,KCNK5;ABCC9;KCNQ3;KCNB2;KCNMA1;KCNS3;KCNB1;GRIK4;KCNK13;KCNQ1;KCNT1;KCNMB4;KCNA1;KCNQ5;KCNN2;HCN1;TMEM38B;KCNQ2;KCNH7
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),-0.3954841290261384,-0.9397489000107193,0.5481335952848723,0.7946627704129067,1.0,5/11,25.10%,NUDT3;NUDT4;NUDT1;DCPS;NUDT16
prerank,glycine binding (GO:0016594),-0.3936065613381434,-0.9374832270576806,0.538899430740038,0.7963853267737747,1.0,7/11,31.55%,GRIN3A;GRIN1;GLRA3;GLRA1;GLDC;GNMT;GRIN2B
prerank,glucuronosyltransferase activity (GO:0015020),0.36865870935244766,0.9362711133360189,0.5485714285714286,0.9019649432912578,1.0,3/19,7.54%,LARGE1;CHSY1;EXTL1
prerank,lipoprotein particle binding (GO:0071813),-0.33665025628835804,-0.9358032400878665,0.549800796812749,0.797099196122151,1.0,7/20,12.42%,PLTP;THBS1;SCARB1;SCARF1;STAB1;CDH13;HSPD1
prerank,actinin binding (GO:0042805),0.3624873726167853,0.9338882408579405,0.5213178294573644,0.9038019557735247,1.0,3/21,4.74%,KCNA5;CSRP3;CACNA1D
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.24298856692672874,0.9321275103768787,0.6193265007320644,0.9040975299258395,1.0,29/188,13.20%,SOX5;TCF7L2;ARID5B;SMAD6;PRDM5;SOX6;TBL1XR1;ZBTB20;NFYB;ASH2L;ARID4A;BCOR;XRCC5;SMAD3;GABPB1;GABPB2;TCF12;PER3;NFYC;CREB3L2;TFAP2A;ZNF568;RXRA;SOX13;HSF1;PSPC1;AR;NONO;FOXK2
prerank,ubiquitin-specific protease binding (GO:1990381),0.3572988176084152,0.9284209645017159,0.5555555555555556,0.9091410162207002,1.0,3/19,8.17%,PRKN;PTEN;AMFR
prerank,metallocarboxypeptidase activity (GO:0004181),0.33770808702963645,0.9271574670605977,0.5277777777777778,0.9082236396040256,1.0,3/26,8.19%,AEBP1;AGBL2;CPXM1
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.37726028444373105,0.9265839782041744,0.5383064516129032,0.9056240486024889,1.0,2/15,2.14%,HS3ST3A1;HS3ST3B1
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.28290539570876516,0.9264960548011857,0.5960912052117264,0.9018709598683352,1.0,15/69,14.31%,LPGAT1;ZDHHC1;SPHK1;CERS6;CERS5;DBT;ZDHHC3;KAT8;KAT6B;CERS1;SOAT2;ESCO1;PLA2G4C;CREBBP;AWAT2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.4083887792039714,0.9244289670015784,0.5670995670995671,0.9029165192415614,1.0,1/11,1.77%,AGMAT
prerank,phosphoric diester hydrolase activity (GO:0008081),-0.29004262120794294,-0.9235964577259206,0.5867237687366167,0.8214795666278373,1.0,9/35,14.10%,GPCPD1;PLCB4;SMPD4;GDPD1;PLCB3;GDPD3;PLCXD3;PLD3;PDE11A
prerank,acyl-CoA hydrolase activity (GO:0047617),0.3674693049414765,0.9211924926150415,0.5476673427991886,0.9064638727410479,1.0,7/17,24.79%,ACOT4;ACAA2;ACOT1;ACOT11;ACOT13;ACOT6;PPT1
prerank,magnesium ion binding (GO:0000287),0.2543774779969959,0.9207067730401994,0.5963020030816641,0.9036923366042858,1.0,31/135,16.89%,OXSR1;EYA2;SRPK2;SPHK1;SIK1;TDP2;LRRK2;EPHX2;PDCD6;HMGCL;SRR;IDH2;XYLT2;LATS1;CLYBL;ABL1;RAP2A;IDH3G;FOXK2;THTPA;PRKACB;NUDT12;STK26;NIM1K;NLK;HACL1;SIK3;WRN;BRSK1;PI4K2A;XXYLT1
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.33512306710099204,0.9164361372094029,0.5677179962894249,0.909673910550745,1.0,5/27,8.48%,PPARA;PRKN;RNF217;SIAH2;RNF180
prerank,myosin binding (GO:0017022),-0.2626397914681498,-0.9144886438153077,0.6324582338902148,0.8385560352696005,1.0,11/55,12.90%,MYRIP;SHROOM4;GSN;RAB3C;NKD2;MYOC;SHROOM1;RHOA;RAB3B;LMTK2;MLPH
prerank,FMN binding (GO:0010181),-0.3953613702686857,-0.9142987280655056,0.5809716599190283,0.8354542194631224,1.0,6/11,32.68%,NOS3;NOS1;PPCDC;PNPO;POR;NOS2
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.24238957198612562,0.91409120314272,0.6354319180087847,0.9111175323530808,1.0,31/173,13.83%,AEBP1;PPARA;ZEB2;KCNIP3;MXI1;SATB1;PRDM5;ZEB1;ASCL2;ZBTB20;VSX2;ZFP90;IRF8;MXD1;ZBTB32;ZFP37;THAP1;EN1;MITF;IRX1;TFAP2A;ZBTB39;ZBTB37;ZNF177;E2F6;SOX13;HSF1;NFATC4;FOXK2;SNAI1;ZNF148
prerank,growth factor receptor binding (GO:0070851),0.2672274335539347,0.9131074713934562,0.6043613707165109,0.9095872577240136,1.0,15/95,12.50%,EFEMP1;PDGFRB;KL;FER;FAM83B;PDGFRA;PDGFD;FGF1;FRS2;IL6;VEGFB;FGF9;JAK2;TGFA;AREG
prerank,nucleotidyltransferase activity (GO:0016779),0.3572085494349166,0.9125574025266295,0.5607287449392713,0.9069537354519284,1.0,9/19,23.49%,CRPPA;TENT2;REV1;TUT1;MOCS3;TUT4;TUT7;THG1L;PAPSS1
prerank,ligand-gated cation channel activity (GO:0099094),-0.2463575630972716,-0.912264952936845,0.6583541147132169,0.8363385650287203,1.0,28/75,34.81%,KCNJ2;PTK2B;GRIK4;GRIN3A;GRIN1;KCNN2;KCNJ8;KCNJ15;GRIA2;TRPM4;GRIK2;KCNH2;CHRNB1;KCNJ6;MCOLN1;TRPM2;KCNJ16;SCNN1A;ASIC1;KCNJ10;GRIA1;GRIN2B;P2RX5;GRIK1;P2RX7;TRPM8;P2RX3;P2RX6
prerank,carboxy-lyase activity (GO:0016831),-0.31359957765437363,-0.9119547207681874,0.5961945031712473,0.8333549392375902,1.0,7/23,17.39%,DDC;AMD1;AZIN1;GAD1;PPCDC;UROD;CSAD
prerank,calcium channel inhibitor activity (GO:0019855),0.404062983101947,0.9112069231604055,0.5612244897959183,0.9061840398760382,1.0,1/11,0.79%,ITPR1
prerank,aspartic-type peptidase activity (GO:0070001),-0.3965837438665949,-0.9108379256268881,0.5836431226765799,0.8322429127169809,1.0,3/10,27.35%,CTSD;PSEN1;CTSE
prerank,tau-protein kinase activity (GO:0050321),0.35291127382249093,0.9092216889212164,0.5803212851405622,0.9069035246864375,1.0,1/20,0.39%,ROCK2
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.4012268556471334,0.9090592496816231,0.5386178861788617,0.9034795984266948,1.0,3/12,9.01%,KDM7A;PHF8;KDM3B
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.2314971469274351,0.9087192222466284,0.6707988980716253,0.9003996763021628,1.0,44/254,15.32%,TCF4;RBPJ;HLF;PPARA;HOXC4;PRRX1;MEIS1;MYBL1;SCX;NR1I2;HOXB3;NFYB;NFAT5;HOXA7;NFIB;ELF4;GMEB1;RFXAP;SMAD3;TCF12;NFIA;MITF;CEBPG;MDM2;NFYC;IRF3;TFAP2A;TFAP2B;MYB;GTF2I;AR;KLF5;HOXD4;NR1I3;FOXK2;TFDP2;MLXIP;CLOCK;SRF;HOXD8;NKRF;SOX12;BARX2;MEIS2
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.2995608246259898,0.907170274382389,0.5944055944055944,0.9002451742835843,1.0,3/46,2.72%,B3GALT1;LARGE1;B3GNT5
prerank,tRNA methyltransferase activity (GO:0008175),0.3713407559949079,0.9062124669581123,0.5812619502868069,0.8985404639035707,1.0,4/16,15.02%,TRMT9B;LCMT2;TRDMT1;THUMPD3
prerank,nuclear receptor binding (GO:0016922),0.2573011117721943,0.9051527930922293,0.640625,0.8971289270648489,1.0,21/111,11.89%,TCF7L2;BRD8;NR1I2;PPARGC1B;NCOA2;GRIP1;STAT5B;WIPI1;PRKCB;NCOA3;SMAD3;NCOA7;NSD1;MED1;LATS1;MED13;SMARCE1;TACC1;RXRA;CRY1;RNF14
prerank,nucleosomal DNA binding (GO:0031492),0.34824993311967717,0.9038813945227655,0.5970695970695971,0.8962808528030712,1.0,7/21,15.42%,RBBP4;HNRNPC;CHD4;HDAC1;SMARCE1;SMARCB1;SMARCC1
prerank,voltage-gated cation channel activity (GO:0022843),0.2623011922142546,0.9033801274237964,0.6287878787878788,0.8938030146511299,1.0,9/97,7.35%,CACNA2D3;KCNQ4;KCNA5;KCND3;CACNA1D;CACNB4;CACNG7;TMC2;CACNA2D1
prerank,adenylyltransferase activity (GO:0070566),0.33920656722151654,0.9025402081892391,0.5667311411992263,0.8921244645222783,1.0,7/21,14.43%,NMNAT2;TENT2;ABL1;TUT1;NMNAT1;FLAD1;PAPOLB
prerank,nucleotide diphosphatase activity (GO:0004551),0.3742394445939261,0.9020045878275716,0.5971943887775552,0.8896637725689455,1.0,4/14,13.82%,FHIT;NUDT13;NUDT6;NUDT12
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.4015777298538021,0.9006312049318269,0.566,0.8890657229577906,1.0,1/11,2.04%,PPP1R1A
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.3485439726065614,0.9002453706941879,0.5722326454033771,0.8863648759610646,1.0,5/21,10.07%,AKAP7;WASF1;WASF3;ARFGEF2;AKAP8L
prerank,voltage-gated potassium channel activity (GO:0005249),0.2647479641520288,0.8978495741235105,0.6313213703099511,0.8879351376188427,1.0,5/80,4.07%,KCNK2;KCNQ4;KCNA5;KCNT2;KCND3
prerank,ribonuclease P activity (GO:0004526),-0.373161367951529,-0.8951556256610923,0.6056074766355141,0.8631510510158756,1.0,7/11,34.18%,POP5;POP4;RPP21;RPP30;PRORP;POP7;RPP40
prerank,glucose transmembrane transporter activity (GO:0005355),-0.34734548072106275,-0.894848733779478,0.6164948453608248,0.8601269943439894,1.0,1/17,0.80%,SLC2A1
prerank,exonuclease activity (GO:0004527),0.30202731933133403,0.8942356582110331,0.6112903225806452,0.8921082440774689,1.0,16/46,20.63%,REXO5;APEX2;ENPP2;EXOSC8;DCLRE1B;ENPP3;ISG20L2;MRE11;APEX1;ERI1;WRN;CNOT7;REXO4;EXOSC3;PDE12;RAD50
prerank,neuropeptide receptor activity (GO:0008188),0.31795799354722526,0.8942267793602044,0.6190476190476191,0.8885735263708935,1.0,7/29,15.80%,SSTR2;KISS1R;GPR143;NTSR1;TACR3;HCRTR2;NPY2R
prerank,NF-kappaB binding (GO:0051059),-0.30671035802913166,-0.8925740390761561,0.6162046908315565,0.8616459238441339,1.0,12/24,35.87%,NFKBIA;FAF1;GSK3B;COMMD7;BRMS1;RNF25;RELA;HDAC3;HIF1AN;NPM1;CDK5RAP3;ANXA4
prerank,cysteine-type peptidase activity (GO:0008234),-0.23873494175320817,-0.8909276200008563,0.6785714285714286,0.8615490931416842,1.0,40/73,41.37%,USP38;LGMN;CTSB;CAPN2;USP29;UCHL1;USP50;USP37;CTSZ;CASP8;USP28;USP9X;USP8;ATG4A;CTSL;CTSC;OTUD7B;CASP1;USP5;OTULIN;USP49;USP33;USP2;USP10;USP9Y;BLMH;ATG4D;CTSF;USP35;ESPL1;ATG4B;CASP9;USP40;GGH;USP30;USP26;CTSO;CTSK;ATG4C;TINAGL1
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),-0.34850371298896377,-0.8900613076698528,0.6135458167330677,0.8597887750646642,1.0,6/14,22.59%,SYNJ1;MTM1;MTMR6;MTMR9;MTMR12;MTMR1
prerank,endopeptidase activator activity (GO:0061133),-0.3819411777571433,-0.8892081633526165,0.6003787878787878,0.8581568150371728,1.0,4/10,28.77%,PSME3;PSME1;VSIR;NLRC4
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.3067016973355801,-0.8888170800481168,0.6124497991967871,0.8554924026327879,1.0,5/23,8.81%,EDNRA;PLCG2;PLCB4;CHRM3;PLCB3
prerank,dynactin binding (GO:0034452),0.39362645179416345,0.8871434772243947,0.592901878914405,0.9002618763699541,1.0,3/12,13.96%,SNX6;PAFAH1B1;BICD2
prerank,ligand-gated calcium channel activity (GO:0099604),0.3508122143033546,0.8870771402046034,0.6090534979423868,0.8968582831740888,1.0,1/19,0.79%,ITPR1
prerank,G protein-coupled receptor activity (GO:0004930),0.22553963501068502,0.8841404014245411,0.715076071922545,0.8991771429927662,1.0,16/239,8.30%,ADGRV1;NPR3;LGR4;BDKRB2;ADGRL1;LPAR1;CXCR5;PDGFRB;CXCR6;LPAR2;SSTR2;ADRA1D;KISS1R;PTH2R;GPR143;F2RL2
prerank,peptide N-acetyltransferase activity (GO:0034212),0.4041451303779222,0.8841246077431509,0.579476861167002,0.8956931817237727,1.0,2/10,12.98%,NAA80;NAA60
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.37905229659981315,-0.8834355207829742,0.6446886446886447,0.8604018611814087,1.0,6/10,30.54%,DUSP16;DUSP8;DUSP1;DUSP6;DUSP4;DUSP7
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.37905229659981315,-0.8834355207829742,0.6446886446886447,0.8604018611814087,1.0,6/10,30.54%,DUSP16;DUSP8;DUSP1;DUSP6;DUSP4;DUSP7
prerank,H4 histone acetyltransferase activity (GO:0010485),0.4015731627063354,0.8820009730884982,0.5853658536585366,0.8966640697489662,1.0,5/10,21.84%,KAT8;BRCA2;NAA60;MSL3;NAA50
prerank,death domain binding (GO:0070513),-0.3638230588961313,-0.879849126104,0.626746506986028,0.8641046997453036,1.0,4/11,13.99%,RACK1;DAPL1;BCL2L1;DAP
prerank,DNA replication origin binding (GO:0003688),-0.30430612212880503,-0.8775598950238237,0.652,0.8653891650902804,1.0,10/23,33.17%,HSPD1;MCM4;MCM8;POLA1;MCM5;MCM10;ORC1;DHX9;MCM6;CDC6
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.3273313908169696,0.8775182328783283,0.6087786259541985,0.9027081252104011,1.0,4/24,11.81%,DAPK1;CAMK1D;CAMK2D;MAPKAPK2
prerank,nuclear receptor coactivator activity (GO:0030374),0.2806705588849668,0.8767218305873069,0.6236933797909407,0.9008368292079456,1.0,11/52,12.86%,BRD8;PPARGC1B;NCOA2;PRKCB;ZMIZ1;NCOA3;NCOA7;MED1;MED13;TACC1;ZMIZ2
prerank,nuclear localization sequence binding (GO:0008139),-0.32241397066594574,-0.871204659339416,0.6396588486140725,0.8745861844874642,1.0,9/18,35.08%,NFKBIA;KPNA4;KPNA3;POM121;NUP153;CABP1;TNPO2;KPNA2;IPO4
prerank,RNA polymerase binding (GO:0070063),0.3458005802505787,0.8711489451493095,0.6278586278586279,0.9092519239529951,1.0,4/18,8.59%,NEDD4;CCNT2;CCNT1;PKN2
prerank,ion channel inhibitor activity (GO:0008200),0.3043584953297034,0.8709734755970975,0.6499068901303539,0.9061237409941346,1.0,8/35,12.63%,ITPR1;WNK4;NEDD4;PCSK9;CAMK2D;SCN3B;STX8;PACSIN3
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.3374158028734203,0.8696330637987819,0.6082089552238806,0.9019302763308091,1.0,5/21,14.83%,CDK8;CDK7;CDK1;CDK15;CDK4
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.3374158028734203,0.8696330637987819,0.6082089552238806,0.9019302763308091,1.0,5/21,14.83%,CDK8;CDK7;CDK1;CDK15;CDK4
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),-0.30804490243006294,-0.8694732962971546,0.6843177189409368,0.8747034347473451,1.0,16/21,56.67%,GRIK2;CHRNB1;P2RX5;P2RX7;P2RX3;P2RX6;CHRNA9;GLRB;CHRNA5;CHRNA4;CHRNA3;P2RX1;CHRNB4;TRPV1;CHRNA1;P2RX2
prerank,ATPase activator activity (GO:0001671),-0.3122483256130647,-0.8684806497784132,0.6659793814432989,0.8732967984084686,1.0,7/20,25.93%,ATP1B1;DNAJA1;DNAJC1;DNAJC10;DNAJB1;DNAJA2;DNAJB6
prerank,voltage-gated chloride channel activity (GO:0005247),-0.3729762834186714,-0.8671144643282989,0.6388349514563106,0.872637412997109,1.0,2/10,5.60%,ANO1;CLCN5
prerank,Lys48-specific deubiquitinase activity (GO:1990380),-0.3411208546513079,-0.8670252225626127,0.6510721247563352,0.8693948392470032,1.0,3/14,5.19%,ATXN3;MINDY2;MINDY1
prerank,zinc ion binding (GO:0008270),0.21880266395102096,0.8657836525277984,0.7777777777777778,0.9063351649571876,1.0,56/293,14.67%,PAPPA;KDM7A;PRKN;UPB1;KMT2A;ZEB1;BAZ1B;RNF2;IKZF4;KDM2B;SORD;ACE;TET1;ZBTB32;NAPEPLD;ZFP37;PHF8;CXXC5;THAP1;RABIF;ENPP2;SMAD3;NPEPPS;BLM;MMP9;CHD4;BBOX1;ZKSCAN5;KDM2A;SLC30A8;SLU7;DPYS;KDM5B;TRAF7;MDM2;NSD1;ZNF8;RXRA;ENPP3;MYCBP2;PAM;KMT2B;ITGB1BP2;EEA1;CYLD;RCHY1;S100A9;SHMT1;PRIMPOL;ESCO1;TRIM24;NUDT12;KDM5C;MNAT1;GLI2;BIRC2
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.3141240996359584,0.8657288641843226,0.6145454545454545,0.9030133067503876,1.0,5/28,10.77%,MAP2K6;PRKAA2;LRRK2;TTK;RPS6KB1
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.36142952705896203,0.8650263141831445,0.5905511811023622,0.900931733367929,1.0,5/14,18.55%,DUOX2;NCF2;DUOX1;CYB5R4;AIFM1
prerank,ribonuclease P RNA binding (GO:0033204),-0.36725057890281254,-0.8615351010607427,0.6679174484052532,0.876744828591354,1.0,4/10,17.51%,POP5;POP4;RPP21;RPP30
prerank,peptidase activator activity (GO:0016504),-0.2972195415047765,-0.8548313783492574,0.6659340659340659,0.8871598837270225,1.0,8/22,24.17%,CAV1;MAL;PSME3;CASP8AP2;PSME1;PINK1;VCP;VSIR
prerank,phospholipase C activity (GO:0004629),-0.29152779832405573,-0.8545062670759423,0.6777546777546778,0.8843109138342419,1.0,5/25,8.81%,EDNRA;PLCG2;PLCB4;CHRM3;PLCB3
prerank,protein kinase C binding (GO:0005080),-0.25149327500606444,-0.8513968120527029,0.7292161520190024,0.8867956774846489,1.0,17/43,24.50%,RACK1;HSPB1;ADCY4;HDAC5;CCDC88A;CAVIN2;YWHAG;HINT1;PICK1;TOP2A;ADAM9;DSP;TIRAP;HDAC7;HDAC9;DACT2;DACT3
prerank,retinoic acid receptor binding (GO:0042974),-0.32268213063792417,-0.8505377154383615,0.6666666666666666,0.8850228382208252,1.0,4/17,16.90%,ACTN4;ARID5A;NRIP1;NR4A2
prerank,protein phosphatase 2A binding (GO:0051721),-0.2896062801410082,-0.8497861470076707,0.6829268292682927,0.882970880688594,1.0,7/23,18.21%,DAB2IP;PPME1;GRIN3A;FOXO1;MASTL;BOD1;SMG5
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.3196888998008275,0.8490843433423894,0.6543438077634011,0.9305155490725215,1.0,2/25,2.11%,PLEKHA2;ADAP2
prerank,1-phosphatidylinositol binding (GO:0005545),-0.32745006155021095,-0.8468626984119353,0.6834381551362684,0.8850773796310134,1.0,2/15,2.50%,EPB41;SCARB1
prerank,ferrous iron binding (GO:0008198),-0.3048483644932566,-0.8455211260479871,0.6762295081967213,0.8844859058798245,1.0,5/21,12.25%,FTH1;FTL;EGLN3;ISCU;EGLN2
prerank,core promoter sequence-specific DNA binding (GO:0001046),-0.27157921539561863,-0.8428805418898591,0.7019867549668874,0.8861402706251837,1.0,9/35,24.36%,FOXP1;H3-3A;PIH1D1;RRN3;ZBTB17;TAF4;KLF10;RELA;STAT1
prerank,tRNA binding (GO:0000049),-0.25501421939700947,-0.8415452609128442,0.7405764966740577,0.8852803820034003,1.0,17/43,30.10%,EEF1A1;PSTK;SARS1;SSB;RPUSD4;ALKBH8;EIF2A;DALRD3;ELP5;TRMT10C;AARS2;MRPS27;YRDC;CARS1;KARS1;PUS1;TRNAU1AP
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.34849997353007844,0.8409854249113424,0.6625766871165644,0.943091184397344,1.0,2/14,4.07%,KCNA5;KCND3
prerank,DNA polymerase binding (GO:0070182),-0.3084416391626973,-0.8342681866573349,0.6577946768060836,0.8953585118400178,1.0,2/18,2.37%,HSP90AA1;HSP90AB1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.36184906219336926,-0.8335738577427153,0.6983240223463687,0.8931129127562383,1.0,6/10,31.42%,ADARB2;GDA;CDA;ADA;DCTD;CDADC1
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.3041541850594942,-0.8334485632077134,0.7033898305084746,0.8899556878313444,1.0,11/19,35.16%,GRIK4;GABRG3;GRIK2;GABRA5;GRID2;GABRE;CHRNB1;GABRG2;GRIK1;GRID1;GABRG1
prerank,high voltage-gated calcium channel activity (GO:0008331),0.3817161529485545,0.8304854996349457,0.6534446764091858,0.9606058593270634,1.0,2/10,4.86%,CACNA1D;CACNB4
prerank,pseudouridine synthase activity (GO:0009982),-0.3315610406711008,-0.8302612483112548,0.6936416184971098,0.8922418048981863,1.0,7/13,29.60%,RPUSD4;RPUSD1;TRUB2;PUS7;PUSL1;RPUSD2;PUS1
prerank,serine-type endopeptidase activity (GO:0004252),0.2483712777716231,0.8288582704561701,0.7410852713178294,0.9602951411551374,1.0,5/80,3.79%,CORIN;KLK2;CTSH;MMP2;PCSK9
prerank,mRNA methyltransferase activity (GO:0008174),-0.34162743676631335,-0.8268747557358017,0.6971428571428572,0.8947747164924195,1.0,5/12,23.62%,TRMT61B;METTL3;CMTR2;TRMT10C;PCIF1
prerank,galactosyltransferase activity (GO:0008378),0.3681150835484335,0.8248597442583799,0.6287425149700598,0.9644494184985152,1.0,4/11,12.58%,A4GALT;B4GALT1;B3GALT6;B4GALT2
prerank,signal sequence binding (GO:0005048),-0.25207743672506744,-0.8240317577512613,0.7439293598233996,0.896347782487481,1.0,19/35,35.08%,NFKBIA;TOMM20;PEX5L;AP2M1;KCNIP2;KPNA4;AP2B1;PEX5;TIMM22;KPNA3;POM121;KDELR3;NUP153;CAT;CABP1;SEC61A2;TNPO2;KPNA2;IPO4
prerank,voltage-gated anion channel activity (GO:0008308),-0.3197455039348973,-0.823935753008247,0.704,0.8931798023322126,1.0,2/15,5.60%,ANO1;CLCN5
prerank,lysine N-methyltransferase activity (GO:0016278),0.3164168909039311,0.821070545317737,0.6871401151631478,0.9681865656247539,1.0,3/20,9.77%,SETD6;SETD7;EEF1AKMT1
prerank,kinase inhibitor activity (GO:0019210),-0.2622764103668175,-0.8196156429829738,0.7687224669603524,0.8972392549434294,1.0,12/33,30.50%,WARS1;NCK1;YWHAB;CDKN1B;SPRY4;SMCR8;PRKRIP1;CDKN1A;SOCS1;GMFB;AHSG;MAPK8IP1
prerank,endodeoxyribonuclease activity (GO:0004520),-0.29125574003875637,-0.8160443084622491,0.7296222664015904,0.9000104295070728,1.0,9/20,33.40%,RPS3;EXOG;RBBP8;APLF;EXO1;ERCC5;DNA2;DCLRE1C;FEN1
prerank,DNA secondary structure binding (GO:0000217),0.29141677517356435,0.8159304291325684,0.711864406779661,0.9745052207148271,1.0,6/31,10.44%,KMT2A;RAD51B;RAD51C;BLM;CLSPN;ABL1
prerank,carbohydrate:cation symporter activity (GO:0005402),0.36651902652629126,0.8135789115903648,0.7004310344827587,0.9753313307234218,1.0,1/11,6.09%,SLC2A10
prerank,cholesterol transfer activity (GO:0120020),-0.3016030475499243,-0.8120033329461572,0.7191235059760956,0.9034107358795666,1.0,6/16,23.65%,PLTP;GRAMD1A;STARD5;MTTP;ABCG1;NPC2
prerank,ion channel activity (GO:0005216),0.24124600601162371,0.8066226266755993,0.7933884297520661,0.9847393054353957,1.0,2/80,1.67%,TRPM3;NALCN
prerank,growth factor activity (GO:0008083),0.2425701085236765,0.8039766495274394,0.807153965785381,0.9859991447819755,1.0,12/74,12.83%,DKK1;IGF2;ARTN;FGF1;PTN;IL6;CSF1;VEGFB;FGF9;TGFA;AREG;GDNF
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",-0.30629616819910893,-0.8033785710325848,0.7353497164461248,0.91478661735778,1.0,7/16,32.08%,PIR;ALOX12;ETHE1;HGD;ADI1;ALOXE3;HAAO
prerank,microtubule motor activity (GO:0003777),0.2572291410181181,0.8020205916629427,0.7773972602739726,0.9860369692734097,1.0,5/51,7.06%,KIF13B;KIF2A;KIF6;DNAH2;KIF27
prerank,single-stranded RNA binding (GO:0003727),-0.23898642959302752,-0.8019375133831901,0.8058690744920993,0.9135843105784822,1.0,22/43,35.89%,ADARB2;HNRNPU;STRBP;SNRPC;EIF4H;IFIH1;POLR2G;EXOSC10;PTBP1;AGO3;FMR1;EIF4B;HNRNPF;TLR7;CNBP;PUS1;ZFR;JMJD6;DHX9;RBM11;HNRNPA1;TLR8
prerank,signaling receptor complex adaptor activity (GO:0030159),0.26982803145542855,0.7997307133618831,0.730909090909091,0.9866469713178116,1.0,12/38,20.28%,SORBS1;GRIP1;LRRK2;FRS2;PIK3R1;MAGI2;GAB2;AXIN1;BLNK;PTPN11;SHC1;LAT
prerank,chemokine receptor binding (GO:0042379),0.27108737607318206,0.7985159856921362,0.7615780445969125,0.985333675253105,1.0,7/35,18.01%,CXCL13;CCL19;ITCH;CCL4;CKLF;CX3CL1;CCL28
prerank,MAP kinase kinase activity (GO:0004708),0.32763413078824416,0.798364553394017,0.7131630648330058,0.9820405787693566,1.0,2/15,5.48%,MAP2K6;LRRK2
prerank,sterol transfer activity (GO:0120015),-0.29331639097806483,-0.7972294684927449,0.744,0.917533424471724,1.0,6/17,23.65%,PLTP;GRAMD1A;STARD5;MTTP;ABCG1;NPC2
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.3513712896226675,0.7970378904917502,0.7121535181236673,0.9810362734198476,1.0,6/11,25.53%,AMFR;UBE4A;PPIL2;UBE4B;UBE2K;PRPF19
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.27807504582144554,0.7930498933779047,0.7495495495495496,0.9845709479979728,1.0,5/33,8.48%,PPARA;PRKN;RNF217;SIAH2;RNF180
prerank,motor activity (GO:0003774),0.2460279796675582,0.7858987477082575,0.8191126279863481,0.9934953025961998,1.0,6/60,7.06%,KIF13B;KIF2A;KIF6;DYNC2H1;DNAH2;KIF27
prerank,ligand-gated channel activity (GO:0022834),-0.25564411721380087,-0.780079436500117,0.8260869565217391,0.9405853904182178,1.0,8/29,22.89%,GRIK4;GABRB1;GRIN3A;GRIN1;GRIA2;GRIK2;GRID2;CHRNB1
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),-0.2862497901437276,-0.7794708141155464,0.7841880341880342,0.9382120725133682,1.0,3/18,10.32%,STXBP6;BAIAP2L1;PPP1CA
prerank,adrenergic receptor binding (GO:0031690),0.31843388493482383,0.7761470250595659,0.7473684210526316,1.0,1.0,5/16,15.91%,GNAS;NEDD4;DLG4;MAGI2;GRK2
prerank,nucleotidase activity (GO:0008252),-0.29910021659550323,-0.7749157314971694,0.7917485265225933,0.9419716797405147,1.0,5/15,19.89%,NT5C2;NT5C;BPNT2;NT5E;NT5DC1
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.3180321032728191,-0.7704247445685186,0.7810077519379846,0.9450456142998158,1.0,2/12,8.61%,PAN2;CNOT6L
prerank,metalloendopeptidase inhibitor activity (GO:0008191),-0.3003059735950865,-0.7695025979443139,0.79182156133829,0.9431558815788422,1.0,7/14,26.33%,SPOCK2;NGF;SPOCK1;TIMP2;BST2;SPOCK3;TIMP1
prerank,ligand-gated ion channel activity (GO:0015276),-0.2508043712588814,-0.7689579532495654,0.8314350797266514,0.9406363077885139,1.0,8/30,22.89%,GRIK4;GABRB1;GRIN3A;GRIN1;GRIA2;GRIK2;GRID2;CHRNB1
prerank,CXCR chemokine receptor binding (GO:0045236),0.3409016464739011,0.767940783461059,0.7426160337552743,1.0,1.0,2/11,9.79%,CXCL13;ITCH
prerank,chemokine activity (GO:0008009),0.26947637379889866,0.7661389847216497,0.8072072072072072,1.0,1.0,6/31,18.01%,CXCL13;CCL19;CCL4;CKLF;CX3CL1;CCL28
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.27598244891114043,0.764842068235326,0.7781954887218046,1.0,1.0,8/29,15.86%,MGAM;HEXD;GANC;CTBS;GBA2;MOGS;PGGHG;GLA
prerank,serine-type peptidase activity (GO:0008236),0.22223411905483448,0.7621825835954398,0.8729198184568835,1.0,1.0,7/96,7.32%,CORIN;KLK2;CTSH;MMP2;PCSK9;TPP1;MMP9
prerank,carboxypeptidase activity (GO:0004180),0.2619007939208728,0.7568409013468764,0.7901234567901234,1.0,1.0,4/35,8.19%,AEBP1;SCPEP1;AGBL2;CPXM1
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.24733709323363037,0.7527422041910986,0.8380281690140845,1.0,1.0,8/44,11.77%,KMT2A;ASH2L;SETD7;SETD1A;ASH1L;NSD1;SMYD3;KMT2B
prerank,ATP hydrolysis activity (GO:0140603),-0.23427095780912047,-0.752594125723155,0.8571428571428571,0.9604164124257053,1.0,12/41,16.69%,HSP90AA1;SMCHD1;KIF26A;ABCB10;TOR1B;TOR3A;ATP2B1;CLU;ABCD2;CFTR;RUVBL1;ABCA3
prerank,protein phosphatase inhibitor activity (GO:0004864),-0.2525472316760683,-0.7522769003901204,0.8397435897435898,0.9574568649740394,1.0,7/26,20.05%,PPME1;PPP1R2;SET;PPP1R14A;LMTK2;BOD1;MGAT5
prerank,SH2 domain binding (GO:0042169),0.26499199468692847,0.7522045753077016,0.8065099457504521,1.0,1.0,8/31,16.22%,AFAP1;SH3PXD2B;ABL1;JAK2;PAG1;NLK;RUFY1;BLNK
prerank,microtubule plus-end binding (GO:0051010),0.29838903032502956,0.7511713935855833,0.7670103092783506,1.0,1.0,3/20,8.84%,STIM1;MAPRE2;PAFAH1B1
prerank,Hsp70 protein binding (GO:0030544),0.26510400630671815,0.7501131410701142,0.7797513321492007,1.0,1.0,2/31,4.20%,PRKN;HDAC8
prerank,chemoattractant activity (GO:0042056),-0.253871385959344,-0.749618771971385,0.8305084745762712,0.9574235650112007,1.0,11/26,35.25%,VEGFA;FGF7;SCG2;MIF;BMP4;CXCL10;FGF2;NTF3;VEGFC;GPNMB;CCL5
prerank,phospholipase A2 activity (GO:0004623),0.26816448689968064,0.7463217817896793,0.7894736842105263,1.0,1.0,4/26,15.33%,PLA2G10;PLA2G4B;PLA2G4C;PLA2G12A
prerank,channel activity (GO:0015267),-0.22499135450215157,-0.7461943440914177,0.8697478991596639,0.9584296596952915,1.0,11/41,23.79%,AQP4;AQP11;TMEM266;PANX1;TRPV2;MCUB;TMEM120A;SLC14A1;TRPA1;CHRNB1;BAX
prerank,calcium-release channel activity (GO:0015278),0.3032619637590347,0.7437001252131719,0.780040733197556,1.0,1.0,1/17,0.79%,ITPR1
prerank,RNA polymerase II complex binding (GO:0000993),0.25875390838613316,0.7417566417764123,0.8186813186813187,1.0,1.0,14/32,23.72%,NCOA3;RPRD1B;AGO2;RPRD2;CDC73;SCAF1;CTR9;RECQL5;ELP2;PAF1;AGO1;SUPT4H1;WAC;BRD4
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",-0.2153437859272952,-0.7415236755743968,0.9026128266033254,0.9612213004585539,1.0,15/54,23.55%,ACER3;ACER2;GLS;TGM2;HDAC5;HINT1;SIRT4;HDAC11;NIT1;HINT3;SIRT7;HDAC9;HDAC6;AMDHD2;SIRT6
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.342170411591164,0.7383497605367443,0.7595190380761523,1.0,1.0,3/10,16.01%,USP27X;CYLD;DESI2
prerank,methyl-CpG binding (GO:0008327),0.27573191991599943,0.7331914457148998,0.8026819923371648,1.0,1.0,6/22,23.33%,TET1;CXXC5;ZBTB38;CXXC4;TET3;LRWD1
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.33409130186616,0.7328536160732527,0.759656652360515,1.0,1.0,2/10,12.18%,CASP12;CFLAR
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.2834144781059777,0.7308319718402092,0.8062622309197651,1.0,1.0,3/22,8.05%,RBMS3;CPEB2;EXOSC8
prerank,protein kinase regulator activity (GO:0019887),0.21354957681943457,0.7306306751864082,0.9102564102564102,1.0,1.0,10/95,12.89%,PRKAG2;PRKAG3;MBIP;CCNT2;CCNT1;GPRC5C;PARVA;PRKAG1;CCNE1;GPRC5B
prerank,ribosomal small subunit binding (GO:0043024),-0.27499201795383726,-0.7297726354139383,0.8346456692913385,0.9720320534852901,1.0,11/17,39.25%,EIF1B;ERAL1;EIF4H;EIF1;DHX29;EIF4B;MTIF3;NME1;NPM1;PIM1;UNG
prerank,vitamin D receptor binding (GO:0042809),0.2954928787791474,0.7241229881649426,0.790224032586558,1.0,1.0,3/14,11.41%,MED1;MED13;RXRA
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.3215266571395458,0.7197319983299104,0.7723577235772358,1.0,1.0,2/11,12.98%,NAA80;NAA60
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.2981069005641419,0.7195941218889058,0.8062622309197651,1.0,1.0,3/15,13.12%,SH3PXD2B;PLEKHF1;VEPH1
prerank,neuropeptide hormone activity (GO:0005184),-0.25282832937311567,-0.7195421957680601,0.8736842105263158,0.9803637226413352,1.0,16/22,56.40%,SPX;NPY;PNOC;ADCYAP1;PENK;NMB;VIP;CRH;GAL;PPY;CALCB;UCN;NPPA;GHRH;HCRT;QRFP
prerank,NADPH binding (GO:0070402),-0.2898834901102563,-0.7185348305938957,0.8333333333333334,0.9782694945603005,1.0,3/13,15.96%,KCNAB1;LBR;QDPR
prerank,water transmembrane transporter activity (GO:0005372),0.3173564968358082,0.718349970786736,0.8179916317991632,1.0,1.0,1/11,3.58%,PDPN
prerank,sequence-specific mRNA binding (GO:1990825),-0.3103393560453066,-0.7083571223551454,0.8355640535372849,0.9864414666881256,1.0,6/10,31.95%,SSB;SHFL;FMR1;RBM24;ETF1;DHX9
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.30374220753191705,0.7079096357227304,0.8030592734225621,1.0,1.0,1/13,1.22%,SLC38A3
prerank,alpha-actinin binding (GO:0051393),0.26531783398621905,0.7050963206006585,0.8333333333333334,1.0,1.0,7/24,19.87%,KCNA5;CACNA1D;PKD2;PALLD;PDLIM5;DAG1;PKD2L1
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.21347211543051453,0.7043043234961547,0.9359605911330049,1.0,1.0,13/75,14.16%,CRYL1;EHHADH;SORD;HSD17B10;PTGR1;H6PD;BDH1;DHRS3;UGDH;DHDH;ME3;DHRS11;BDH2
prerank,phosphatidate phosphatase activity (GO:0008195),0.30340759861017225,0.7034585895880202,0.8096192384769539,1.0,1.0,1/13,1.84%,PLPP3
prerank,cyclic nucleotide binding (GO:0030551),-0.2507512394245681,-0.7032524600189249,0.8818565400843882,0.9880856041436868,1.0,4/21,14.10%,PDE4D;PDE2A;HCN1;PDE11A
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.24458022557048478,0.7017337842008374,0.8662900188323918,1.0,1.0,14/33,22.88%,NCOA3;RPRD1B;AGO2;RPRD2;CDC73;AR;CTR9;RECQL5;ELP2;PAF1;AGO1;DRAP1;SUPT4H1;WAC
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.2937572389080174,-0.7006552279182939,0.8644400785854617,0.9875114649189627,1.0,5/11,22.47%,RPS3;NEIL1;NEIL3;NTHL1;APLF
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.24582343919841929,0.6981120960780215,0.8747731397459165,1.0,1.0,6/31,17.43%,UBE2E2;UBE2L3;BIRC6;UBE2A;UBE2H;UBE2E1
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.23804172218949723,0.6923609591505675,0.886654478976234,1.0,1.0,11/35,24.48%,TRMT9B;LCMT2;TRDMT1;DUS2;DTWD1;GATC;AARS1;TARS2;ELAC2;DUS1L;GATB
prerank,antiporter activity (GO:0015297),0.2744027299689245,0.6912187070432962,0.8594059405940594,1.0,1.0,7/20,17.57%,SLC25A11;SLC35E2B;SLC35E2A;SLC35A1;CLCN4;TMEM241;SLC35D2
prerank,SUMO binding (GO:0032183),0.29657218858098816,0.690744288818715,0.8238866396761133,1.0,1.0,5/13,19.65%,USP25;SIMC1;CBX4;PML;USPL1
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.2397174206774646,0.6900690836871309,0.8859813084112149,1.0,1.0,9/34,20.67%,SETD6;SETD7;CAMKMT;EEF1AKMT1;SMYD3;N6AMT1;SETD2;SETD4;NSD3
prerank,cardiolipin binding (GO:1901612),0.3138737514495853,0.6876868065547677,0.8301075268817204,1.0,1.0,3/10,13.28%,GSDMD;GSDME;NME4
prerank,5'-nucleotidase activity (GO:0008253),-0.27738729349437397,-0.6856066259229322,0.8839458413926499,0.9989080215018525,1.0,7/13,35.22%,NT5C2;NT5C;NT5E;NT5DC1;NT5C1A;NT5DC2;NT5DC3
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.30727844789440717,0.6805366002637935,0.8387096774193549,1.0,1.0,2/11,12.18%,CASP12;CFLAR
prerank,RNA stem-loop binding (GO:0035613),0.2958392046240731,0.6787263198330985,0.8300653594771242,1.0,1.0,3/12,11.58%,RC3H2;MYH10;LARP6
prerank,nucleoside diphosphate kinase activity (GO:0004550),-0.2748242381197431,-0.6777503470802162,0.8778625954198473,1.0,1.0,9/14,46.79%,CMPK1;AK5;NME2;AK9;NME1;NME6;DTYMK;AK1;NME3
prerank,nuclease activity (GO:0004518),0.21780567817136645,0.6745928462673247,0.9336823734729494,1.0,1.0,10/52,16.83%,REXO5;RNASEL;SND1;ISG20L2;MRE11;APEX1;WRN;PARN;REXO4;RNASEH2A
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.28600360062962804,0.6735191460326023,0.8725490196078431,1.0,1.0,1/14,2.68%,CAPN9
prerank,3'-5' DNA helicase activity (GO:0043138),0.2789745169629734,0.6716560511830533,0.8441295546558705,1.0,1.0,6/16,20.57%,BLM;HELQ;WRN;MCM2;MCM7;RECQL5
prerank,ribosomal large subunit binding (GO:0043023),0.3019119842806447,0.6686452208543561,0.8590021691973969,1.0,1.0,3/11,13.46%,CPEB2;LTN1;NEMF
prerank,RNA polymerase core enzyme binding (GO:0043175),0.2325965188321148,0.6650045706439279,0.8974358974358975,1.0,1.0,13/33,22.88%,NCOA3;RPRD1B;AGO2;RPRD2;ERBB2;CDC73;CTR9;RECQL5;ELP2;PAF1;AGO1;SUPT4H1;WAC
prerank,protein phosphatase 1 binding (GO:0008157),-0.23735129282929818,-0.6633477239543035,0.9224137931034483,1.0,1.0,3/21,7.61%,PPP1R16B;AKAP11;KCNQ1
prerank,CCR chemokine receptor binding (GO:0048020),0.23990615523479958,0.6615138147681736,0.9118705035971223,1.0,1.0,3/28,10.07%,CXCL13;CCL19;CCL4
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),-0.2795333566380699,-0.6540023981471245,0.9065040650406504,1.0,1.0,4/10,30.59%,CDKN1B;CDKN1A;CDKN2D;INCA1
prerank,retinoid X receptor binding (GO:0046965),-0.2787666889413475,-0.6537127062946736,0.8864970645792564,1.0,1.0,3/11,16.90%,ARID5A;NRIP1;NR4A2
prerank,I-SMAD binding (GO:0070411),0.2810278090989368,0.6534219278918065,0.871578947368421,1.0,1.0,4/13,15.68%,SMAD6;SMAD3;AXIN1;SMAD4
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.2246721868389286,0.6533838722821391,0.9197860962566845,1.0,1.0,11/40,17.84%,METTL4;METTL8;PRMT7;DPH5;AS3MT;RRP8;LRTOMT;THUMPD3;N6AMT1;ASMT;NNMT
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.2257619561543738,0.644638928899448,0.9125874125874126,1.0,1.0,13/33,24.66%,ERI3;ERI2;DCP2;ERI1;PARN;CNOT8;CNOT7;EXOSC3;PDE12;XRN1;DIS3L;EXOSC4;DIS3
prerank,histone methyltransferase activity (GO:0042054),-0.20927113664715308,-0.6436345094219935,0.9363057324840764,1.0,1.0,12/32,34.64%,PRMT8;KMT2E;MEN1;FBL;SMYD1;EHMT2;DOT1L;EED;SUZ12;KMT5A;TTLL12;SMYD2
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.2124637258140938,-0.6430416091280247,0.9454148471615721,1.0,1.0,8/28,24.99%,GRIK4;GABRG3;GRIK2;GABRA5;GRID2;GABRE;CHRNB1;GABRG2
prerank,O-methyltransferase activity (GO:0008171),0.2877905819609844,0.6420742553704261,0.8886509635974305,1.0,1.0,3/10,17.31%,FTSJ3;LRTOMT;ASMT
prerank,gamma-tubulin binding (GO:0043015),-0.23138480072055073,-0.6412490606594567,0.93158953722334,1.0,1.0,4/21,13.52%,BLOC1S2;PAK1;GIT1;RAB11FIP5
prerank,alpha-tubulin binding (GO:0043014),-0.20835324441146463,-0.6410320710583015,0.9487750556792873,1.0,1.0,4/31,10.56%,TTLL7;FYN;EFHC2;ARL8A
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",-0.21370286747204664,-0.6403312704614095,0.9237113402061856,1.0,1.0,13/28,34.18%,POP5;POP4;RPP21;RPP30;EDC3;AGO3;PRORP;NUDT16;EXO1;POP7;DROSHA;FEN1;RPP40
prerank,endoribonuclease activity (GO:0004521),0.228029405030726,0.6386469931341765,0.9396092362344582,1.0,1.0,6/32,15.24%,RNASEL;ZC3H12B;SND1;AGO2;DICER1;NYNRIN
prerank,cysteine-type endopeptidase activity (GO:0004197),0.18846677574909057,0.6302748232822146,0.9739413680781759,1.0,1.0,8/78,8.96%,CAPN9;CTSH;USP11;CASP12;USP24;USP25;USP7;USP34
prerank,phospholipase activity (GO:0004620),0.19135343354269896,0.6291851084074883,0.9767441860465116,1.0,1.0,11/67,15.33%,PLA2G10;FAM83B;NAPEPLD;ENPP2;LIPH;LIPC;PLA2G4B;PLA2G4C;PLCL1;PLCE1;PLA2G12A
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.27037037037037037,0.6285599377170614,0.8948497854077253,1.0,1.0,12/12,72.98%,GPR88;OPN1MW;OPN1MW3;RRH;OPN4;GNAT2;OPN1SW;OPN5;RHO;ELOVL4;GPR52;OPN3
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.23558207528033454,0.6233689496219117,0.9110671936758893,1.0,1.0,10/25,25.62%,PARP4;PARP10;PARP9;SIRT3;TIPARP;PARP14;SIRT5;TNKS2;ART4;PARP2
prerank,aminopeptidase activity (GO:0004177),0.22806263461928766,0.6224594349783802,0.9372623574144486,1.0,1.0,6/26,22.21%,CTSH;NPEPPS;NAALADL1;XPNPEP3;MMP14;MMP17
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),-0.18675038536314767,-0.6204248066454346,0.9819587628865979,1.0,1.0,20/42,42.36%,CCNY;CDKN1B;CCNYL1;CCNF;CCNL2;CCNG2;CDKN1A;CDKN2D;CCNB2;CKS2;CCNQ;INCA1;CDK5R2;CCND1;CCND3;CCNA2;CKS1B;CCNB1;CCNC;CDKN2C
prerank,GABA receptor binding (GO:0050811),0.278809985627543,0.6168290723106752,0.8968421052631579,1.0,1.0,3/11,15.36%,ARFGEF2;TRAK1;TRAK2
prerank,muscle alpha-actinin binding (GO:0051371),-0.23576194012276797,-0.6152641554685927,0.9390756302521008,1.0,1.0,2/15,9.04%,PDLIM7;LDB3
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.26380292001833366,0.608095084242334,0.9298969072164949,1.0,1.0,4/12,19.01%,AGO2;EIF4E3;LARP1;GEMIN5
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),-0.257177030648557,-0.605008791405,0.9320388349514563,1.0,1.0,2/11,17.86%,HCN1;HCN2
prerank,methyltransferase activity (GO:0008168),0.19994454243320206,0.6003743274464264,0.9705372616984402,1.0,1.0,12/46,18.46%,METTL4;FTSJ3;PRMT7;EEF1AKMT1;AS3MT;RRP8;LRTOMT;METTL27;N6AMT1;ASMT;NNMT;NSUN3
prerank,mannose binding (GO:0005537),-0.2456273054200876,-0.5994671588501183,0.9204545454545454,1.0,1.0,4/12,27.68%,LMAN2;LMAN2L;CLN5;ACR
prerank,R-SMAD binding (GO:0070412),0.24716988484948835,0.5994251478978496,0.9268774703557312,1.0,1.0,6/18,20.61%,SMAD6;SMAD3;LDLRAD4;SMAD4;PMEPA1;SMAD2
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.21032523555666757,0.599116009786011,0.974169741697417,1.0,1.0,6/34,17.43%,UBE2E2;UBE2L3;BIRC6;UBE2A;UBE2H;UBE2E1
prerank,exopeptidase activity (GO:0008238),-0.1765653321890205,-0.5989866256250015,0.9904534606205251,1.0,1.0,22/50,40.35%,FAP;NAALAD2;DPP4;ACE2;CTSZ;PRCP;RCE1;ENPEP;NUDT16;LTA4H;JMJD7;DPP9;BLMH;CPB1;PM20D2;CPA2;DPEP1;KDM8;GGH;DPP10;DPEP3;DPP6
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",-0.24313958841917246,-0.5976618297190227,0.947261663286004,1.0,1.0,4/13,23.65%,SREBF2;MIF;IDI1;DDT
prerank,N-methyltransferase activity (GO:0008170),-0.21630730296899378,-0.5973274960663509,0.9529652351738241,1.0,1.0,2/20,6.67%,TFB2M;TRMT11
prerank,cGMP binding (GO:0030553),0.2715930128358657,0.59497924615473,0.9294871794871795,1.0,1.0,4/11,21.35%,PDE5A;CNGA3;CNGB3;RAPGEF2
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.2689537867531263,0.5917182195335685,0.9142259414225942,1.0,1.0,3/10,15.82%,RPE;RENBP;DSEL
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.22906852584636667,0.59016323595436,0.9509433962264151,1.0,1.0,21/21,77.12%,CHRNE;CHRNB2;ANXA9;CHRNA7;CHRFAM7A;DRD4;CHRNA2;CHRNA6;DRD1;CHRNA1;DRD5;GRM5;CHRNB3;CHRNB4;CHRNA3;CHRNG;CHRNA4;CHRNA5;GRM1;GRIA1;CHRNB1
prerank,endonuclease activity (GO:0004519),0.19196421939781044,0.5900209204910923,0.9866220735785953,1.0,1.0,10/49,16.69%,RNASEL;ZC3H12B;MBD4;SND1;AGO2;MRE11;DICER1;APEX1;NYNRIN;REXO4
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.24756051313795113,0.5893751140422145,0.9363449691991786,1.0,1.0,2/14,5.99%,RPP14;TSEN34
prerank,single-stranded DNA helicase activity (GO:0017116),-0.21610874682497253,-0.5878302897788554,0.9662698412698413,1.0,1.0,10/19,36.53%,WRNIP1;POLQ;MCM5;RFC5;DHX9;MCM6;DNA2;PIF1;HELB;RFC2
prerank,ribonuclease activity (GO:0004540),0.18888947952263782,0.5840445742299407,0.978441127694859,1.0,1.0,16/56,21.79%,RNASEL;ZC3H12B;EXOSC8;SND1;AGO2;DICER1;NYNRIN;CNOT7;RNASEH2A;EXOSC3;NOB1;SAMHD1;AGO1;PIWIL4;PPP1R8;ELAC2
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),-0.21044807971356577,-0.5783995022603301,0.9632829373650108,1.0,1.0,6/20,26.34%,EIF3F;USP50;OTUB1;USP9X;YOD1;SENP5
prerank,histone deacetylase activity (GO:0004407),-0.20806632303956935,-0.5766643870184862,0.9595959595959596,1.0,1.0,9/19,35.79%,HDAC5;HDAC11;SIRT7;HDAC9;HDAC6;SIRT6;HDAC3;MIER1;HDAC10
prerank,single-stranded telomeric DNA binding (GO:0043047),-0.24817845322240084,-0.5764456366673892,0.9453860640301318,1.0,1.0,6/11,39.92%,RPA1;TERF2IP;RPA2;HNRNPA1;TERF1;CTC1
prerank,5'-3' exonuclease activity (GO:0008409),0.24888846897440547,0.5739150540944942,0.9288537549407114,1.0,1.0,4/14,13.43%,DCLRE1A;DCLRE1B;DCP2;MRE11
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),-0.23376211207717906,-0.5693313222262576,0.9712092130518234,1.0,1.0,3/12,24.36%,H3-3A;RELA;STAT1
prerank,miRNA binding (GO:0035198),-0.18747168146466453,-0.5687005341076257,0.9887892376681614,1.0,1.0,8/30,23.63%,PUM2;YBX1;ZC3H7A;SOX2;ZC3H12A;AGO3;FMR1;ZNF346
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.24769905243246088,0.5652959172176659,0.9436008676789588,1.0,1.0,1/11,4.07%,KCND3
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.2447886497808368,0.5628330661035853,0.9373737373737374,1.0,1.0,4/12,19.67%,TENT2;TUT1;PAPOLB;PAPOLG
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),-0.23442472444620155,-0.5533986547778729,0.970703125,1.0,1.0,7/11,54.22%,CHRNB1;CHRNA9;CHRNA5;CHRNA4;CHRNA3;CHRNB4;CHRNA1
prerank,telomerase RNA binding (GO:0070034),-0.19037373300643026,-0.5500894215958794,0.974,1.0,1.0,8/22,30.96%,PINX1;HNRNPU;SMG5;EXOSC10;NHP2;SMG6;NOP10;TENT4B
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.1924414464007559,0.5496651636041021,0.9822064056939501,1.0,1.0,12/34,24.66%,ERI3;ERI2;CNOT2;ERI1;PARN;CNOT8;CNOT7;EXOSC3;PDE12;DIS3L;EXOSC4;DIS3
prerank,snRNA binding (GO:0017069),-0.16439025754537823,-0.543200160937756,1.0,1.0,1.0,8/42,20.49%,HNRNPU;LARP7;DDX39B;MEPCE;SNRPC;PRPF4;EIF5A;RBM22
prerank,damaged DNA binding (GO:0003684),0.17675127170511967,0.5383588125787075,0.9929328621908127,1.0,1.0,10/44,17.37%,DDB2;AUNIP;DCLRE1A;DCLRE1B;CUL4B;MPG;APEX1;CREBBP;RAD18;XPC
prerank,nucleobase-containing compound kinase activity (GO:0019205),-0.20574119618512238,-0.5379998645570943,0.9782608695652174,0.999451198043395,1.0,8/17,39.37%,CMPK1;CLP1;AK5;NME2;AK9;NME1;NME6;DTYMK
prerank,solute:proton symporter activity (GO:0015295),-0.2016000471756907,-0.5366741442572294,0.9731800766283525,0.9967558751066563,1.0,6/16,29.59%,SLC39A8;SLC36A1;SLC25A3;SLC2A9;SLC15A4;SLC2A13
prerank,neuropeptide receptor binding (GO:0071855),0.2346232704405985,0.5331650791442522,0.9638783269961977,1.0,1.0,2/14,11.05%,AGRP;APLN
prerank,3'-5' exonuclease activity (GO:0008408),0.17558126869253954,0.5281773096273052,0.9896907216494846,1.0,1.0,14/45,20.63%,ERI3;ERI2;TATDN1;MRE11;APEX1;ERI1;WRN;PARN;CNOT8;CNOT7;REXO4;EXOSC3;PDE12;RAD50
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.22989290811339766,0.5243470212872194,0.9541666666666667,1.0,1.0,2/11,12.51%,PRMT7;FBXO11
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.21948769462581624,0.5202041423977496,0.962671905697446,1.0,1.0,14/14,78.07%,DHRS3;RDH11;SDR16C5;ADH1A;RDH5;ADH7;ADH4;SDR9C7;HSD17B6;RDH16;DHRS9;RDH12;RDH10;AKR1A1
prerank,sulfuric ester hydrolase activity (GO:0008484),0.22746729968665605,0.5159644472866134,0.9604166666666667,1.0,1.0,4/12,21.33%,SULF1;ARSG;ARSK;GALNS
prerank,neuropeptide binding (GO:0042923),0.20412927380087592,0.5124853408364816,0.97,1.0,1.0,1/18,5.44%,SSTR2
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.21514219348358332,0.5097484061965645,0.9670103092783505,1.0,1.0,13/13,78.50%,ZGRF1;DICER1;DNASE1L3;FAN1;SLX4;DNASE1L2;DNASE1;ENDOV;DNASE1L1;FEN1;DNA2;EXO1;GEN1
prerank,deoxyribonuclease activity (GO:0004536),-0.1998493335153932,-0.5026811274358643,0.9842829076620825,1.0,1.0,1/14,3.54%,RPS3
prerank,regulatory RNA binding (GO:0061980),0.16616676432866637,0.49561206176728206,0.9910071942446043,1.0,1.0,11/38,21.92%,ZC3H7B;AGO2;DICER1;RBM10;TUT4;HNRNPA2B1;RBM4;AGO1;ELAVL1;PIWIL4;TUT7
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.19705702730693214,-0.49062025430659634,0.9899396378269618,1.0,1.0,3/13,22.90%,TRMT11;TRMT10C;METTL1
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),-0.20959226471409156,-0.48697727306437455,0.9941747572815534,0.9975187320535667,1.0,4/11,30.47%,RDH14;DHRS13;AKR1A1;RDH12
prerank,RNA cap binding (GO:0000339),0.19794222391452435,0.4849234048440974,0.9840637450199203,1.0,1.0,5/16,19.29%,AGO2;EIF4E3;LARP1;GEMIN5;LSM1
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",-0.19646086204733731,-0.47849220951315447,0.98046875,0.9956540113161574,1.0,4/12,30.07%,NDUFS7;DCXR;CBR1;NQO2
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.1754911193343331,0.4655528163836762,0.9831460674157303,1.0,1.0,8/24,22.24%,PMVK;NME4;PPIP5K2;ITPKA;AK8;IP6K2;AK4;AK3
prerank,nuclear export signal receptor activity (GO:0005049),-0.19141932434844466,-0.4601870863148346,0.9943714821763602,0.9948790010751268,1.0,6/11,44.55%,CSE1L;NUP42;XPO6;RAN;XPO1;XPO7
prerank,nuclear import signal receptor activity (GO:0061608),0.19250329628931978,0.4589346389426115,0.9878787878787879,1.0,1.0,15/15,80.77%,TNPO1;IPO9;KPNB1;TNPO3;HIKESHI;RANBP6;KPNA6;IPO5;KPNA7;KPNA1;IPO4;KPNA2;TNPO2;KPNA3;KPNA4
prerank,acetylcholine receptor activity (GO:0015464),0.17240968282012337,0.44333317068862876,0.9962264150943396,1.0,1.0,1/22,4.61%,CHRNE
prerank,aspartic-type endopeptidase activity (GO:0004190),0.1926553672316382,0.4381457678475199,0.9936575052854123,1.0,1.0,12/12,80.75%,BACE1;SPPL3;DDI2;PGC;BACE2;ASPRV1;NAPSA;SPPL2A;SPPL2B;HM13;CTSE;PSEN1
prerank,tumor necrosis factor receptor binding (GO:0005164),0.17594256539688163,0.40222066910579063,0.9958677685950413,1.0,1.0,3/12,18.36%,BABAM2;TRAP1;TRAF6
prerank,exoribonuclease activity (GO:0004532),0.1783341393846305,0.39696673457118714,0.9942196531791907,1.0,1.0,4/12,23.35%,EXOSC8;CNOT7;EXOSC3;EXOSC4
prerank,metalloaminopeptidase activity (GO:0070006),0.15572501542200567,0.3866424391241471,0.997979797979798,0.9986350154734003,1.0,4/16,22.21%,NPEPPS;XPNPEP3;MMP14;MMP17
